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1. GENERAL INTRODUCTION 
The aim of this work was to investigate the 
following aspects of the interaction of agonists and 
antagonists in amino acid-mediated transmission in the 
feline central nervous system: 
1 
(1) The 'active'· conformations of GABA and L-glutamic 
acid for interaction with their respective post-
synaptic receptors, conformations suggested by a 
study of the structure-activity relationships of 
analogues of GABA and L-glutamic acid having 
restricted conformations. 
(2) The differentiation of two distinct populations 
of excitatory amino acid postsynaptic receptors 
(L-glutamate and L-aspartate populations) by the 
use of relatively selective agonists for each type 
of receptor population. 
(3) The mechanism of action of certain neurotoxins and 
convulsants and the structure-activity relation-
ships of these substances. 
(4) The identification of new, selective antagonists 
of the postsynaptic actions of putative inhibitory 
or excitatory amino acid transmitters. 
The general introduction to this thesis thus reviews 
the present state of knowledge concerning the 'active' 
conformations of GABA and L-glutamate, and discusses the 
use of analogues of restricted conformation to analyse 
GABA, L-glutamic and L-aspartic acid receptors. Micro-
electrophoretic methods have been used extensively in the 
2 
experiments described in this thesis and in the quoted 
literature. The data obtained from this type of 
investigation must be interpreted with considerable caution 
because of the complexities of the method and the necessary 
assumptions upon which interpretations are based. For this 
reason the technique has been reviewed in parallel with the 
discussion of structure-activity relationships revealed in 
this and related investigations. 
The chemical nature of synaptic transmission in the 
mammalian central nervous system is now well accepted, and 
the interactions of transmitters, putative transmitters, 
related agonists and antagonists with their appropriate 
receptors has formed the basis of considerable pharmaco-
logical investigation. The purpose of this introduction 
is to review certain aspects of the microelectrophoretic 
use of agonists and antagonists in structu re-activity 
relationship (SAR) studies, and in studies designed to 
identify the transmitters of particular pathways in the 
mammalian central nervous system (CNS) which are believed, 
on the basis of pharmacological and neurochemical evidence, 
to be mediated by simple amino acids (see Curtis and 
Johnston, 1974a). 
Although autoradiographic techniques have become 
available for identifying and quantitating receptor areas 
on excitable membranes, for example, the mouse neuromuscular 
junction (Barnard, 1973; Barnard, Wieckowski and Chiu, 1971), 
and improved techniques have been reported for the isolation 
of a 'receptor' protein, the nicotinic cholinoceptive 
receptor protein (Heilbronn and Mattson, 1974), these 
techniques are limited and it is still not possible to 
study transmitter-receptor interaction at the atomic or 
molecular level. This problem continues to be attacked 
indirectly by studying the structure and activity of 
selected compounds, which act on a common receptor, to 
either mimic or antagonise the action of putative 
transmitters. The basic assumption in the general 
analysis of SARs is that the agonist or antagonist has a 
structure which, to some extent, is complementary to its 
receptor site on the membrane, and that progressive 
changes in the structure of the agonist or antagonist 
molecule can be correlated with changes in its pharmaco-
logical activity. The validity of this general analysis 
is challenged by at least three major problems. First, 
the neurotransmitters and many of their analogues are 
3 
small, relatively flexible, molecules and the conformations 
of these molecules, as receptor-bound species, may bear ·no 
relationship to the conformations that can be determined 
in solution or in the crystalline state. Second, there 
could be multiple modes of binding between ligand and 
receptor. Third, the differences in pharmacological 
activities of a series of analogues may also reflect 
differences in the processes that link the initial analogue-
receptor interaction with the final measured response. The 
chain of events that occurs after agonist-receptor inter-
action is only poorly understood, and hence the physiological 
response that is measured should be as closely related to 
4 
the initial interaction as possible. Despite these 
constraints, which will be considered again when specific 
examples are discussed, SAR studies have been widely 
employed in attempts to determine the molecular basis for 
neurotransmitter action. 
The use of agonists to analyse receptors 
The first attempts to analyse the structure-
activity relationships of pharmacologically active 
compounds were directed towards drugs active at acetyl-
choline receptors. Ravent6s (1937) made the first 
quantitative study of the relative potency of a series of 
quaternary ammonium salts in terms of potency in causing 
contracture of various isolated muscle preparations. 
Such isolated preparations allow a quantitative treatment 
of agonist-receptor interactions, based on the assumption 
that the agonist is uniformly distributed throughout the 
bathing fluid and tissue. In vitro preparations of the 
mammalian CNS, however, are not available for such studies, 
and the structure-activity relationship analysis must be 
conducted in vivo. The effects of various substances on 
the CNS can be observed after administering them directly 
to the tissue, for example by microinjection, or after 
indirect administration through the blood supply of the 
tissue. These methods of administration, however, are 
often unsatisfactory because of distribution problems and 
the possible longlasting and wide reaching effects of a 
systemically administered substance. Microelectrophoresis 
has been used as a means of overcoming some of these 
problems. This technique, of using an electrical current 
5 
to control the ejection of chemical substances from fine 
glass micropipettes, was first developed by Nastuk (1953) 
and del Castillo and Katz (1955) as a means of 
administering small quantities of acetylcholine to single 
muscle fibres. Curtis and R.M. Eccles (1958) later 
developed this technique using multibarrel micropipettes 
to investigate systematically neurones in the CNS. 
Microelectrophoretic considerations 
Details of the microelectrophoretic technique have 
been published by several workers (Curtis, 1964; Krnjevic, 
1964; Salmoiraghi and Weight, 1967), and the techniques 
employed by Curtis are outlined in more detail in the 
Methods section of this thesis (Section II). The main 
advantage of the microelectrophoretic method is that it 
allows small, controlled quantities of substances to be 
delivered directly into the extracellular environment of 
individual neurones in intact preparations of the CNS. 
Diffusional barriers, such as the blood brain barriers are 
by-passed, and the action of a substance ejected from a 
micropipette is restricted to a small volume of tissue 
adjacent to the tip of the micropipette. Neuronal activity 
can be recorded by means of a microelectrode adjacent to 
the micropipette used to administer substances, and 
observed alterations in neuronal activity cannot arise 
indirectly from an action upon peripheral receptors or 
other distant neurones having synaptic connections with 
the neurone under observation. The main disadvantages of 
the technique are those which arise from the use of an 
6 
electric current to eject substances which are ionised to 
varying degrees from what may be considered as point 
sources within a non-uniform medium. Changes in neuronal 
activity produced by current flow per se can usually be 
distinguished from direct drug effects (see Curtis, 1964), 
but the evaluation of the concentration of ejected agents, 
a parameter of major importance in determining the 
relative potency of agonists, presents certain difficulties. 
Since the electrical resistance of the drug-containing 
micropipette is high, compared with that of the external 
medium which lies between the pipette orifice and an 
indifferent electrode, the potential across the medium 
associated with the electrophoretic ejecting current is 
small (Curtis, Perrin and Watkins, 1960). Thus the 
movement of ejected substances within the medium is not 
significantly controlled by potential gradients across it, 
and the concentrations which are attained in the environ-
ment of the tip of the micropipette depend upon the rate 
of ejection of the agent and the nature of the external 
medium. 
The electrophoretic ejection of substances from 
solutions contained within glass micropipettes involves 
both iontophoresis and electro-osmosis. The rate of 
ejection of a fully ionised substance, by iontophoresis 
alone, is directly proportional to the current and 
transport number of the particular ion (i.e. the fraction 
of the current carried by that ion). It is not possible, 
however, to determine the actual rate of iontophoretic 
ejection by measuring the current, for the transport number 
depends upon the mobility of the ion and such factors as 
7 
the total ionic concentration, especially within and just 
outside the tip of the micropipette, and these concen-
trations can only be known approximately for an in vivo 
preparation. The determination of the total electro-
phoretic flux from the measured electrophoretic current 
is further complicated by the contribution that electro-
osmosis makes to the total flux. Attempts have been made 
to calibrate the rate of ejection of compounds for which 
there are suitable chemical, physical or biological assay 
methods (see Curtis, 1964; Krnjevic, Laverty and Sharman, 
1963; Krnjevic, Mitchel and Szerb, 1963). The in vitro 
conditions that were employed for these calibrations 
(especially the current and time of ejection) were not 
similar, however, to the in vivo experimental conditions. 
Radioisotopic techniques have been recently applied to 
this problem, and it has been possible to measure rates of 
ejection with currents and ejection periods that were 
similar to those used for the microelectrophoretic testing 
of the compounds that were radioisotopically estimated. 
Among the substances ejected, and radiosiotopically 
estimated in · vitro, the microelectrophoretic release of 
glutamate (Zieglgansberger, Herz and Teschemacher, 1969; 
Obata, Takeda and Shinozaki, 1970; Gent, Morgan and 
Wolstencroft, 1974), aspartate (Gent, Morgan and 
Wolstencroft, 1974), GABA (Obata, Takeda and Shinozaki, 
1970; Zieglgansberger, Sothmann and Herz, 1974), glycine 
(Zieglgansberger, Sothmann and Herz, 1974), and noradrena-
line (Bradley and Candy, 1970; Hoffer, Neff and Siggins, 
1971; Bradshaw, Roberts and Szabadi, 1973; Candy, Boakes, 
Key and Worton, 1974) has been shown to be directly 
8 
proportional to the ejecting current. The transport 
numbers that were calculated from these determinations, 
however, indicated that there was considerable variability 
between pipettes of the same size when tested under the 
same conditions. Thus the rate of ejection of any one 
substance may vary between different micropipettes when 
the same currents .are passed. 
Even if it is possible to estimate the amount of a 
substance that is released from a micropipette by an 
electrophoretic current, the concentration developed in 
the region of a particular neurone is still exceedingly 
difficult to predict, for the second factor upon which the 
concentration depends, the nature of the external medium 
is a very complex one. If the orifice of the micropipette 
is regarded as a continuous point source within a uniform 
medium, then the concentration at any particular distance 
from the source can be estimated using the principles of 
diffusion (for this treatment see Carslaw and Jaeger, 
1959; Curtis, Perrin and Watkins, 1960; Jaeger, 1965), 
provided the rate of ejection and the diffusion coefficients 
are known. Because of the difficulty in measuring the 
distance from the orifice to the point at which it is 
desired to know the concentration, an alternative approach 
has been to consider the micropipette orifice as an 
instantaneous point souxce in a uniform medium. Using 
this approach the theoretical concentration resulting from 
a brief electrical pulse has a peak value which can be 
calculated from the observed time to peak response, the 
9 
quantity of drug ejected and the diffusion coefficient, 
without estimating the distance from orifice to cell 
membrane (see del Castillo and Katz, 1955; Ogston, 1955). 
These calculations, however, are of limited p~actical 
value due to the complex anatomical arrangement of the 
extraneuronal space within the CNS. 
The 'extraneuronal' space into which microelectro-
phoretic ejection occurs is presumably a space which is 
larger than the extra cellular space that is seen in 
electronmicrographs, and it is partly created by the 
relatively large tip of the micropipette. The path 
between the tip of the micropipette and the true 
extraneuronal space is probably barred by tissue debris, 
glial cells and any diffusional barriers that may be 
intimately associated with the synaptic areas on neurones 
(Eccles, J.C., Eccles, R.M. and Fatt, 1956). It is 
unlikely that uniform diffusion occurs in such an environ-
ment, and hence it is unlikely that the receptors located 
upon any one neurone are subjected to a uniform 
concentration of an electrophretically ejected agent, unless 
the distance over which the receptors are distributed is 
small compared with the diffusion path. After electro-
phoretic ejection into the extracellular environment an 
ejected agent not only passively diffuses, but it may also 
interact physically or chemically with one or more 
components of the extracellular medium. It is conceivable 
that an ejected substance could be rendered pharmacologi-
cally inert by the formation of complexes with components 
of the extracellular medium, but the possible active 
uptake and enzymic modification of ejected agents that 
are similar to the neurotransmitters (Curtis, Duggan and 
Johnston, 1970), is even more likely to modify the 
concentration of an ejected agent from the theoretically 
predicted concentration. 
It is thus virtually impossible to determine the 
active concentration, at the receptor site, of an agent 
that has been ejected electrophoretically. Despite this 
problem assessment of the relative potencies of a series 
10 
of agonists can be made by using multibarrel micropipettes 
such that the orifices are located at approximately the 
same distance from a given neurone. Under the usual 
recording conditions in the CNS, the diffusion paths can 
be assumed to be very similar, provided the compounds to 
be compared act upon the same receptors. Such tests would 
then, presumably, be subjected to the same uncontrolled 
variables, provided the compounds were similar in 
behaviour regarding diffusion, uptake, binding etc. The 
only remaining systematic error arises from the assumption 
that equal rates of administration are produced by equal 
electrophoretic currents. Even using the same micropipette 
the measured relative potency of a group of agonists can 
vary by as much as 30% (Curtis and Watkins, 1963) when 
estimates are obtained on several neurones. This difference 
probably reflects variation in the relative spatial 
disposition of the neurones and the micropipette orifice, 
variation in extracellular environment and variation in 
rates of ejection. It has been reported that rates of 
ejection of isotopically labelled noradrenaline into 
saline or Ringer's solution can be either similar to 
(Candy, Boakes, Key and Worton, 1974) or differ from 
(Hoffer, Neff and Siggins, 1971) that into brain slices, 
whilst the ejection of tritium-labelled acetylcholine 
11 
in vitro agreed with the in vivo ejection rate (Bradley 
and Candy, 1970). Furthermore, in view of the variable 
amount of tissue debris that can 'cap' microelectrodes 
during penetration of central nervous tissue (Andersen and 
Curtis, 1964; Yamamoto, 1967), it is not surprising that 
the rates of ejection of isotopically labelled L-aspartate 
and L-glutamate, as measured in vitro into saline, before 
and after penetration of the feline brain stem, differed 
(Gent, Morgan and Wolstencroft, 1974). Hence it is not 
possible to make accurate, direct comparisons of 
potencies in terms of electrophoretic currents, unless the 
rates of ejection during the test can be measured. In 
practice, it is not always possible to obtain such 
measurements due to the unavailability of radioactively 
labelled compounds, or because the nature of the experiment 
does not allow tissue sampling after each estimation of 
potency. The in vivo measurement of rates of ejection are 
also questionable because the distribution volume of the 
ejected compound, or its labelled metabolites, may exceed 
the volume of tissue that is sampled for measurement. At 
present, there appears to be no way in which the problem 
of accurately determining the rate of electrophoretic 
ejection in vivo, and its relationship to extraneuronal 
concentration, can be overcome to render the technique 
12 
more quantitatively reliable. By performing a number of 
experiments with many cells, and by using different 
micropipettes in which the combination of test compounds 
is varied, an assessment can be made of the relative 
potencies of a series of substances assuming that the rates 
of ejection, and therefore the local tissue concentrations, 
are directly proportional to the electrophoretic currents 
which are used. It must be remembered, however, that any 
differences in potency that are so demonstrated may be 
partially explained by the factors discussed above, viz: 
(i) Apparent transport numbers may vary from compound 
to compound, from micropipette to micropipette 
and may not be constant for any one micropipette. 
(ii) The 'effective diffusion coefficients' of different 
substances in central nervous tissue may vary, 
similarly rates of inactivation or uptake by the 
tissue may vary and hence the volumes of tissue 
affected by ejected substances may differ. 
Consequently, for equal ejection rates different 
numbers of receptors could be affected, and by 
different concentrations of substances. 
(iii) Substances may be acting on different receptors, 
which are present in their respective tissue 
distribution volumes in different numbers. 
Alternatively, there may be any one of a number 
of functionally overlapping receptor populations. 
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For these reasons no great accuracy can be claimed 
for this comparative method. Finally, it is not possible 
to determine whether a substance is more potent in terms 
of its affinity for a receptor or its intrinsic activity 
(Ariens, 1954). Despite these limitations upon the 
microelectrophoretic method, when used for determining 
relative potencies, the information so obtained can be of 
considerable assistance in neuropharmacological studies, 
and two examples of such studies involving the excitatory 
and the inhibitory amino acid receptor will now be 
discussed. 
The excitatory amino acid receptor(s) 
Considerable neurochemical and neuropharmacological 
evidence has been collected to suggest that both L-glutamate 
and L-aspartate could be excitatory transmitters of 
afferent and efferent pathways within the mammalian CNS 
(for recent reviews see Curtis and Johnston, 1974a; 
Krnjevic, 1974). Microelectrophoretically administered 
L-glutamate and structurally related amino acids excite 
feline central neurones by a reversible depolarisation 
accompanied by an increase in membrane conductance (Curtis, 
Phillis and Watkins, 1960; Krnjevic and Schwartz, 1967; 
Ziegelgansberger and Puil, 1973a). L-Aspartate reversibly 
depolarises feline motoneurones in a manner similar to that 
of L-glutamate (Curtis, Phillis and Watkins, 1960). By 
comparing the potencies of a series of acidic amino acid 
analogues as excitants of feline neurones (Curtis and 
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Watkins, 1960; Curtis and Watkins, 1961; Curtis and 
Watkins, 1963; Crawford and Curtis, 1964; Krnjevic and 
Phillis, 1963) definitive structure-activity relationships 
concerning these excitant substances have emerged. By 
extensively modifying the chain length and the charged 
groups, and by assuming that the analogues acted on a 
common receptor, a three point receptor was hypothesised 
to account for the data (Curtis and Watkins, 1960). The 
most significant features arising from these studies are 
as follows. Excitatory activity is associated with two 
acidic (anionic) groups and one basic (cationic) group, 
the anionic groups being separated by a distance apart 
which approximates the distance between th~ a- and 
w-carboxylate groups in the glutamate and aspartate 
molecules. The cationic group is positioned close to the 
a-carboxylate (anionic) group, and it appears that the 
optimum position is a with respect to the cationic group. 
Excitatory activity was abolished if the acidic or basic 
groups were not free (that is converted to esters or 
amides), and was reduced or abolished by substitutions 
within the intermediate carbon chain or upon the amino 
group, depending upon the size, number and position of the 
substituents. N-Alkylation of aspartic acid produced a 
compound, the potency of which depended upon the size of 
the substituent and whether the parent compound was D- or 
L-aspartic acid. N-Alkylation of D- or L-glutamic acids 
produced compounds of potency approximately equal to, or 
lower than, the parent compound. The conclusions, however, 
that could be drawn from this data were restricted by the 
possible conformations that glutamic and aspartic acids 
and their ana1ogues can adopt. 
The problem of determining the conformation of a 
receptor-bound ligand has been approached from at least 
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four different directions. X-ray crystallography can be 
used to elucidate the structure of a ligand in the 
crystalline state, but the relevance of the application of 
structural data obtained for the crystal lattice to 
considerations of the conformation of a receptor-bound 
ligand can be questioned. This same criticism must arise 
from the second approach to the problem, the extrapolation 
of conformational data obtained for a ligand in solution 
by proton or neutron magnetic resonance methods. 
Partington and co-workers have used the neutron magnetic 
resonance spectra of a series of cholinergic agonists, and 
the Karplus equation, to calculate the fractional population 
of the three particular conformations, assumed to be of 
low energy, that would be found in a solution of each of 
the agonists (Partington, Feeney and Burgen, 1972). What 
appeared to be a rational use of the neutron magnetic 
resonance data, however, demonstrated no apparent 
correlation between the predominant conformation found and 
the reported activity of the agonist. A third approach to 
the problem is completely theoretical in that extended 
Hiikel theory (Hoffman, 1963) has been used to determine 
preferred conformations of agonists. Such calculations 
treat the molecules as if they were in vacuo, but 
biological processes do not occur in the conservative state, 
and hence these calculations would be more relevant if they 
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could be extended to include interaction between the 
agonist, water and functional groups of potential 
relevance to the receptor system. A fourth approach is to 
consider the activity of structurally rigid, or semirigid 
analogues of the agonist in which the number of possible 
conformations is reduced. By studying the SARs of these 
compounds, common three dimensional features may be more 
readily demonstrated in the analogues and the parent 
compound. It is obvious that an analogue of restricted 
conformation should preferably have a structure that does 
not deviate too significantly from that of the parent 
compound, for the molecular changes that produced the 
structural rigidity could also alter the pharmacological 
activity of the molecule. 
Two conformationally restricted analogues of 
glutamic acid, ibotenic and kainic acids, have been shown 
to excite central neurones (Johnston, Curtis, de Groat 
and Duggan, 1968; Shinozaki and Konishi, 1970), but the 
SARs of these and other conformationally restricted 
analogues of glutamic and aspartic acids have not been 
fully investigated. An examination of the structures of 
ibotenic acid, kainic acid and other excitant analogues 
of glutamic acid that are conformationally restricted, may 
assist in determining whether glutamate interacts with its 
receptor in a folded or extended conformation. Van Gelder 
(1971) has suggested that glutamate combines with its 
receptor in a folded conformation. His argument is based 
on the suggestion of Curtis and Watkins (Curtis and Watkins, 
1965) that L-glutamate and L-aspartate interact with the 
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same receptor, and consequently there is a high 
probability that the equivalent ionised groups should 
adopt sufficiently congruent conformations to combine with 
an identical receptor. Van Gelder supports his argument 
with the observation (Curtis and Watkins, 1965) that 
dicarboxylic acids which have four carbon chains and are 
otherwise identical to L-glutamate and L-aspartate display 
no excitant activity, and the distance between terminal 
cationic (basic) and anionic (acid) groups are in excess 
of the equivalent distance in the folded glutamate or 
aspartate molecule. The assumption, however, that 
L-glutamate and L-aspartate must have the same dimension 
between equivalent interactive groups for interaction 
with a common receptor is questionable, for an hypothetic 
receptor could undergo conformational changes to interact 
with ligands of slightly different dimensions. Further-
more, L-glutamate and L-aspartate may interact with 
different receptors, being the excitatory transmitters of 
different excitatory pathways. 
The incorporation of semirigid three dimensional 
structures into the molecules of L-glutamate and L-aspartate, 
and subsequent investigations of their pharmacological 
activities, could assist not only in elucidating their 
structure-activity relationships, but could also be of 
assistance in distinguishing aspartate-mediated from 
glutamate mediated excitatory pathways in the CNS. 
Apparent differences in the sensitivity of neurones to 
glutamate and aspartate may indicate two populations of 
receptors - one for aspartate and one for glutamate -
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(which may or may not overlap) and hence a predominance 
of one type of amino acid releasing terminal on the 
particular neurones that are being studied. For example, 
it has been reported that feline Renshaw cells are more 
sensitive to electrophoretically administered L-aspartate 
than to L-glutamate, whereas spinal dorsal horn inter-
neurones are more sensitive to L-glutamate than to 
L-aspartate (Duggan, 1974). Hence there is a differential 
sensitivity of the two types of neurones and this difference 
may indicate a greater proportion of glutamate than 
aspartate receptors on dorsal horn interneurones and the 
reverse for Renshaw cells. Furthermore, it may be 
possible to correlate the differential sensitivity of the 
two types of neurones with a predominance of one type of 
excitatory synapse on dorsal horn interneurones, and 
another type on Renshaw cells (see Section VII). 
The structural similarity and flexibility of the 
glutamate and aspartate molecules makes it conceivable 
that if there is a population of receptors for each acid, 
then there could be an overlap in the populations of the 
glutamate and aspartate receptors, in which case it may 
be difficult to demonstrate significant differences in the 
sensitivity of specific populations of neurones to these 
two excitants. The use of conformationally restricted 
analogues of these two amino acids, which interact more 
selectively with one of these receptors, could improve the 
probability of detecting such relative sensitivity 
differences. 
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The microelectrophoretic determination of the 
differential sensitivity of neurones suffers from many of 
the interpretational problems that have been previously 
outlined for the determination of differential potency of 
electrophoretically administered agents. In comparing 
the differential sensitivity of different types of 
neurones, however, the problem of different rates of 
electrophoretic ejection is reduced (see Duggan, 1974). 
In these types of experiments an approximately equal 
number of different types of neurones must be tested with 
any one micropipette, in which case the apparent transport 
numbers for the substances being ejected are expected to 
remain relatively constant, and thus should be of minor 
importance to the determination of relative sensitivity. 
In practice it is likely that the apparent transport 
numbers could alter between tests, for example if variable 
'capping' of the micropipette was occurring (Andersen and 
Curtis, 1964), or if ejection of an agonist was 
accompanied by appreciable electrical noise and changes in 
electrical resistance (Zieglgansberger, Herz and 
Teschemacher, 1969). It is also possible that the 
histological and neurochemical environments of the two cell 
types may differ sufficiently to cause either, or both, 
test substances to be treated differently in the two 
environments, resulting in different relative diffusion 
patterns and different relative volumes of tissue being 
affected by the ejected substances. If the receptors are 
located only postsynaptically, and if the distribution 
of the relevant types of synapses can be histologically 
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or physiologically determined, the difference in observed 
sensitivity may be explained by a difference in the 
distribution of the receptors relative to the tissue 
distribution volumes of the ejected substances. In 
addition, either test substance could have a different 
affinity for or different intrinsic activity (Ariens, 1954) 
at receptors on different types of neurones, and because 
of the present inability to determine the concentration of 
ejected substance at the active site, it is not possible 
to calculate these parameters. It is also not possible, 
at present, to determine whether the diffusion, uptake or 
physical inactivation of ejected substances differs 
between two types of neuronal environments in the CNS. 
The final explanation for the observation of different 
relative sensitivities, that the two cell types have 
different relative proportions of receptors, can thus only 
be used to support additional neurochemical or pharmaco-
logical evidence that indicates a predominance of one type 
of synapse on the cells in question. 
The inhibitory amino acid receptor 
There are now reasonable grounds for considering 
glycine and garnrna-aminobutyric acid (GABA) as transmitters 
mediating certain inhibitions in the mammalian CNS (see 
Curtis and Johnston, 1974a; Krnjevic, 1974). In this 
section, however, the emphasis will be placed on GABA and 
its receptor, an aspect that is further investigated in 
this thesis. GABA depresses the firing of neurones 
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throughout the mammalian CNS, and hyperpolarisation of 
the neuronal membrane with an increase in conductance has 
been demonstrated in spinal and supraspinal regions of the 
feline CNS (Curtis and Johnston, 1974a; Krnjevic, 1974). 
From a comparison of the electrophoretic potency of a 
series of GABA analogues (Crawford and Curtis, 1964; 
Curtis and Watkins, 1960, 1961, 1965; Krnjevic and Phillis, 
1963) the following general requirements for depressant 
activity have been reported. Depressant activity is 
associated with amino acids containing one acidic (COOH, 
SOOH or SOOOH) and one basic group (NH 3). An excitatory 
amino acid can be converted to an approximately equi-
potent depressant amino acid by a-decarboxylation. The 
optimum separation of the basic and acidic groups is two 
or three carbon atoms, if the amino group, however, is 
substituted by a guanidino group the chain must be some-
what shortened. Substituents on carbon atoms within the 
chain, or on the nitrogen atom, reduce or abolish 
depressant activity according to their position, size and 
number. The acidic and basic groups must be free. 
The GABA molecule, like many of its analogues, 
. 
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flexible and hence, as with glutamate, there is considerable 
difficulty in determining its conformation when in the 
receptor-bound state. X-ray diffraction methods have been 
used to determine the structure of GABA (Tomita, 1971; 
Steward, Player, Quilliam, Brown, and Pringle, 1971; 
Warner, Player and Steward, 1973), the results of which 
reveal a partially folded molecule with nitrogen-oxygen 
distances of about 4.2 and 5.75 i. This conformation, 
within the crystal state where each molecule is 
influenced by crystal packing forces, may also be of 
importance when GABA is in close association with the 
receptor and again inter-molecular forces are present. 
Molecular orbital calculations, however, have predicted 
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a fully extended conformation. Kier and Truit (1970) used 
extended Ruckel theory (Hoffman, 1963) in which the 
conformation associated with the lowest calculated energy 
is predicted to be the preferred conformation, and the 
results suggested that the preferred GABA conformation was 
fully extended with nitrogen to oxygen distances of 5.0 
0 
to 6.1 A. Similar calculations have been performed for 
the GABA analogue S-hydroxy GABA (Kier and George, 1973) 
and two equivalent conformational preferences were 
predicted. The first preference had an oxygen to nitrogen 
distance that was identical to that found for GABA using 
molecular orbital calculations (i.e. fully extended 
conformation) whilst the second preference resembled that 
found for GABA in the crystal lattice (i.e. partially 
folded conformation). Proton magnetic resonance studies 
have favoured the extended conformation of GABA in 
solution (Parry, Jones, Roberts and Ahmed, 1971). Pullman 
and Berthod (1974) have recently applied quantum mechanical 
procedures (PCILO and SCF) to calculate the preferred 
conformations of the isolated GABA molecule. These 
calculations (see Pullman and Berthod, 1974) suggest that 
partially folded conformations of GABA are the energetically 
favourable ones. 
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The SARs of two conformationally restricted 
analogues of GABA have also been investigated. Muscimol, 
an isoxazole betaine, depresses the firing rate of 
spinal neurones (Johnston, Curtis, de Groat and Duggan, 
1968) and this depressant action is reduced by the GABA 
antagonist bicuculline (Curtis, Duggan, Felix and 
Johnston, 1971), hence muscimol probably exerts its effect 
by an interaction with the same receptors that subserve 
the depressant action of GABA. Muscimol has been 
classified as "GABA-like" (see Section III) on the basis 
of its structural resemblance to GABA, the sensitivity of 
its depressant action to bicucilline, and because the 
glycine antagonist, strychnine, in concentrations 
sufficient to block the depressant action of glycine does 
not antagonise the depressant action of muscimol (Johnston, 
Curtis, de Groat and Duggan, 1968). (Strychnine and 
bicuculline are discussed later in Section I.) Muscimol 
and GABA have similar potencies as neuronal depressants 
(Johnston, Curtis, de Groat and Duggan, 1968), and there 
is good agreement between the crystal conformation data 
for muscimol (Brehm, Hjeds and Krogsgaard-Larsen, 1972) 
and GABA (Warner, Player and Steward, 1973) (both 
conformations being partially folded), and the GABA 
structure predicted by molecular orbital calculations 
(Kier and Truit, 1970). The bicuculline-sensitive 
depressant activity of 4-aminotetrolic acid (4-aminobut-2 -
ynoic acid) (Beart, Curtis and Johnston, 1971), however, 
suggests that the active conformation of GABA is an 
extended conformer. Within the 4-aminotetrolic acid 
molecule the linear demands of the triple bond prevent the 
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molecule from folding, and fix the four carbon atoms such 
that the charged centres are separated by 5.2 to 5.8 R. 
4-Arninotetrolic acid is less potent than GABA, but there 
could be several features of the molecular structure other 
than the extended conformation, that are responsible for 
the potency being less than that of GABA. Thus although 
the SARs of 4-aminotetrolic acid provided evidence for 
the extended conformation of GABA being the active 
conformer there is no agreement amongst the available 
evidence for GABA and its analogues on this point, and 
additional compounds, particularly of restricted con-
formation, need to be investigated. Additional evidence 
has also been obtained from SAR studies involving GABA 
antagonists. 
The use of antagonists to analyse receptors 
Although antagonists of peripheral neurotransmitters 
have been known and extensively studied for many years, it 
is only in recent years that specific and effective 
antagonists of putative central transmitters have been 
discovered. A pharmacological and physiological 
investigation of any nervous system must be severely 
limited if suitable antagonists are not available to 
provide additional evidence regarding the identity of a 
transmitter involved in a particular pathway, to provide 
SAR information, and to provide information on the 
mechanism of action of centrally acting compounds. For 
these purposes a suitable antagonist must display a high 
degree of substrate and process selectivity, and reversi-
bility. The ideal antagonist should interfere 
reversibly with one of the following transmission processes: 
transmitter synthesis, release, postsynaptic action and 
inactivation. In theory there are other mechanisms of 
interference with the transmission process, but it is 
unlikely that they would be specific and hence of 
pharmacological value. 
There are few substances which will selectively 
interfere with the synthesis or release of a particular 
transmitter, and thus there have been few investigations 
of this type conducted in the CNS. Electrophoretically 
administered hemicholinium III, however, has been shown 
to selectively block the cholinergic synaptic excitation 
of Renshaw cells in the feline spinal cord (Quastel and 
Curtis, 1965), apparently by a progressive reduction in 
the amount of transmitter release. Recent experiments 
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with tetanus toxin have demonstrated that it reduces the 
release of both glycine and GABA from electrically 
stimulated synaptosomal preparations isolated from spinal 
tissue of mice treated with tetanus toxin (Osborne, Bradford 
and Jones, 1973), and in vivo experiments indicated that 
microinjected tetanus toxin reduces the synaptic release 
of both GABA and glycine (Curtis, Felix, Game and 
McCulloch, 1973). Hence this toxin would be of no use in 
distinguishing between GABA releasing and glycine 
releasing terminals. 
Attempts at selectively antagonising the post-
synaptic action of putative transmitters have been more 
successful than the attempts to antagonise synthesis or 
release, and in particular, microelectrophoretic 
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experiments utilising post-synaptic antagonists of glycine 
and GABA have provided valuable pharmacological information 
for the tentative identification of transmitters and for 
SAR studies. 
Microelectrophoretic considerations 
In the previous discussion of the microelectro-
phoretic administration of agonists it was noted that a 
neurone under test was subjected to a non-uniform distri-
bution of an ejected agent. This non-uniform distribution 
raises several difficulties in determining the degree of 
selectivity and the type of antagonism displayed by a 
potential antagonist, for the classical sigmoid dose-
response curves are derived under conditions where a finite 
number of receptors are exposed to uniformly distributed 
agonists and antagonists. Thus the parallel shift in 
equilibrium dose-response curves due to successive 
increases in the rate of ejection of an antagonist, may be 
explained on the basis of a different population of 
receptors being occupied by the antagonist, compared with 
the population that is accessible to the ejected agonist. 
These two populations may be functionally the same, but 
they have different distribution patterns. For this reason 
an agonist may appear to surmount the influence of an 
antagonist because with increasing rates of ejection it 
gains access to more receptors remote from the ejecting 
micropipette which are unaffected by the antagonist, and 
a dose-response curve may then be displaced in a parallel 
fashion even in the presence of a non-competitive 
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antagonist, until all receptors on a neurone are affected 
by the agonist (see Curtis, Duggan and Johnston, 1971). 
A further complication arising from increasing the rate of 
ejection of a non-uniformly distributed antagonist is that 
the concentration of the antagonist may reach relatively 
high levels at membrane areas close to the micropipette 
orifice at which non-specific effects of the antagonist 
begin to complicate the agonist-antagonist interaction. 
Obviously, with such non-uniform distribution of agents, 
the location of the relevant receptors on a particular 
neurone is of importance in determining agonist-antagonist 
interactions. Thus an agonist may appear to be unaffected 
by another substance because the accessible receptors for 
the agonist lie beyond the volume of tissue affected by 
the potential antagoraist, and increasing the rate of 
ejection of the potential antagonist could, as previously 
noted, produce non-specific effects at the membrane regions 
of relatively high antagonist concentrations. In comparing 
the sensitivity of different agonists to a given antagonist 
it is at present necessary to assume that the appropriate 
receptors are similarly distributed in relation to the 
orifices of the multibarrel micropipette from which the 
compounds are ejected. 
It would seem likely that some of the problems of 
studying agonist-antagonist interactions in the CNS could 
be overcome by systemic administration of the antagonist. 
Many antagonist, however, do not readily penetrate blood-
brain barriers. Furthermore, after systemic administration 
of an antagonist the concentration in the extracellular 
environment of a neurone is not accurately known, unless 
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it is measured, although an approximate concentration can 
be determined by assuming uniform distribution throughout 
total body water. There are technical and other limitations 
on the amount of a substance that can be given systemically. 
For example, if an antagonist of inhibitory transmitters 
is administered systemically, the firing behaviour and 
excitability of a neurone under test could be altered by 
changes in synaptic inputs to the neurone, and hence a limit 
is imposed on the amount of antagonist that can be systemic-
ally administered. Under certain conditions the maximum 
concentration of antagonist attained by systemic 
administration may not be sufficient to antagonise the 
localised concentration of an electrophoretically 
administered agonist, although antagonism is demonstrated 
when they are both ejected from a multibarrel micropipette. 
A somewhat related concentration problem is that which may 
be observed when an electrophoretically administered 
antagonist does not attain sufficient local concentration, 
and distribution parameters, to influence a particular 
synaptic input to a neurone that is under investigation. 
In such a case systemic administration may achieve the 
required concentration and distribution, but complex 
changes brought about in the pathway being tested or in 
related pathways could prevent a definitive result being 
obtained. 
29 
Hill and Simmonds (1973) have proposed the use 
of time-response curves as an alternative to dose-response 
curves constructed from equilibrium responses. From what 
has been discussed above regarding the microelectrophoretic 
administration of agonists and antagonists it is quite 
clear that there is a complex relationship between the 
rate of drug ejection and the time course of its concentration 
at any one point in the tissue, and equilibrium conditions 
may take many seconds to be established (Curtis, Perrin and 
Watkins, 1960). It is thus difficult to interpret and 
compare non-equilibrium type responses, the magnitude of 
such a response being critically dependent upon the time 
of ejection. If sufficient time is allowed, the rate of 
ejection of a substance from a micropipette becomes 
constant and a steady state concentration gradient develops 
from the tip of the micropipette in a radial direction. 
Under these equilibrium conditions the concentration at a 
given distance from the orifice of the micropipette is 
directly related to the ejecting current, and inversely 
related to the distance. The distance is of minor 
importance when comparisons are made of the relative 
potencies of substances, ejected from the adjacent barrels 
of a multibarrel micropipette, on the one neurone, provided 
the substances interact with the same receptors. In the 
absence of a direct measure of concentration, the ejecting 
current must be used to compare the electrophoretically 
administered 'doses'. Steady state responses are 
approximately constant, readily reproducible and maximum 
for a given rate of ejection. Comparison of non-equilibrium 
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responses can produce apparent differences in potency that 
are not observed with equilibrium responses. Such apparent 
potency differences may reflect different rates of increase 
of concentration at the receptor sites, a variable that 
needs to be dissociated from estimations of relative 
potency. 
The rate of onset of the effects of an excitant or 
depressant is invariably reduced when an appropriate 
antagonist is simultaneously administered. This reduced 
rate of onset, which may in part be explained by the 
additional time required for an agonist to attain an 
effective concentration at receptor sites distal to those 
blocked by the antagonist, has been employed by Hill, 
Simmonds and Straughan (1973a,b) to compare the effective-
ness of depressant amino acid antagonists. Their method 
entails estimating the time (TSO), from a time-response 
curve, for a control ejection of an agonist to depress the 
firing rate of a neurone to SO%, and any change in this 
response which is subsequently caused by an ejected 
antagonist is then expressed as a proportion of the control 
TSO value. The change in the TSO value is said to represent 
a displacement of the time-response curve and hence can be 
used to compare the effectiveness of depressant amino acid 
antagonists (see Hill and Simmonds, 1973; Simmonds, 1974). 
This method of comparison appears to offer no advantage 
over that based on a comparison of equilibrium responses, 
a method which does not make use of parameters that are 
derived directly from the complex, and poorly understood, 
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initial phase of a response to an electrophoretically 
administered agent. Furthermore, some of the conclusions 
drawn f~om comparisons using time-response curves appear 
to be at variance with the findings of other investigators. 
For example, the reports that bicuculline is a weak GABA 
antagonist, capable of 'potentiating' GABA, (Hill and 
Simmonds, 1973; Hill, Simmonds and Straughan, 1973b; 
Straughan, Neal, Simmonds, Collins and Hill, 1971) can be 
contrasted with the numerous reports quoted by Curtis and 
Johnston (1974b) that bicuculline selectively antagonises 
GABA, and synaptic inhibitions believed to be mediated by 
GABA, in various regions of the feline CNS. 
That the microelectrophoretic method · has produced 
results that are apparently at variance is indicative of 
the technical and interpretational difficulties of this 
complicated technique which has perhaps been too readily 
undertaken by those unaware of its complexities. As 
discussed above, the method is at present not amenable to 
exact quantitation, and the results of investigations 
utilising microelectrophoresis must be viewed in this light. 
Unfortunately, the investigation of SARs, which is essential 
for expansion of pharmacological information concerning 
the CNS, necessitates a quantitative approach. The 
application of microelectrophoresis, in its present form, 
to SAR studies is time consuming, and it is obvious that 
the problems that need to be solved before the technique 
can be rendered more quantitative will in themselves 
require considerable time, concentrated effort and acquired 
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expertise. In the meantime, a compromise needs to be made 
between quantitative reliability and the demand for 
structure-activity data, even if it is of a semi-
quantitative nature. 
Structure-activity relationships involving antagonists 
SAR studies that are similar to those described 
for agonists have also been carried out for antagonists 
as a means of determining the macromolecular structure and 
function of the sites at which agonists and antagonists 
interact. Again, systematic structural variation 
accompanied by biological testing can reveal trends which 
influence activity, if it is assumed that receptor affinity 
depends upon specific structural features which are common 
to both agonist and antagonist molecules. It is possible, 
however, to note examples of antagonists that have only a 
distant structural relationship to the parent agonist 
molecule. For example, the rather diverse collection of 
molecular structures which have been reported to be 
antagonists of noradrenergic a-receptor mediated responses 
could not all be expected to relate to the site of 
catecholamine interaction at the a-receptor. It is highly 
probable that their SARs refer to some other site(s) at 
which modulation of some stage(s) in the post receptor-
agonist interaction sequence occurs. Monod, Changeaux and 
Jacob (1963) have indicated in their discussion of 
allosteric proteins that the concept of competitive 
interaction between agonist and antagonist does not 
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necessarily imply physical competition for the same 
binding site. Hence an antagonist could either directly, 
or allosterically influence agonist-receptor interaction, 
or a subsequent process, and the number of potential sites 
of antagonist interaction could thus be quite large. For 
this reason an investigation of the SARs of antagonists 
that are not specific or do not have a common and obvious 
structural resemblance to the parent agonist may be of 
doubtful value in providing information about the agonist 
receptor. 
Specific antagonists of the inhibitory amino acid 
transmitters, GABA and glycine, have been discovered, and 
some SAR data for these antagonists are available. 
The GABA receptor 
Bicuculline and picrotoxinin have been accepted 
as central GABA antagonists (see Curtis and Johnston, 
1974a, b; Krnjevic, 1974 and Section IV), and, unlike GABA 
and its active analogues, the molecules of these two 
antagonists are relatively inflexible. Hence it may thus 
be easier to identify a common three dimensional pattern 
of functional groups required for interaction with GABA 
receptors. Data are available on the crystal structures 
of bicuculline and picrotoxinin, and in addition, molecular 
orbital calculations have been performed for the bicuculline 
molecule, although the relative rigidity of this molecule 
tends to ensure that the crystal data and the molecular 
orbital calculations produce similar results. 
34 
It would be expected that picrotoxinin and 
bicuculline have a charged cationic centre at a certain 
distance from a carboxyl anionic centre or a lactone ring 
in order to combine with the GABA receptor. The cationic 
centre in the bicuculline molecule is the nitrogen atom, 
and two of the three methyl groups in the picrotoxinin 
molecule are likely to be partially charged. Craven (1962) 
has reported that in the crystal structure of 
al-picrotoxinin hydrobromide one methyl group participates 
in hydrogen bonding to the bromine atom, whilst Jerslev 
and co-workers (Jerslev, Ravn-Jonsen and Danielsen, 1968) 
have reported that in S-picrotoxinin hydrobromide a second 
methyl group forms a similar hydrogen bond. Thus with 
the two lactone rings there is a total of four possible 
charge arrangements of importance in the picrotoxinin 
molecule. A close agreement has been reported between 
the crystal structures of GABA, muscimol and bicuculline 
(Warner, Player and Steward, 1973), indicating that they 
may all adopt conformations giving similar distributions 
of charge centres. 
It was suggested, from a study of Drieding stereo-
models of GABA, muscimol and bicuculline, that the nitrogen 
atoms and the three atom grouping of the carboxylate 
GABA (O=C-0) in an extended conformation, or the 
. in 
equivalent in muscimol (N=C-0), can be exactly isosteric 
with the nitrogen atom and the O=C-C grouping in 
bicuculline (Curtis, Duggan, Felix and Johnston, 1970; 
Johnston and Curtis, 1973). In a similar manner it has 
been shown that when the carboxylate group of 4-amino-
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tetrolic acid is superimposed on the C-C=O grouping in 
bicuculline the nitrogen atoms in each molecule can be 
within 0.5 R of each other (Beart, Curtis and Johnston, 
1971). An alternative model of GABA-bicuculline antagonism 
(Steward, Player, Quilliam, Brown and Pringle, 1971; 
Steward, Player and Warner, 1973) is based on the carboxy-
late group of a partially folded conformation of GABA 
being isosteric with the 0-C=O grouping in bicuculline, 
but 4-aminotetrolic acid cannot assume the folded 
conformation required by this model. 
It is apparent that a large number of GABA 
antagonists and agonists need to be considered before any 
significant SARs may emerge, and at this stage it seems 
to be too early to speculate on a 'recognition' conformation 
that is available to all active GABA analogues and 
antagonists, and a second 'active' conformation that is 
only available to GABA agonists (Warner, Player and 
Steward, 1973). Despite the early stage of development 
of GABA SARs, Smythies (1971, 1974) has developed an 
hypothetical three dimensional GABA receptor from a 
knowledge of the molecular structure of GABA, 
picrotoxinin and bicuculline, and the model has 
successfully predicted, on the basis of molecular 
complementarity to the simple protein structure of the 
receptor, that a number of known convulsant poisons act 
by competitive antagonism at the GABA receptor. 
The glycine receptor 
At a number of sites within the mammalian CNS 
strychnine is a reversible and selective antagonist of 
the inhibitory action of glycine (see Curtis and 
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Johnston, 1974a, b), and the antagonism appears to be 
competitive in type (Johnson, Roberts and Straughan, 1970; 
Curtis, Duggan and Johnston, 1971). A very large number 
of compounds have been shown to suppress spinal inhibition 
of the strychnine sensitive type, and to antagonise the 
effects of glycine when administered electrophoretically. 
The structures of these glycine antagonists vary 
considerably from strychnine-like, such as brucine (Curtis, 
Hosli and Johnston, 1968), to bicuculline-like, such as 
laudanosine (Curtis, Duggan, Felix and Johnston, 1971), 
or picrotoxinin-like, such as dendrobine (Curtis, Duggan, 
Felix and Johnston, 1971). Because of the wide variety 
of structures that display the property of glycine 
antagonism it is difficult to identify common conformational 
elements that may be responsible for this property, and 
hence knowledge of these structures has not helped greatly 
in analysing the glycine receptor. It is conceivable that 
the glycine antagonists may act at several different sites 
either at or in the vicinity of the glycine receptor . 
Nevertheless, Smythies (1971, 1974) has used the structures 
of glycine and strychnine to construct an hypothetical 
glycine receptor which accommodates many of the known 
glycine antagonists, and predicts that several compounds 
owe their convulsant activities to blockade of the 
glycine receptor. Srnythies hypothesis speculates on the 
actual three dimensional nature of the glycine receptor, 
and as such it can only be tested by satisfying the 
available SAR data and predicting the activity of new 
compounds. 
In view of the apparently diverse molecular 
structures that display glycine antagonism it would seem 
that a profitable line of approach may be the extension 
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of the work by Young and Snyder (1973), who have reported 
the binding of tritiated strychnine to, membrane fractions 
of rat brain stern and spinal cord tissue. The binding 
was competitive with glycine-like amino acids, and of 
the subcellular fractions examined, the highest specific 
strychnine binding activity occurred in the synaptic-
membrane fraction, suggesting that the binding sites were 
concentrated on postsynaptic glycine receptors. Extension 
of this work may lead to isolation of the glycine 
'receptor', in which case a direct examination of the 
'receptor' could possibly be undertaken. 
Antagonism of transmitter inactivation 
Synaptically released transmitters or electro-
phoretically administered putative transmitters and their 
analogues could be removed from the receptor environment 
by diffusion, extracellular enzymic modification, and 
binding to or uptake by surrounding tissue components. 
The electrophoretic administration of hydrazides, 
hydroxylarnine and arnino-oxyacetic acid (Curtis, Hosli 
and Johnston, 1968; Curtis, Duggan and Johnston, 1970; 
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Steiner, 1969; Gottesfeld, Kelly and Renaud, 1972), all 
of which are inhibitors of enzymes that are likely to be 
involved in the degradation of amino acid transmitters, 
has not produced evidence of the selective modification of 
amino acid or transmitter action. Systemic administration 
of these agents may produce changes that cannot be inter-
preted solely in terms of effects on extracellular amino 
acid inactivation. On the other hand, the inhibitory 
action of GABA and glycine on the firing rates of feline 
spinal neurones is potentiated by p-chloromercuriphenyl-
sulphonate, and higher concentrations of this mercurial 
also potentiate the excitation of these neurones by 
L-glutamate and L-aspartate (Curtis, Duggan and Johnston, 
1970). This mercurial has been shown to inhibit the 
active transport of glycine, GABA and DL-aspartate into 
rat brain slices (Curtis, Duggan and Johnston, 1970), and 
hence it is likely that active transport is an important 
factor in terminating the actions of amino acids in the 
extraneuronal environment. If carrier-mediated cellular 
uptake is responsible for limiting the immediate action 
of amino acids in the subsynaptic region (Iversen and Neal, 
1968; Curtis, Duggan and Johnston, 1970; Snyder, Logan, 
Bennett and Arregui, 1973), then the uptake receptor is 
of considerable interest in that it is a site for potential 
modification of synaptic processes. Selective antagonism 
at the uptake site would be expected to prolong and enhance 
the action of electrophoretically administered putative 
transmitters and the appropriate synaptic processes, thus 
providing evidence concerning the identification of a 
transmitter. Clearly, for such an uptake antagonist 
to be developed it is necessary to determine whether the 
receptors that subserve excitation or depression are 
structurally different from those for uptake. 
Uptake processes are most readily investigated 
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in vitro using tissue slices and subcellular particulate 
preparations which actively transport amino acids. These 
preparations allow a study of the kinetics and substrate 
specificity of the processes, and the effects of 
antagonists, but due consideration must be given to 
regional and species differences in the transport of 
amino acids. CNS tissue has complex metabolic, ionic 
and organisational requirements, and the transport of 
amino acids by CNS tissue preparations in vitro must 
represent the accumulation of amino acids by glial and 
neuronal elements under abnormal metabolic and ionic 
conditions. The results obtained in vitro may thus not 
be strictly relevant to conditions in vivo in the 
vicinity of synapses. Although a large number of compounds 
have been reported to inhibit the uptake of amino acids 
in vitro, few are suitable for use for specific modification 
of amino acid or transmitter inactivition in vivo. 
Hydrazinoacetic acid and chlorpromazine have been 
reported to inhibit the specific high affinity uptake of 
glycine by rat spinal cord slices in vitro (Iversen and 
Johnston, 1971) and cat spinal cord slices in vitro 
(Balcar and Johnston, 1973), but both substances have 
direct depressant actions on spinal neurones, and no 
glycine analogues have been found to enhance the 
inhibitory action of glycine (Curtis, Hosli and Johnston, 
1968). Various mercurials, for example, 
p-chloromercuriphenyl-sulphonate, which was mentioned 
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above, will potentiate the inhibitory effect of glycine, 
but the potentiation is relatively non-specific (Curtis, 
Hosli and Johnston, 1968; Curtis, Duggan and Johnston, 
1970) and reflects the non-specific inhibition of transport 
processes that is seen in vitro (Balcar and Johnston, 
1973). Strychnine does not inhibit glycine uptake by 
cat spinal cord slices in vitro (Balcar and Johnston, 
1973). Similarly, there are differences between the GABA 
postsynaptic receptor and the GABA uptake receptor -
bicuculline does not inhibit the uptake of GABA by cat 
spinal cord slices (Balcar and Johnston, 1973) and neither 
picrotoxinin nor bicuculline inhibits GABA uptake by rat 
brain slices (Curtis, Duggan, Felix and Johnston, 1970; 
Iversen and Johnston, 1971; Johnston and Mitchel, 1971). 
A number of GABA analogues inhibit the uptake of GABA 
by nervous tissue in vitro (Balcar and Johnston, 1973; 
Beart and Johnston, 1973; Beart, Johnston and Uhr, 1972; 
Iversen and Johnston, 1971) but none of the most potent 
inhibitors, which include 4-aminovaleric acid, 2-methyl-
GABA, 2-fluoro-GABA, 2-chloro-GABA, 2-methyl-GABA, has 
yet been reported to be a specific GABA uptake inhibitor 
without direct depressant effects on neuronal firing. 
L-Glutamate and L-aspartate appear to be substrates 
of comparable affinity for the same high affinity, acidic 
amino acid uptake system in rat brain (Balcar and Johnston, 
1972a), and the proposed three point receptor for the 
postsynaptic action of excitant amino acids (Curtis and 
Watkins, 1965) may also apply to the uptake site. Thus 
derivatives of L-glutamate or . L-aspartate in which the 
polarity of any of the three charged centres was modified 
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are without effect on glutamate or aspartate uptake 
(Hammerschlag, Potter and Vinci, 1971; Balcar and 
Johnston, 1972a,b). Mono-amino-dicarboxylic acids 
containing a longer carbon chain than glutamate were 
either weak (DL-3-aminoadipate) or ineffective (DL-2-
aminoadipate, DL-2-aminopimelate and 4-aminopimelate) 
inhibitors of glutamate uptake (Balcar and Johnston, 
1972a), indicating that the uptake receptor has certain 
steric requirements. Several potent amino acid excitants 
(N-methyl-D-aspartate, D-homocysteate and N-ethyl-D-
aspartate) have no influence on glutamate uptake (Balcar 
and Johnston, 1972b), and hence the uptake receptor 
presumably displays structural requirements that are 
different from those of the postsynaptic receptor. (This 
observation emphasises the problem of comparing the 
potencies ' of excitants which may be treated differently 
by the acidic amino acid transport system.) Ibotenic 
acid, a relatively rigid and extended conformation of 
glutamate, did not inhibit glutamate uptake in rat brain 
slices (Balcar and Johnston, 1972a), suggesting that 
folded conformations of glutamate may be more important 
at the uptake site. Antagonists of the excitatory action 
of glutamate: L-glutamate diethylester, DL- a -methyl 
glutamic acid (Haldeman, Huffman, Marshall and McLennan, 
1972), L-methionine-DL-sulphoximine (Curtis, Duggan, 
Felix, Johnston, Tebecis and Watkins, 1972) and lysergic 
acid diethylamide (Boakes, Bradley, Briggs and Dray, 1970) 
do not influence glutamate uptake by either rat brain 
slices or cat spinal cord slices (Balcar and Johnston, 
1972a and 1973). No selective inhibitor of either 
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L-glutamate or L-aspartate uptake has been reported, and 
amongst the most effective inhibitors of the excitant 
amino acid uptake system, D-aspartate, threo-3-hydroxy-
DL-aspartate, L-a-cysteinesulphinate and L-cysteate are 
comparable in strength with L-glutamate as excitants of 
feline spinal neurones (Curtis and Watkins, 1960; Curtis, 
Duggan, Felix, Johnston, Tebecis and Watkins, 1972). Thus 
whilst several compounds will excite neurones directly, 
without significantly affecting excitant amino acid uptake, 
a compound has yet to be reported that will selectively 
inhibit the uptake of glutamate or aspartate and not itself 
produce excitation. 
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II. METHODS 
The experiments described in this thesis were 
performed on various in vivo preparations of the feline 
central nervous system. These preparations were used 
either for the recording of extracellular action potentials 
of single neurones during the microelectrophoretic or 
systemic administration of substances, or for the recording 
of spinal reflexes in order to determine the effects of 
intravenously administered substances on the inhibition 
of spinal reflexes. 
(1) Feline central nervous system preparations 
One of five differ~nt types of feline preparation 
was employed depending upon the aim of the experiment; 
some methods, however, were common to all of these 
preparations. 
(a) General methods 
Cats of either sex were lightly anaesthetised 
with pentobarbitone sodium (35 mg/kg intraperitoneally 
initial, supplemented intravenously when required) 
and following the induction of anaesthesia the left 
cephalic vein, the right common carotid artery (spinal 
cord preparation) or left femoral artery (supraspinal 
preparations) and the trachea were cannulated. After 
preparation of the recording site and peripheral 
nerves for stimulation, as described in the following 
paragraphs, the animal was mounted in a frame of 
extreme rigidity using thoracic and pelvic clamps 
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in addition to the head frame (supraspinal preparations) 
and lumbar clamps (spinal cord preparation). The 
animal was suspended so that the abdomen and thorax 
was held clear of the base of the frame to reduce 
respiratory movement of the cerebral tissue. When 
necessary, gallamine triethiodide was administered 
intravenously (4 mg/kg initially, 2 mg/kg half hourly) 
and the animal artificially respired to maintain an 
end tidal co2 level at 4-4.5%. A bilateral 
pneumothorax was occasionally performed to further 
reduce respiratory movement of cerebral tissue. The 
temperature of all animals was maintained between 
36-38°C by means of heating pads placed beneath the 
abdomen and chest. A thermometer and temperature 
sensitive probe were placed between the rib cage and 
right scapula and the current flowing through one of 
the heating pads was controlled by a solid state current 
regulating unit. The carotid or femoral blood pressure 
was continuously monitored. 
(b) Spinal cord preparations 
The laminae of all lumbar vertebrae were removed 
and the spinal cord transected at the lower thoracic 
level after infiltration with 1% procaine solution. 
The dural sac was opened dorsally over the lumbar and 
sacral cord, and the seventh lumbar and first sacral 
ventral roots were divided at the intervertebral 
foramen and mounted on platinum electrodes which served 
for either stimulation or recording. In some experiments 
(Section VIII(2)) the seventh lumbar dorsal root was 
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also transected, separated into upper and lower 
portions and mounted on electrodes for stimulation. 
After mounting the animal in a frame of extreme 
rigidity, as previously described,. the exposed spinal 
cord and vertebral muscles were covered with warmed 
liquid paraffin (BP) which was retained by skin flaps. 
(i) Spinal interneurone and Renshaw cell 
preparation 
Prior to preparation of the recording site, 
the left sural, common peroneal and tibial nerves 
were transected and mounted on platinum stimulating 
electrodes, the exposed nerves being immersed in 
warmed paraffin oil. These nerves were stimulated 
at 3-5 X threshold, a platinum ball electrode 
placed on the dorsal surface of the cord being 
used to monitor the resulting afferent volleys 
and thus to determine nerve thesholds and central 
latencies of excited internuerones. The ball 
electrode on the dorsal surface of the cord was 
also used to record the 'Renshaw ripple' (Eccles, 
Fatt and Koketsu, 1954) in response to ventral 
root stimulation. After suitable amplification 
these potentials were displayed on a cathode ray 
oscilloscope from which filmed records could be 
made. Renshaw cells were identified by responses 
which followed antidromic stimulation of ventral 
roots. Small areas of pia-mater were carefully 
removed from the left lower lumbar and upper 
sacral segments of the dorsal surface of the cord 
at the site of proposed electrode penetration. 
Fine forceps and a dissecting microscope were 
used to prepare these recording sites. 
(ii) Spinal reflex preparation 
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Monosynaptic reflexes were recorded mono-
phasically from the seventh lumbar (L7) or first 
sacral (Sl) ventral root in response to electrical 
stimulation (0.5 or 1/sec, maximum intensity for 
the fastest afferent fibres) of transected hind 
limb muscle nerves - posterior biceps and 
semitendinosus (PBST); medial, lateral gastroc-
nemius and soleus (GS); flexor digitorum longus 
(FDL); perone1 and muscles innervated by the deep 
peroneal nerve (PDP) and quadriceps (Q). These 
reflexes were usually faciliated and stabilised 
by preceding submaximal stimulation of the same 
nerve, this stimulus being subliminal for a 
reflex response. Reflexes initiated by stimulation 
of one muscle nerve were inhibited by volleys in 
other muscle or cutaneous nerves. 
Reflexes were suitably amplified and displayed 
on a cathode ray oscilloscope. The area beneath 
the monosynaptic reflex was measured using a 
voltage to frequency converter (VIDAR 260), and 
a gated counter with analogue output (Hewlett 
Packard Counter 5214L and Digital Recorder 
H23-562A), The recorder output was used to 
construct inhibitory curves which were plotted 
directly on an X-Y recorder (Varian F-80, 
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converted to a point plater): the X-voltage was 
proportional to the interval between the 
inhibitory and testing volleys, the Y-voltage was 
proportional to the area beneath the monosynaptic 
reflex. 
Dorsal root potentials and dorsal root 
reflexes were recorded from the most caudal 
rootlet of the sixth lumbar (L6) dorsal root 
with an amplifier having a time constant of 
1 sec. The 'Renshaw ripple' (see paragraph (I) 
(b) (i) above) and 'quadriceps notch' (Eccles, 
Fatt and Landgren, 1956), in response to stimu-
lation of the ventral roots and the left 
quadriceps nerve respectively, were recorded by 
a ball electrode on the dorso-lateral surface of 
the spinal cord. These potentials were suitably 
amplified and filmed from an oscilloscope display. 
(c) Cerebellar cortex preparation 
Lobules V and VI of the cerebellar vermis (culmen 
and lobulus simplex) were exposed by removal of an 
approximately circular piece of bone (8-10 mm in 
diameter) just anterior to the lamboid ridge. The 
underlying dura-mater was sectioned and the exposed 
cortex continuously flushed with a warmed (38°C) 
mammalian Ringer solution which was equilibrated with 
5% co2 , 95% o2 . The head was held in a modified 
Horsley-Clark head frame which allowed rotation about 
an axis parallel to the interaural line, and thus the 
area of vermis from which recordings were taken could 
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be placed in an approximately horizontal plane. After 
preparation of the recording site the head frame was 
fixed to the animal frame and the cat suspended as 
previously described. 
An area for recording was chosen that was 
relatively free from superficial cortical vessels and 
a small perspex pressor foot was carefully placed 
upon the tissue to reduce cortical pulsations. No 
attempt was made to remove the pia-mater, for such 
removal results in damage to the superficial cell 
layers and in most cases the micropipettes penetrated 
the pia without difficulty. A co-axial stimulating 
electrode (0.5 mm in diameter) was also placed on the 
surface of the vermis, 1-2 mm medial to the recording 
site and on the crest of the same folium. Both the 
pressor foot and the co-axial stimulating electrode 
were carried on manipulators fixed to the head frame. 
Cerebellar Purkinje cells were identified by their 
depth beneath the cortical surface (150-400 µm), the 
recording of spontaneous 'inactivation responses' 
(Granit and Philips, 1956), and the inhibitory response 
to electrical stimulation of the cortical surface 
using the co-axial electrode 'off-line' from the 
recording site (Andersen, Eccles and Voorhoeve, 1964). 
(d) Cerebral cortex preparation 
The medullary pyramids were exposed from the 
ventral aspect by partial removal of the basi-occiput, 
and the head of the animal was then fixed in a modified 
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Horsley-Clark head frame which was attached to the 
frame in which the cat was suspended, and allowed the 
pericruciate cortex to be orientated in an approximately 
horizontal plane. The left pre- and postcruciate 
cortical areas were exposed by removal of the over-
lying bone and the posterior wall of the left frontal 
sinus. After opening the dura the cortex was covered 
with polyethylene sheeting, apart from a small opening 
left at the recording site. During microscopic 
examination of the cortex the pia-mater was gently 
removed with fine forceps from suitable small, super-
ficially avascular, areas. Throughout the experiment 
the whole area was irrigated with warmed (38°C) 
mammalian Ringer solution which was equilibrated with 
5% co2 , 95% o2 . A small perspex pressor foot plate, 
which was carried on a micromanipulator fixed to the head 
frame, was used to stabilise the cortex at the 
recording site. 
Deep pyramidal cells of the postcruciate cortex 
were identified by a constant latency antidromic 
response to electrical stimulation of the exposed 
ipsilateral medullary pyramid (latency within the 
range 0.5-5 msec), and by the ability to follow tetanic 
antidromic volleys (see Philips, 1956, 1959, 1961). 
(e) Ventrobasal thalamus preparation 
The right median and superficial radial nerves 
were transected and mounted on platinum stimulating 
electrodes in a warmed paraffin pool formed by skin 
flaps. With the head of the animal held in a modified 
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Horsley-Clark head frame, the left cranial vault was 
removed and the dorsal surface of the thalamus exposed 
by partial removal of the overlying cerebral cortex. 
The exposed thalamus and surrounding brain were 
continuously irrigated with mammalian Ringer solution 
(38°C, equilibrated with 5% co2 and 95% o2 ) and the 
head frame was fixed to the rigid frame which suspended 
the animal as previously described. 
Thalamic neurones were located stereotaxically 
by passing micropipettes in a vertical plane, using 
the co-ordinates published by Jasper and Ajmone-Marsan 
(1954). Thalamo-cortical relay neurones were located 
in the region of the left nucleus ventralis posterio-
lateralis and nucleus ventralis posteriomedialis and 
were identified on the basis of short latency (6-8 
msec) responses to impulses in one contralateral 
peripheral cutaneous nerve of the forelimb. 
(2) Microelectrophoresis 
The technique of microelectrophoresis was used to 
determine the pharmacological effect of substances on 
individual neurones. Ionised compounds were electrically 
ejected into the extraneuronal space from multibarrel 
glass micropipettes whilst simultaneously recording the 
extracellular action potentials of neurones adjacent to 
the tip of the micropipette. The methods used were those 
described by Curtis (1964). Seven barrel micropipette 
'blanks' were drawn out to a fine tip in a vertical 
electrode puller. These very fine tips were viewed 
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microscopically, and, by means of a fine glass rod attached 
to a micromanipulator (de Fonbrune No. 190), the tips 
were broken back to a total diameter of 5-8 µm. The dry 
micropipettes were then filled from above with centrifuged 
solutions and filling was completed by centrifuging the 
partially filled micropipette. The centre barrel of each 
micropipette was filled with 4 M NaCl, and the six outer 
barrels contained aqueous solutions of the substances to 
be tested, in the particular combination required for an 
experiment. Details of the solutions of standard excitants, 
depressants and antagonists are contained in Table 1, 
and details of the other microelectrophoretic solutions 
are given in the appropriate results sections. 
TABLE 1 Standard solutions for 
microelectrophoresis 
Compound Molarity 
Acetylcholine bromide 0.5 
y-Aminobutyric acid (GABA) 0.5 
L-Aspartic acid 1.0 
(+)-Bicuculline metho-
chloride (BMC) 0.005* 
(+)-Bicuculline hydro- 0.010* 
chloride or 0.100 
L-Glutamic acid 111 0 
Glycine 0.5 
DL-Homocysteic acid (DLH) 0.2 
Noradrenaline bitartrate 0.1 
Strychnine hydrochloride 0.002* 
or 0.01* 
* in 165 mM NaCl 
pH 
3 
8 
3 
3.5 
8 
3 
7.5 
3.6 
Acid/alkali 
added 
HCl 
NaOH 
HCl 
-
NaOH 
HCl 
NaOH 
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After filling, the micropipettes were examined 
microscopically using a water immersion lens and the 
electrical resistance of each barrel was measured. 
Micropipettes were also examined microscopically after 
use. The micropipettes were carried on a micromanipulator 
which allowed movement in three axes (Eccles, Fatt, 
Landgren and Winsbury, 1954), and which was attached to 
the rigid animal frame. The vertical movement of this 
micromanipulator was occasionally replaced by a remotely 
controlled micromanipulator (Eide and Kallstrom, 1968; 
St~lex Micromanipulator, type Lundberg). When the 
microelectrode was placed in the tissue, the resistance 
of each barrel was again measured. Electrical contact 
was made with the centre (recording) barrel by means of 
a small Ag/AgCl junction, and with the other barrels by 
means of a silver wire. An Ag/AgCl junction, covered 
with gauze saturated with 165 mM NaCl, was sutured to 
exposed muscle near the recording site to act as the 
indifferent electrode (earth). The resistance of each 
barrel in situ was determined by establishing a 0.5 V 
potential difference across each solution and measuring 
the resulting current flow. Retaining potentials of the 
order of 0.5 V were applied to each outer barrel in order 
to control the diffusional efflux of active ions, the 
resulting retaining current was maintained throughout 
the experiment. Currents ejecting cations have been termed 
cationic (+), whilst those ejecting anions have been 
termed anionic (-). Ejecting and retaining currents have 
-9 been quoted in nano-amperes (nA, 10 A) and were measured 
with an accuracy of± 0.5 nA. 
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(a) The recording of extracellular action potentials 
The Ag/AgCl junction which made electrical 
connection with the recording barrel of the micro-
pipette was connected to a negative capacitance 
cathode follower. After suitable amplification the 
spike potentials were displayed upon a double beam 
oscilloscope from which photographic records could 
be made. In addition, the output of the cathode 
follower was also amplified and used to trigger a pulse 
generator. The output pulses of this generator and 
the spike potentials were observed simultaneously on 
the double beam oscilloscope, and a voltage discriminator 
was used to select the size of the action potential 
that triggered the pulse generator. The pulses so 
generated were counted by means of a rate meter and 
the output of the rate meter (time constant 0.2 sec) 
was displayed on a rectilinear pen recorder (Texas 
Instruments Recti-Riter) upon which side marker pens 
indicated periods of microelectrophoretic ejection of 
compounds. There was thus a continuous display of 
mean cell firing frequency, and this could be readily 
correlated with the effects of electrophoretically 
administered compounds. The number of Renshaw cell 
action potentials in response to ventral root stimu-
lation were counted using a gated counter and digital 
recorder (Hewlett Packard Counter 5214L and Digital 
Recorder H23-562A). 
(b) Experimental design 
The neurones studied were either firing 
spontaneously, in response to electrophoretic pulses 
of excitants, or were excited by the continuous 
electrophoretic administration of an excitant. The 
current ejecting the excitant was adjusted, if 
necessary, to maintain a constant firing frequency 
despite changes in the excitability of neurones 
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brought about by the administration of other substances 
(e.g. bicuculline). The following procedures were 
adopted for specific experiments. 
(i) The depressant activity of GABA analogues 
Neurones were selected that were sensitive 
to the depressant action of GABA, and the responses 
to electrophoretically ejected test substances 
were compared with those to GABA and glycine. 
The potency of a test substance relative to the 
potency of GABA or glycine was obtained by 
determining the equipotent current ratio, the 
ratio of ejecting currents which produced equal, 
submaximal and steady state firing rates when the 
substances to be compared were ejected from the 
same micropipette. The latencies of onset and 
offset of responses to depressants could not be 
accurately compared from the rate meter recording 
of the firing frequency, unless these times 
exceeded 2-5 seconds. In some experiments 
photographic records were used to determine offset 
times, The criteria of Curtis and Koizumi (1961) 
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were used to identify current effects from true 
depression, and with weak depressants it was 
often necessary to include a current control 
barrel (165 rnM NaCl) in the micropipette, in 
addition to DL-homocysteate (DLH), GABA, glycine 
and the one or two barrels that contained the 
analogues to be tested. (See Table I for details 
of the standard solutions and Section III for 
details of the GABA analogue solutions.) 
S-(p-Chlorophenyl)-GABA was also administered 
intravenously as a 1 mg/kg solution in 165 mM 
NaCl to determine the effect of this compound on 
spinal reflexes, DRPs, the 'quadriceps notch' and 
the 'Renshaw ripple'. 
(ii) GABA and glycine antagonism or potentiation 
Currents ejecting glycine and GABA were 
chosen to produce just maximal or submaximal 
depression of firing when equilibrium firing 
rates were established (usually within 10 sec), 
and these responses were used to determine the 
effectiveness of a test substance as a glycine or 
GABA antagonist. The test substance was 
continuously administered for a period judged 
to be sufficient to allow equilibrium conditions 
to be developed. The specificity of antagonism 
was determined by the differential effect on 
GABA and glycine responses, and any observed 
antagonism was compared with that due to known 
antagonists - bicuculline for GABA antagonism 
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and strychnine for glycine antagonism~ Some 
substances which were tested electrophoretically 
as GABA or glycine antagonists were also tested 
for their effects on the inhibition of spinal 
reflexes after intravenous administration. 
The following substances, dissolved in 165 
rnM NaCl, were administered intravenously for 
testing on the inhibition of spinal reflexes: 
corlumine (1 mg/ml), benzylpenicillin sodium 
(0.18 g/ml: approximately 0.3 mega units/ml), 
shikimin (1 mg/ml), strychnine hydrochloride (0.1 
mg/ml) and tutin (0.5 mg/ml). (The significance 
of a reduction in spinal 'direct' or 'presynaptic' 
inhibitions after systemic administration of a 
convulsant substance is outlined in the discussion 
to Section IV). 
A similar experimental design was used to 
determine the potentiation of glycine or GABA 
depressant responses by an electrophoretically 
administered test substance, however, the control 
glycine and GABA responses were kept at a magnitude 
which would allow for significant potentiation 
to be recorded. 
The outer barrels of the micropipettes used 
in these experiments usually contained the 
following combination of solutions (for details 
of the standard solutions see Table 1): DLH, 
GABA, glycine, bicuculline (or bicuculline metho-
chloride), strychnine hydrochloride and one of the 
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compounds to be investigated as an antagonist 
(for details of the latter solutions see Section 
IV or V). 
(iii) Anticholinesterase activity of bicuculline 
hydrochloride and bicuculline methochloride 
(BMC) 
Either bicuculline hydrochloride or BMC was 
used to antagonise the inhibitory action of GABA 
on Renshaw cells that were being excited by the 
continuous administration of DLH. The current of 
bicuculline hydrochloride or BMC that was thus 
demonstrated to significantly antagonise electro-
phoretically ejected GABA was administered again 
whilst the cell was excited by alternate electro-
phoretic pulses of DLH and acetylcholine. 
Potentiation of the acetylcholine response could 
be gauged by comparison of control responses with 
those during the administration of BMC or 
bicuculline hydrochloride. 
The outer barrels of the micropipettes used 
in these experiments contained the following 
solutions: DLH, acetylcholine, GABA, glycine, 
BMC, bicuculline hydrochloride (see Table 1 for 
details). 
The effect was also determined of intravenously 
administered physostigmine salicylate (0.1 mg/ml 
165 rnM NaCl) and bicuculline hydrochloride (0.1 
mg free base/ml 165 rnM NaCl) on the responses of 
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Renshaw cells to electrophoretically administered 
excitants or to stimulation of the ventral roots . 
(iv) Relative potency of excitants and relative 
sensitivity of neurones to excitants 
The relative potencies of excitants were 
obtained by determining equipotent current ratios, 
the ratio of ejecting currents (from the same 
micropipette) which produced equal, submaximal 
and steady state firing rates, the more potent 
excitant being effective with the lower ejecting 
current. The reciprocal of the equipotent current 
ratio was taken as the sensitivity ratio for any 
one neurone. This method assumes that the agents 
are interacting with the same receptor, and that 
the active concentrations produced at the neuronal 
membrane are directly proportional to the electro-
phoretic current. (These assumptions are discussed 
in Section 1). Despite the necessary assumptions, 
the method is preferable to a comparison of 
effects produced by 'equal' extraneuronal 
concentrations and thus a determination of 
potency ratios which depend upon the portions of 
the dose-response curves which are being studied 
~ (compare Crawford and Curtis, 1964; Krnjevic and 
Phillis, 1963. p.282). 
Kainic and N-methyl-D-aspartic acids were 
found to be potent neuronal excitants, and on 
structural grounds were considered to be 
potentially specific for glutamate and aspartate 
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receptors, respectively (see Sections VI and VII). 
It was thus decided to use these two excitants to 
determine the relative sensitivity of interneurones 
and Renshaw cells to two excitants that might be 
relatively more specific for glutamate and aspart-
ate receptors than the parent amino acids. Both 
kainate and NMDA (N-methyl-D-aspartate) were potent 
neuronal excitants when administered as anions 
from 0.1 or 0.2 M solutions, and excitation fre-
quently occurred with mere reduction of the 
cationic retaining currents. The relative sensi-
tivity of neurones, or the relative potencies of 
agonists cannot be accurately obtained from responses 
that are produced by reduced retaining currents. In 
such cases the amount of agonist that leaves the 
micropipette need not be directly related to the 
reduction in retaining current, and furthermore, 
the zero 'dose' level on the retaining scale is 
not accurately known. Similarly, accurate compari-
sons of potencies or sensitivities cannot be made 
from responses produced by removal of the retaining 
potential When the retaining potential is 
removed free diffusion occurs, and although a 
response may be observed, no measure of the 'dose' 
of agonist is possible, and the resulting rate of 
diffusion of substances from different micropipette 
barrels would depend upon a large number of 
variables. Thus, in order to compare accurately 
the responses to kainate and NMDA, it was necessary 
for these excitants to be administered with anionic 
currents that were readily measured. 
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Preliminary experiments established that 
approximately equal anionic ejecting currents 
(within the range 20-80 nA) were adequate to 
excite spinal neurones submaximally when solutions 
of kainate and NMDA were diluted with NaCl 
(kainate 5 mM in 250 mM NaCl; NMDA, 50 mM in 200 
mM NaCl). The fraction of the electrophoretic 
current ejecting the amino acid anions from dilute 
solutions in NaCl was assumed to be 1/51 of that 
passed through the kainate barrel, and 1/5 of that 
through the NMDA barrel The sensitivity ratios 
were thus corrected for this dilution factor of 
IO. To minimise any errors due to comparisons 
being made with different micropipettes an 
approximately equal number of Renshaw cells and 
interneurones were tested with any one micro-
pipette. 
The excitants that were to be compared were 
contained in the outer barrels of micropipettes 
as follows: DLH, L-glutamate, L-aspartate or 
'cycloglutamate' (1 M, adjusted to pH 7.3 with 
NaOH), ibotenate (O.l M, pH 7, NaOH) or 
dihydrokainate (0.2 M, pH 7, NaOH), NMDA (0.1 M, 
pH 8) and kainate (0.1 M, pH 8, NaOH). Those 
micropipettes that were used to determine the 
relative sensitivity of interneurones and Renshaw 
cells contained solutions of NMDA and kainate 
that were diluted with NaCl as described above. 
(For details of the standard solutions see Table 1). 
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(v) Glutamate antagonism 
The ability of an electrophoretically adminis-
tered substance to antagonise the excitation of 
neurones by L-glutarnic acid was tested on either 
spinal interneurones or Renshaw cells, except for 
I-hydroxy-3-aminopyrrolidone-2 (HAP) which was 
also tested on acetylcholine sensitive neurones of 
cerebral cortex and ventrobasal thalamus. The test 
substance was examined for depressant/antagonistic 
activity on neurones that were excited by L-glutamate. 
Specificity of antagonism was determined by testing 
the proposed antagonist on both glutamate and 
aspartate mediated excitation, and in the case of 
acetylcholine sensitive neurones it was also 
possible to test the effect of substances on acetyl-
choline mediated excitation. Reduction of glutamate 
and acetylcholine, or aspartate and acetylcholine 
mediated excitations was termed 'non-specific' 
depression. A further indication of 'non-specific' 
depression was reduction in spike height during the 
administration of the test substance, an indic-
ation of a local anaesthetic-like effect (Curtis 
and Phillis, 1960). When Renshaw cells were 
used to test for glutamate antagonism, the effect 
of the test substance on the synaptic excitation 
of these cells by stimulation of the ventral 
and dorsal roots could also be examined. 
Reduction of the Renshaw cell submaximal ventral 
root response was an additional indication of 
'non-specific' depression, The testing procedures 
( 3 ) 
(a) 
that were employed also permitted the detection 
of excitation of neurones by test substances. 
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The following combination of solutions was 
contained in the outer barrels of micropipettes 
used in these experiments: L-glutamate, L-aspartate, 
DLH, acetylcholine and two of the substances to 
be tested as glutamate antagonists (for details 
of the standard solutions see Table 1, the details 
of the other solutions are contained in Table 7). 
Sources of drugs and chemicals 
Provided by: 
Dr W.L.F. Armaregc, Canberra: 
(±)-cis-2-aminocyclohexane-l-carboxylic acid 
(±) trans-2-aminocyclohexane-l-carboxylic acid 
Dr R.B. B-Johns, Melbourne: 
Coriamyrtin 
CIBA 
s-(p-chlorophenyl)-y-aminobutyric acid 
Dr C.H. Eugster, Zurich: 
Ibotenic acid 
Professor F. Pastier, Otago: 
Tutin 
Dr F.R. Hewgill, Nedlands: 
(±) trans-3-aminocyclohexane-l-carboxylic acid 
Professor Y. Kajimoto, Tokushima: 
Shikimin 
Dr D.I.B. Kerr, Adelaide: 
(±)-cis-3-aminocyclohexane-l-carboxylic acid 
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Dr P. Krogsg~rd-Larsen, Copenhagen: 
3-Hydroxy-5-(1-arninobutyl)isoxazole 
3-Hydroxy-5-(1-arninoethyl)isoxazole 
3-Hydroxy-5-(2-arninoethyl)isoxazole 
3-Hydroxy-4-(2-arninoethyl)-5-rnethylisoxazole 
3-Hydroxy-4-aminornethyl-5-rnethylisoxazole 
3-Hydroxy-5-arninornethylpyrazole 
3-Hydroxy-5-(1-arninopropyl)isoxazole 
3-Hydroxy-5-(3-arninopropyl)isoxazole 
3-Hydroxy-4-ethyl-5-arninornethylisoxazole 
3-Hydroxy-4-rnethyl-5-(2-arninoethyl)isoxazole 
3-Hydroxy-4-rnethyl-5-arninornethylisoxazole 
Nipecotic acid (piperidine-3-carboxylic acid) 
Perhydrooxazine-6-carboxylic acid 
S,6,7,9,-Tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol 
4,S,6,7-Tetrahydroisoxazolo[4,5-c]pyridin-3-ol 
Dr R.H.F. Manske, Waterloo: 
Corlurnine 
Dr A. Meister, New York: 
'Cycloglutamic acid' 
L-Methionine-SR-sulphoxirnine phosphate 
Dr J.C. Watkins, Bristol: 
Arnbenoxarn 
5-Arninoethyltetrazole 
1-(2-Arninoethyl)uracil 
3-(2-Arninoethyl)uracil 
(b) 
DL-a-(2-Arnino-l-methylethyl)benzhydrol 
5-Arninomethyltetrazole 
1,3-Di-(2-aminoethyl)uracil 
4-Fluroglutamic acid diethyl ester 
4-Fluroglutamic acid-1-amide 
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L-Glutamic acid di-tert-butyl ester 
N-Methyl-DL-aspartic acid diethyl ester 
N-Methyl-DL-aspartic acid di-n-propyl ester 
1-(2-Pyridyl)-1,2,4,-triazole-3-sulphonic acid 
4-(4-Pyridyl)-1,2,4,-triazole-3-sulphonic acid 
4-(3-Pyridyl)-1,2,4-triazole-3-sulphonic acid 
Pyridine-2-phosphonic acid 
1,2,4-Triazole-3-sulphonic acid 
S-(m-Trifluoromethylphenyl)-y-aminobutyric acid 
DL-Willardine 
Synthesised in the Department of Pharmacology, 
John Curtin School of Medi6al Research, Canberra: 
cis-4-Arninocrotonic acid (Mr B. Twitchin) 
trans-4-aminocrotonic acid (Dr P.M. Beart and 
Mr B. Twitchin) 
Bicucine methyl ester (Dr P.M. Beart) 
Bicuculline methochloride (Dr G.A.R. Johnston) 
Bicuculline tetraphenol (Mr B. Twitchin) 
Dihydrokainic acid (Dr G.A.R. Johnston) 
l-Hydroxy-3-aminopyrrolidone-2 (Dr G.A.R. Johnston) 
N-Methyl bicuculleine (Dr G.A.R. Johnston) 
N-Methyl-D-aspartic acid (Dr J.C. Watkins and 
Mr B. Twitchin) 
(c) Purchased from commercial suppliers: 
Drugs and chemicals not mentioned above were 
purchased from commercial suppliers. 
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III. GABA ANALOGUES AS NEURONAL DEPRESSANTS 
Despite X-ray analysis and molecular orbital 
calculations of the GABA molecule and some of its analogues, 
an investigation of the 'active conformations' of the 
relatively flexible GABA molecule must still rely heavily 
upon structure-activity correlation of conformationally 
restricted GABA analogues. Accordance between such 
indirectly determined 'active conformations' and low energy 
conformers of GABA may support the physiological importance 
of the particular conformational modes (see Section I). 
Of the conformationally restricted GABA analogues 
that have been previously investigated, 4-aminotetrolic 
acid and muscimol (3-hydroxy-5-aminoethylisoxazole) have 
GABA-like (see Section I; Curtis, Hosli and Johnston, 
1968; Curtis, Duggan, Felix and Johnston, 1971; Curtis, 
Duggan, Felix, Johnston and McLennan, 1971) postsynaptic 
effects after microelectrophoretic administration (Beart, 
Curtis and Johnston, 1971; Johnston, Curtis, de Groat and 
Duggan, 1968), but differ in their effects on the high 
affinity uptake of GABA by brain slices. 4-Aminotetrolic / 
acid is a competitive inhibitor of high affinity GABA 
uptake by rat brain slices (Beart, Johnston and Uhr, 
1972), however muscimol is only a weak non-competitive 
inhibitor of GABA uptake (Johnston, 1971). This rather 
selective postsynaptic action of muscimol has prompted 
the biological investigation of a series of compounds 
structurally related to muscimol as an attempt to 
evaluate conformationally restricted GABA analogues with 
specific biological activities. This series of GABA 
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analogues (see Table 2) has been evaluated as depressants 
of spinal neurones, and an attempt has been made to 
correlate structure and activity in order to evaluate the 
'active conformers' of GABA. A further aim of this study 
was to evaluate specific inhibitors of the GABA uptake 
process in vivo. The inhibition of GABA uptake processes 
in vivo is of pharmacological interest and may provide 
information regarding the physiological role of uptake 
processes. 
Trans-4-aminocrotonic acid, like muscimol and 
4-aminotetrolic acid is an analogue of GABA in a relatively 
extended conformation, and both trans-4-aminocrotonic 
and 4-aminotetrolic acids are competitive inhibitors of 
the high affinity uptake of GABA by rat brain slices 
(Beart, Johnston and Uhr, 1972). The actions of muscimol 
and 4-aminotetrolic acid as GABA agonists with bicuculline-
sensitive postsynaptic receptors in the feline spinal cord 
(Curtis, Duggan, Felix and Johnston, 1971; Beart, Curtis 
and Johnston, 1971) suggests that extended conformations 
of GABA are important conformational requirements for 
interaction of GABA with its postsynaptic receptors. The 
uptake system, which is competively inhibited by trans-4-
aminocrotonic acid and 4-aminotetrolic acids, would appear 
to have similar conformational requirements. Other studies 
suggest that folded conformations of GABA may be the 
active conformations (see Section I), but an analogue of 
GABA in a folded conformation has yet to be investigated 
in biological systems. Cis-4-aminocrotonic acid is an 
analogue of GABA in a folded conformation, and hence its 
effects on single spinal neurones have been investigated 
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and compared with those of trans-4-aminocrotonic acid. 
A number of aminocyclohexane derivatives were also 
studied as a series of GABA analogues of restricted 
conformation, In this series the conformational 
restriction results from the carbon chain being part of 
a cyclohexane ring and variation of the distance between 
the amino and carboxyl functional groups is possible. 
The potencies of these amino-cyclohexane derivatives as 
depressants of spinal neurones have been compared with 
that of GABA. 
Although not a GABA analogue of restricted 
conformation, B-(p-chlorophenyl)-GABA (BCPG) has been 
included in this study of GABA analogues for several 
reasons. SCPG (Baclofen, Lioresal) is one of a series of 
lipophilic derivatives of GABA which more readily penetrates 
a blood-brain barrier than the parent compound (Faigle 
and Keberle, 1972a; Faigle and Keberle, 1972b; Keberle 
and Faigle, 1972), and it has proved of therapeutic benefit 
in the alleviation of spasticity resulting from a variety 
of neuro~ogical disorders (Birkmayer, 1972; Burke, 
Andrews and Knowles, 1971). When administered intra-
venously to cats BCPG reduced mono~and polysynaptic 
reflexes, and diminished spasticity resulting from either 
mesencephalic transection or ischaemic decerebration (Bein, 
1972). Supraspinal effects appeared to be minimal, and 
although a mode of action for BCPG similar to that of 
GABA has been suspected, no clear evidence has yet been 
obtained to decide this issue (see Bein, 1972). For these 
reasons SCPG was included amongst the GABA analogues that 
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were compared with the parent compound in order to determine 
whether it interacts with bicuculline-sensitive post-
synaptic receptors. The information to be thus obtained 
was sought as a structure-activity relationship and as a 
possible explanation of the mechanism of action of SCPG 
when used in the treatment of spasticity. 
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RESULTS 
(1) Muscimol derivatives 
Twenty-two spinal cord preparations were used to 
study the effects of the compounds that are contained in 
Table 2 on Renshaw cells and spinal interneurones, 
neurones which have a similar sensitivity to GABA and 
glycine (Curtis, Hosli and Johnston, 1968). Most of these 
compounds are structurally related to muscimol which has 
been previously studied (Johnston, Curtis, de Groat and 
Duggan, 1968; Curtis, Duggan, Felix and Johnston, 1971), 
and the reported values for muscimol are included in the 
table. 
(a) Depressants of spinal neurones 
The approximate potency of the postsynaptic 
effects of the compounds relative to that of GABA are 
listed in Table 2. As shown in Fig~ 1, 3-hydroxy-5-
(1-aminoethyl)-isoxazole (compound IV) an analogue of 
GABA, clearly inhibited the firing of spinal neurones. 
The depressant activity of compound IV, which was 
similar in potency and time course to that of GABA, 
could be reversibly suppressed by bicuculline 
methochloride (BMC: see Johnston, Beart, Curtis, Game, 
McCulloch and MacLachlan, 1972; Section IV), but not 
by strychnine hydrochloride (2 neurones). As a 
depressant, compound IV was weaker than muscimol 
(Johnston, Curtis, de Groat and Duggan, 1968; Curtis, 
Duggan, Felix and Johnston, 1971). The depressant 
actions of the structurally related isoxazoles, 
TABLE 2 STRUCTURE AND BIOLOGICAL ACTIVITIES OF SOME GABA ANALOGUES OF RESTRICTED CONFORMATION 
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(See the following page for notes to this table). 
NOTES TO TABLE 1: STRUCTURE AND BIOLOGICAL ACTIVITIES OF 
SOME ANALOGUES OF RESTRICTED CONFORMATION 
1. The structural similarities of the compounds to the parent 
amino acids S-alanine, GABA, o-aminovaleric acid and 
E~aminocaproic acid are indicated by heavy black lines. 
2. The properties of the solution are those of the solution 
used in the microelectrophoretic experiments. The 
following abbreviations have been used: 
HBr, hydrobromide salt of the compound 
HCl, hydrochloride salt of the compound 
(HCl), hydrochloric acid used to adjust 
pH of the solution 
TsOH, toluene sulphonate salt of the compound. 
Compounds containing asymetric centres were racemates. 
3. The potencies of the compounds as depressants are cited 
relative to that of GABA(---). 
4. The Ic50 values (µM) are for inhibition of GABA uptake 
by rat brain slices, the values for muscimol being that 
of Johnston (1971) and the remaining values are from 
Krogsgaard-Larsen and Johnston (1975). 
5. Antagonism of the depressant action of glycine: 0, no 
activity; +, significant activity. 
6. Effects of doubtful significance are cited in brackets. 
7. Abbreviations: BMC, bicuculline methochloride 
Ic50 , concentration of compound (µM) 
causing 50% inhibition of the 
uptake of [ 3 H] GABA by rat brain 
slices 
n.t., not tested. 
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The effect of bicuculline methochloride (BMC) on the 
inhibition of firing of a spinal interneurone by GABA, glycine 
and 3-hydroxy-5-(1-aminoethyl)isoxazole (HlAI). The rate of 
firing of the interneurone was maintained by the continuous 
electrophoretic ejection of DL-homocysteate (DLH), the rate of 
ejection of which was varied to allow for the excitant effect 
of RMC. GABA (GA, 10 nA), glycine (GL, 2 nA) and 3-hydroxy-
5-(1-aminoethyl)isoxazole (HlAI, 35 nA) were administered for 
the periods indicated by the respective solid and broken 
horizontal bars. The solid horizontal bar and vertical broken 
line indicates the period of continuous ejection of BMC from a 
solution of 10 mM in 165 mM NaCl. A, control responses during 
the administration of DLH, 12 nA; B, responses during the 
administration of BMC with a current of 10 nA, DLH, 8 nA; 
C, 2.5 minutes after the termination of the BMC ejection. 
Ordinates: firing frequency in spikes per second. Abscissae: 
time in minutes. 
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compounds V and VI, were considerably weaker, being 
between 1/5 and 1/10 of GABA. These effects, which 
were slow in both onset and offset, were not clearly 
antagonised by BMC, but antagonism of weak depressants 
is technically difficult to demonstrate. 
Introduction of a methyl or an ethyl group in the 
4-position of muscimol gives compounds VII and VIII, 
respectively, substances which are considerably less 
effective depressants than muscimol. Thus the 
inhibitory action of VII was less than 1/10 of that 
of GABA, whereas VIII did not appreciably affect the 
firing of spinal neurones. 
3-Hydroxy-5-(2-arninoethyl)isoxazole (compound X), 
an analogue of o-aminovaleric acid, was a potent 
depressant of spinal neurones, comparable in potency to 
GABA. The inhibitory effect was rather slow in onset 
and was reversibly antagonised by BMC as shown in 
Fig. 2. Analogous to the 4-alkyl substituted muscimol 
derivatives VII and VIII, the 4-methyl derivative 
(compound XI) of 3-hydroxy-5-(2-arninoethyl) isoxazole 
was less than 1/10 as potent as GABA. 
3-Hydroxy-5-aminomethylpyrazole ('azamuscimol') 
is structurally related to muscimol, but the physico-
chemical properties of the pyrazole nucleus are quite 
different from those of the isoxazole moiety of 
muscimol. 'Azarnuscimol' was a depressant of the firing 
of spinal neurones, being approximately 1/3 as active 
as GABA, but some variation in the sensitivity of 
different neurones was observed. 
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The effect of bicuculline methochloride (BMC) on the 
inhibition of firing of a spinal interneurone by glycine, 
GABA and 3-hydroxy-5-(2-aminoethyl)isoxazole (H2AI). The 
rate of firing of the interneurone was maintained by the 
conti~uous electrophoretic ejection of DL-homocysteate 
(DLH, 5 nA). Glycine (GL, 5 nA), GABA (GA, 15 nA) and 
3-hydroxy-5-(2-aminoethyl)isoxazole (H2AI, 27 nA) were 
administered for the periods indicated by the respective 
solid and broken horizontal lines. The solid bar and the 
vertical broken line indicates the period of continuous 
ejection of BMC from a solution of 10 mM in 165 mM NaCl. 
A, responses before; B, during the administrqtion of BMC 
with a current of 30 nA; C, 1 minute after the termination 
of the BMC ejection. 
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3-Hydroxy-5-(3-aminopropyl)isoxazole (compound 
XVI) an analogue of £-aminocaproic acid, was a weak 
depressant of the firing rate of spinal neurones. The 
isoxazoles VIII and II had no appreciable effects 
on spinal neurones and did not influence the depressant 
effects of similarly administered GABA and glycine. 
None of the GABA analogues that were shown to be 
inactive as depressants was found to antagonise the 
depressant action of electrophoretically administered 
GABA. 
(b) Effects of GABA uptake inhibitors 
The bicyclic isoxazole XIII, and the structurally 
related cyclic amino acids perhydro-1,2-oxazine-6-
carboxylic acid and nipecotic acid, are inhibitors 
of the high affinity uptake of GABA by rat brain slices 
(Krogsgaard-Larsen and Johnston, 1975). The remaining 
compounds in Table 2 did not inhibit GABA uptake, 
in vitro, except muscimol (Johnston, 1971) and compound 
IV, both of which are very weak inhibitors of GABA 
uptake (Krogsgaard-Larsen and Johnston, 1975). These 
findings prompted investigation of the effect on 
single neurones of XIV (perhydro-1,2-oxazine-6-carboxylic 
acid), nipecotic acid and the structurally related 
bicyclic isoxazoles XII and XIII. Fig. 3 illustrates 
the enhancement of the depressant action of electro-
phoretically administered GABA by similarly administered 
nipecotic acid. 
Nipecotic acid was a very weak depressant of the 
firing of spinal neurones, an effect which was very 
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Fig. 3: 
The effect of nipecotic acid on the inhibition of 
firing of a spinal interneurone by glycine and GABA. The 
rate of firing of the interneurone was maintained by the 
continuous electrophoretic ejection of DL-homocysteate 
(DLH). Glycine (GL, 4 nA) and GABA (GA, 20 nA) were 
administered for the periods indicated by the broken and 
solid horisontal lines, respectively. Nipecotic acid was 
administered for the period indicated by the solid 
horizontal bar and broken vertical line. A, control 
responses during the administration of DLH, 6 nA; B, 
responses during the administration of DLH (12 nA) and 
nipecotic acid with a current of 30 nA which was subsequent 
to a current of 20 nA for 2 minutes; C, responses 1.5 
minutes after termination of the nipecotic acid ejection 
and during the administration of DLH (7 nA). 
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slow in both onset and offset. This effect may have 
been a consequence of the accumulation of synaptically 
released GABA following the inhibition of its uptake 
rather than a direct depressant action of nipecotic 
acid per se. The enhancement of the depressant effect 
of GABA on spinal neurones by electrophoretically 
administered nipecotic acid was accompanied by a 
reversible suppression of the depressant effect of 
glycine as illustrated in Fig, 3, The effects of 
compound XIII on spinal neurones, alone and together 
with GABA and glycine were similar to, but probably 
weaker than the respective effects of nipecotic acid 
(Fig. 3) .. Similar experiments were difficult to perform 
with perhydro-1,2-oxazine-6-carboxylic acid because 
of the relatively low conductance of acidified aqueous 
solutions, but selective enhancement of the depressant 
activity of GABA by electrophoretically administered 
perhydro-1,2-oxazine-6-carboxylic acid was demonstrated 
on one neurone. The isoxaxole XII did not significantly 
influence the action of GABA under similar conditions. 
(c) Glycine antagonists 
A reversible antagonism of the depressant action 
of glycine similar to that of nipecotic acid as 
illustrated in Fig. 3 was demonstrated after micro-
electrophoretic administration of bicyclic isoxazoles 
XII and XIII. The isoxazole XII did not influence 
the firing rate of spinal interneurones and it does not 
influence the uptake of either GABA or glycine by rat 
brain slices (Krogsgaard-Larsen and Johnston, 1975). 
This isoxazole thus appears to be a rather specific 
antagonist of the postsynaptic action of glycine, 
although weak when compared with strychnine (Curtis, 
Duggan and Johnston, 1971). 
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(2) Cis and trans-4-aminocrotonic acids as depressants 
of spinal neurones 
Cis-4-aminocrotonic acid depressed the firing of 
all 6 interneurones (2 preparations) tested and was 
approximately 1/4 as potent as GABA. This depressant 
action could not be antagonised by either BMC (3 neurones) 
or strychnine hydrochloride (2 neurones) in concentrations 
adequate to block the effects of GABA or glycine, 
respectively. In contrast, trans-4-aminocrotonic acid, 
tested on 20 neurones (6 preparations) was approximately 
as potent as GABA as a depressant and this action could 
be blocked by BMC (6 neurones), but not by strychnine 
(3 neurones). The firing frequency versus time recordings 
and filmed records indicated that the time courses of 
onset and recovery for trans-4-aminocrotonic acid were 
similar to those for GABA. 
Fig. 4A-C is a recording from a spinal interneurone 
that was being excited by the continuous administration 
of DLH. This neurone responded in a similar manner to 
GABA (10 nA), trans-4-aminocrotonic acid (20 nA) and 
cis-4-aminocrotonic acid (50 nA) m 10 nA of BMC reduced 
the depressant effects of GABA and trans-4-aminocrotonic 
acid but not that of cis-4-aminocrotonic acid. Strychnine 
hydrochloride (30 nA) had no significant effect on any of 
the three depressants. 
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Structures of GABA, trans- and cis-4-aminocrotonic 
acids and t~ ·~ir depressant effects on the firing of a spinal 
interneurode excited by the continuous electrophoretic 
ejection of DL-homocysteate (DLH, 20 nA). The depressant 
amino acids were administered for the times indicated by the 
horizontal black bars and symbols. A, control observations; 
B, during the administration of bicuculline methochloride 
(BMC, 10 mM in 165 mM NaCl) with a current of 40 nA for 
3 minutes; C, after recovery from the effects of BMC and 
during the administration of strychnine hydrochloride (2 mM 
in 165 mM NaCl) with a current of 30 nA for 3 minutes. 
Maximum effects of BMC and strychnine are illustrated. 
( 3) 
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Cyclohexane derivatives as depressants of spinal 
neurones 
Three of the four aminocyclohexane carboxyl i c 
acids that were tested on spinal interneurones and Renshaw 
cells were weak depressants. The approximate potencies 
of these compounds, relative to that of GABA, are shown 
in Table 3. Some difficulty was experienced in studying 
the pharmacology of these compounds due to the small 
magnitude of the responses that were being investigated 
(see Fig. 5), and for this reason the relative potencies 
have not been accurately assessed. The gradation of 
potency as depressants from the top of the table to the 
bottom, however, was considered to be significant. Thus 
the four aminocyclohexane carboxylic acids were weaker 
than GABA, cis-3-aminocyclohexane-l-carboxylic acid was 
the most potent and cis-2-aminocyclohexane-l-carboxylic 
acid was inactive. Fig. 5 illustrates a comparison of 
the potencies of cis-2- and trans-2-aminocyclohexane-l-
carboxylic acids. In this comparison, on a Renshaw cell 
excited by DLH (12 nA), the trans-2- derivative was 
approximately one-fifth as potent as GABA, but the cis-2-
derivative was much weaker or inactive and it was 
impossible to distinguish between a true depression and 
that due to current alone, for the same current of strychnine 
hydrochloride produced a depression that was similar to 
that due to current passed through the cis-2- bar rel. 
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Fig. 5: 
The effects of GABA, cis-2- and t rans- 2-aminocyclo-
hexane-l-carboxylic acids on the fi r ing of a Renshaw cell 
. 
which was excited by the continuous ele ctrophoretic 
administration of DL-homocysteate (DLH, 12 nA). Cis-2-
aminocyc1ohexane-l-carboxylic acid a nd strychnine hydro-
chloride (2 mM in 165 mM NaCl) were retained by the same 
anionic currents and thus their ej ection with currents of 
60 nA represented equal current change. The periods of 
ejection of cis-2-aminocyclohexane- l - carboxylic acid (cis-2-, 
60 nA), trans-2-aminocyclohexane-l-carboxylic acid (trans-2-, 
60 nA), strychnine hydrochloride (strych, 60 nA) and GABA 
(GA, 12 nA) are indicated by the r espective solid and broken 
horizontal lines. 
TABLE 3 Relative potencies of aminocyclohexane-
1-carboxylic acids as depressants of 
spinal neurones 
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Compound Current Relative potency (nA) range 
GABA (27) 0-20 1 
(±)-cis-3- (12)* 10-100 0.20-0.25 
(±)-trans-3- ( 2 3) 20-100 0.05-0.5 
(±)-trans-2- ( 9) 30-100 0.05-0.2 
(±)-cis-2- (5) 30-100 
* See text for significance of these 12 tests. 
The number of neurones tested with each compound 
is shown in brackets. Each solution was 0.2 Mand 
the pH was adjusted to 3 with HCl. 
Cis-3-aminocyclohexane-l-carboxylic acid was 
unusual in that it clearly depressed 2 of the 12 neurones 
on which it was tested, 6 of the remaining 10 neurones 
were weakly excited by this compound, but depressed by 
GABA. As a depressant, cis-3-aminocyclohexane-l-
carboxylic acid was clearly more potent than trans-3-
aminocyclohexane-l-carboxylic acid when the two were 
directly compared as depressants on 2 neurones (the only 
2 that were depressed by the cis-3- derivative). 
Cis-2-aminocyclohexane-l-carboxylic acid was very weak 
or inactive when tested on 5 neurones, a finding that was 
consistent with the unpublished results of D.R. Curtis. 
The relatively low potencies of the three amino-
cyclohexane-1-carboxylic acids that were weak depressants 
precluded an accurate determination of their sensitivities 
to BMC and strychnine hydrochloride. Each depressant 
compound was tested on a minimum of two neurones during 
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the continuous administration of either strychnine hydro-
chloride or BMC and although the depressant actions 
appeared to be insensitive to these antagonists uniquivocal 
results were not obtained. 
(4) ~ -(p-Chlorophenyl)-GABA (SCPG) as a depressant of 
neuronal activity 
(a) Spinal interneurones 
When administered with cationic currents (10-80 nA) 
BCPG reversibly reduced the firing rates of spontaneously 
active or chemically excited spinal interneurones (36 
neurones, 16 preparations). The onset of the effect was 
slow, the potency of BCPG was approximately half that 
of GABA (24 equipotent current ratio determinations) 
and in contrast to the rapid recovery of firing which 
invariably occurs after the termination of GABA-ejecting 
electrophoretic currents, recovery after SCPG was 
prolonged, frequently taking 1-2 minutes (see Fig. 6). 
The tracings of Fig. 6A plot the firing of a spontan-
eously active dorsal horn interneurone, and compare the 
effectiveness and time course of depression produced by 
glycine, GABA and BCPG. Similar results were obtained 
with neurones fired by L-glutamate, L-aspartate or DLH. 
As illustrated in Fig 6B, concentrations of BMC adequate 
to totally block the effect of GABA had little or no 
action on the depression of firing by BCPG (3 spinal 
interneurones). Furthermore, concentrations of strych-
nine hydrochloride sufficient to abolish the effect of 
glycine (Fig. 6C) did not modify the action of BCPG (3 
spinal interneurones). Thus neither GABA nor glycine 
receptors appeared to be involved in the depressant 
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The effects of electrophoretically admi nistered glycine, 
GABA and SCPG, indicated by dotted, solid and broken horizontal 
lines, on the spontaneous firing of a spinal i nterneurone. 
A, control observations of glycine (10 nA), GABA (10 nA) and 
SCPG (20 nA); B, during the microelectr ophore t ic a dministration 
of bicuculline methochloride (BMC, 10 rnM in 16 5 rnM NaCl), 
15 nA for 1.4 min, 30 nA for 0.4 min and throu ghout the period 
of the illustrated recording; C, a f t er recovery from BMC and 
during the administration of strychni ne ( 2 rnM in 165 rnM NaCl) 
with a current of 20 nA. 
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action of SCPG-
(b) Pyramidal tract neurones and Purkinje cells 
The microelectrophoretic administration of SCPG 
close to neurones in the postcruciate cortex and vermal 
cerebellar cortex produced similar results to those 
obtained in the spinal cord. Prolonged depression of 
neuronal firing was observed with pyramidal tract cells 
(5) and Purkinje cells (6) after the administration of 
SCPG. As in the spinal cord SCPG was usually less 
potent than GABA by a factor of approximately 0.5, 
and the depression of all four pyramidal tract neurones 
was not reduced by concentrations of BMC adequate to 
suppress the inhibitory action of initially approximately 
equi-effective amounts of GABA (Fig. 7). 
(c) Renshaw cells 
Additional evidence suggesting that neither GABA 
-
nor glycine receptors were involved in the depressant 
action of SCPG was obtained from observations made on 
21 Renshaw cells, neurones having a sensitivity to 
glycine and GABA of the same order of magnitude as 
dorsal horn interneurones (Curtis, Hosli and Johnston, 
1968). As illustrated in Fig. 8A and B, SCPG was a 
weak depressant of the firing of Renshaw cells when 
compared with glycine and GABA. The micropipette used 
for both neurones was that used to study the inter-
neurones of Fig. 6. In many cases difficulty was 
experienced in determining whether the effects observed 
on Renshaw cells were not due merely to the electro-
phoretic current, and with all cells the depression was 
of comparable duration to that of GABA and glycine, 
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Effect of GABA and SCPG on the firing of a pyramidal 
tract neurone of the postcruciate cortex, maintained with 
DL-homocysteate (DLH). A, GABA (10 nA), SCPG (30 nA) and 
DLH (12 nA, continuous); B, 1 min after beginning the 
ejection of bicuculline methochloride (BMC, 10 mM in 165 mM 
NaCl) with a current of 40 nA. The increased firing rate 
was diminished by reducing the DLH current to 7.5 nA, but the 
record shows periodic bursts of high frequency firing. 
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glycine (10 nA), 8CPG (40 nA) and DLH (9 nA, continuous). 
prolonged depression never being observed. Electro-
phoretic currents of 30~50 nA of SCPG had no effect 
on the submaximal ventral root response of 4 Renshaw 
cells, although GABA (10-20 nA) reduced the response 
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to about 50% of control No differences were observed 
in the sensitivity to SCPG of Renshaw cell firing 
induced by L-glutamate, L-aspartate, DLH or acetylcholine. 
(d) Comparison of SCPG and noradrenaline as depressants 
The prolonged recovery time of interneurones from 
SCPG induced depression was comparable with the 
reported recovery time resulting from the administration 
of noradrenaline (Biscoe, Curtis and Ryall, 1966). 
Of the 15 interneurones tested with both SCPG and 
noradrenaline (20-80 nA), however, only 5 responded 
to both depressants with a slow rate of recovery. Four 
of these 15 interneurones responded slowly to SCPG and 
not to noradrenaline, and the remaining 6 responded 
to sCPG with the usual slow rate of recovery, but 
the response to noradrenaline was of a faster time 
course (Fig. 9A). The slow onset of the first response 
to GABA (10 nA) in Fig. 9A reflects the lengthy period, 
prior to this ejection, during which no electrophoretic 
ejection currents had been passed through the GABA 
barrel. 
The responses of 10 Renshaw cells to noradrenaline 
were also variable in time course, being either slow 
(Fig. 9B) (2 cells), moderate (2 cells) or fast (3 
cells) in their rates of recovery, but cells which 
were apparently not affected by SCPG (10-80 nA) were 
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The structures and effects of electrophoretically 
administered 8CPG, noradrenaline and GABA on a spinal 
interneurone and a Renshaw cell. The rates of firing of the 
interneurone and Renshaw cell were maintained by the 
continuous electrophoretic administration of DL-homocysteate 
(DLH) and acetylcholine (ACh) respectively, and the periods 
of administration of 8CPG, GABA (GA) and noradrenaline (NA) 
are indicated by the respective solid and broken horizontal 
lines. A, the effects of NA (50 nA), 8CPG (20 nA), GABA (10 nA ) 
and DLH (12 nA, continuous) on a spinal interneurone; B, 
the effects of 8CPG (40 nA), GABA (10, 2 nA), NA (26 nA) and 
ACh (4 nA, continuous) on a Renshaw cell. 
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readily depressed by noradrenaline (20-80 nA), 
(e) Systemically administered SCPG 
Intravenously administered SCPG (1-2 mg/kg) 
reduced spinal monosynaptic reflexes with a simultaneous 
reduction of dorsal root potentials (DRPs) (4 
preparations). There was, however, no apparent change 
in the 'Renshaw ripple' or the 'quadriceps notch'. 
Fig. 10 illustrates the results from one experiment 
in which 2 mg/kg SCPG reduced the gastrocnemius-
soleus (GS) monosynaptic reflex to 55% when the DRP 
amplitude was reduced to approximately 70% of its 
control amplitude. There was no apparent change in 
either the 'Renshaw ripple' or the 'quadriceps notch' 
(judged by superimposed filmed records) which are 
illustrated when the GS monosynaptic reflex had been 
reduced to 30% of its control amplitude. 
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Fig. 10: 
The effects of S.-(~-chlorophenyl)-GABA (SCPG) on the 
'quadriceps notch', 'Renshaw ripple' and dorsal root 
potential. A, the 'quadriceps notch' (indicated by the 
arrow) recorded from the dorsal surface of the spinal cord 
in response to stimulation of the quadriceps nerve at 
2 x threshold (Q 2T); B, the 'Renshaw ripple' recorded from 
the dorsal surface of the spinal cord in response to stimul-
ation of the seventh lumbar ventral root (L7 VR); C, the 
dorsal root potential (DRP) recorded from the most caudal 
rootlet of the sixth lumbar dorsal root (amplifier time 
constant 1 sec) in response to stimulation of the posterior 
biceps and semitendinosus nerves (4 volleys, 320 Hz, 3 x 
threshold; 4PBST 3T). 1, before; 2, after 2 mg/kg SCPG, 
intravenous. A2 and B2, 4 min after SCPG when the gastroc-
nemius-soleus monosynaptic reflex (GS MSR) had been reduced 
to 30% of its control value; C2, 2 min after SCPG when the 
GS MSR had been reduced to 55% of its control value. Voltage 
calibration: 0.1 mV. 
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DISCUSSION 
Muscimol should be a valuable model compound for 
investigating the structural and conformational require-
ments of bicuculline-sensitive, postsynaptic GABA 
receptors. This isoxazole is a potent bicuculline-
sensitive depressant of spinal neurones (Johnston, Curtis, 
de Groat and Duggan, 1968; Curtis, Duggan, Felix and 
Johnston, 1971), and yet it is only a weak non-competitive 
inhibitor of GABA uptake by rat brain slices (Johnston, 
1971). Certain structural and conformational requirements 
are essential before a molecule will successfully interact 
with bicuculline-sensitive, postsynaptic GABA receptors 
(see Section I and Curtis and Watkins 1960, 1965). 
Consequently, the GABA-like postsynpatic action of 
muscimol is presumably a consequence of the conspicuous 
structural similarities between GABA and muscimol. 
Unlike GABA, however, the muscimol molecule is relatively 
rigid and the conformational restrictions of this 
compound and structurally related isoxazoles can be used 
to further analyse the bicuculline-sensitive GABA receptor. 
Structural modification of muscimol produced 
compounds that were either weaker than or similar in 
potency to GABA, the potency depending upon the nature of 
the structural changes. Elongation of the side chain of 
muscimol with a further methylene group, or substitution 
of an aliphatic hydrogen atom with a methyl group gives 
compounds X and IV, respectively. The depressant actions 
of these two compounds were weaker than that of muscimol, 
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but comparable in potency with those of their open chain 
analogues, o- and y-aminovaleric acids (Curtis and Watkins, 
1960 and see also Krogsgaard-Larsen, Johnston, Curtis, 
Game and McCulloch, 1975). Further increasing the size of 
the alkyl group in compound IV produced compounds v and 
VI which were weaker agonists than compound IV. On the 
other hand, substitution of the aromatic protons of muscimol 
and compound X with alkyl groups greatly reduced the 
effectiveness of these compounds as neuronal depressants, 
the derivatives VII, VIII and XI being very weak or 
inactive. These derivatives have substituents in the 
4-position, and the 4-positions of muscimol and compound X 
are isosteric with the a-methylene group of GABA and 
o-aminovaleric acid, respectively. Smythies (1974) has 
recently postulated that the a-methylene group of GABA is 
involved in lipophilic binding in the GABA-receptor complex. 
Thus the complete rigidity of the isoxazole ring may mean 
that substituents in the 4-position prevent interaction 
with the GABA receptor. 
The interaction of trans-4-aminocrotonic acid 
with bicuculline-sensitive postsynaptic receptors further 
supports previous suggestions regarding the structural 
similarities of bicuculline, GABA, muscimol and 
4-aminotetrolic acid (Curtis, Duggan, Felix and Johnston, 
1971; Beart, Curtis and Johnston, 1971). Trans-4-
aminocrotonic acid and muscimol represent relatively 
rigid and extended conformations of GABA and the potent 
GABA-like effects of these compounds on spinal neurones 
may indicate that the low energy conformations of the 
compounds reflects the conformations of GABA required 
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for interaction with the GABA receptor. Molecular orbital 
calculations predict an extended conformation of muscimol 
in the conservative state (Kier and Truit, 1970), whereas 
muscimol adopts a twisted conformation in the solid state 
as shown by x~ray crystallography. The intramolecular 
0(2)- and N(l)+ distances from X-ray analysis and molecular 
orbital calculations, however, are in approximate agreement; 
5-6 R from calculations and 5.772 ~ as analysed (Brehm, 
Hjeds and Krogsgaard-Larsen, 1972). These and other 
X-ray crystallographic studies have indicated structural 
similarities between muscimol (Brehm, Hjeds and Krogsgaard-
Larsen, 1972) and GABA (Tomita, Higshi and Fujiwara, 1973) 
and between the hydrochlorides of trans-4-aminocrotonic 
acid and GABA (Tomita, 1971). In addition to the structural 
similarities, however, the relative rotational freedom of 
these agonists may be an important factor, since it is 
likely that formation of the agonist-receptor complex 
involves a process of conformational selection which will 
influence the kinetics and thermodynamics of the inter-
action. 
X-Ray analysis of compound X and 3-hydroxy-5 
(3-aminopropyl)isoxazole (compound XVI) are also available 
(Brehm, Krogsgaard-Larsen and Hjeds, 1974), and despite 
the different aliphatic side chains the distances between 
the charged centres in muscimol and compound X in the solid 
state conformation are very similar, but distinctly 
different from the corresponding distance in compound XVI 
which was a very weak depressant. These structural 
findings, plus the GABA-like depressant effects of muscimol 
and H2AI, indicate that the intramolecular distance between 
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the zwitterionic centres of GABA agonists may be of 
importance for their postsynaptic activity. The 
appropriate distances for muscimol (5.772 R, X-ray 
analysis; Brehm, Hjeds and Krogsgaard-Larsen, 1972) and 
H2AI (5.979 R, X-ray analysis; Brehm, Krogsgaard-Larsen 
and Hjeds, 1974) are within the ranges of those accessible 
to the conformationally restricted GABA-like agonists, 
0 trans-4-aminocrotonic (4.9-6,l A, Dreiding stereomodels) 
and 4-aminotetrolic acids (5.2-5.8 ~' Dreiding stereornodels 
Beart, Johnston and Uhr, 1972). 
Due to the difficulty experienced in obtaining 
precise relative potencies of the aminocyclohexane 
derivatives, a consequence of their weak activities as 
depressants, it is only possible to obtain limited 
information in terms of their structure-activity relation-
ships. A structure-activity analysis is further limited 
due to the number of conformational modes that are 
available to the aminocyclohexane derivatives. It lS 
probably significant, however, that the two analogues in 
which the distance between the zwitterionic centres is 
restricted to less than 5 ~ (Dreiding stereomodels; 
Beart, Johnston and Uhr, 1972), cis- and trans-2-amino-
cyclohexane-l-carboxylic acid were the weakest members of 
the series. Furthermore, the cis-2- derivative, which 
probably has the closest zwitterionic centres, was found 
to be very weak or inactive in these tests. 
Cis- and trans-3-aminocyclohexane-l-carboxylic 
acids were the two most potent depressants in the 
aminocyclohexane series, and although Table 3 suggests 
that they were of similar potency, the cis-3- derivative 
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was the more potent compound in a direct comparison on 
the two neurones that were depressed by the cis-3-
derivative. There appears to be no ready explanation for 
the excitation of 6 of the remaining 10 neurones on which 
cis-3-arninocyclohexane-l-carboxylic acid was tested. The 
chair conformation of cis-3- and trans-3-aminocyclohexane-
l-carboxylic acids are probably the preferred conformations 
of these compounds and they are illustrated in Fig. 11. 
On the basis of pK measurements, Hewgill and Jefferies 
(1955) have concluded that DL-cis-3-aminocyclohexane-l-
carboxylic acid existed in aqueous solution predominantly 
in the diequatorial conformation (Fig. 11), in this 
conformation the distances between the zwitterionic centres 
are from approximately 4.8 ~ to 6.2 ~ (Dreiding steremodels; 
Beart, Johnston and Uhr, 1972). The energy barrier between 
the two conformers, however, might be quite small and either 
conformer may be the active one. The interzwitterionic 
distance in the diaxial conformer of cis-3-aminocyclo-
hexane-l-carboxylic acid is from 3.9 to less than 1.5 ~ 
(Dreiding stereomodels, Beart, Johnston and Uhr, 1972), 
a distance which is less than the maximum distance found 
in the very weak or inactive cis-2- derivatives. Cis-3-
and trans-3-aminocyclohexane-l-carboxylic acids are 
inhibitors of GABA uptake by rat brain slices (Beart, 
Johnston and -Ohr, 1972) and may thus be substrates for 
that transport system, a factor which could complicate 
the estimation of their relative potencies, but these 
two compounds were more potent depressants than the trans-
2- derivatives which did not inhibit uptake (Beart , Johnston 
and Uhr, 1972). It is likely that the cis-2- derivatives 
are not substrates for the GABA uptake system and thus 
Fig. 11: 
GABA 
(fully extended ) 
co -
2 
co; 
DL-cis-3-aminocyclohexane-
1-carboxyl ic acid 
(diaxial) (diequatorial ) 
co; 
DL-trans-3-aminocyclohexane-
1-carboxylic acid 
The structures of GABA, (±)-ci s- and (±)-trans-3-
aminocyclohexane-l-carboxylic acids . Only the chair forms 
of the two cyclohexane de rivat i ve s are shown. 
they may attain higher concentrations in the extra-
cellular space than the cis-3- derivatives, after 
electrophoretic ejection. 
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The results with the aminocyclohexane-1-carboxylic 
acids as neuronal depressants suggest that the optimal 
0 charge separation for depressant activity is from 5-6 A. 
A similar conclusion was reached when these compounds 
were studied as inhibitors of GABA uptake and the optimum 
interzwitterionicdistance for inhibition of uptake was 
found to be from 5-6 ~ (Beart, Johnston and Uhr, 1972). 
The interzwitterionic distances in muscimol and H2AI fall 
within the 5-6 ~ range (see above), but of these two 
compounds only muscimol is a weak inhibitor of GABA uptake 
(Johnston, 1971). 
The activities of certain aminocyclohexane-carboxylic 
acids as depressants of rat hippocampal neurones have been 
reported by Segal and coworkers (Segal, Sims, Maggiora 
and Smissman, 1973). Similar difficulties in estimating 
relative potencies were apparently encountered in this 
work in which the trans-2- and cis-3- conformers were 
reported to be the most potent GABA analogues. A relative 
assessment using submaximal responses was apparently not 
made on each neurone, and the significance of the quoted 
potencies may thus be questioned. The depressant action 
of cis-3-aminocyclohexane-l-carboxylic acid on rat 
hippocampal neurones was reported to be blocked by 
bicuculline, but no details of the testing conditions 
were given (Segal, Sims, Maggiora and Smissman, 1973). 
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The selective enhancement of the depressant action 
of electrophoretically administered GABA on spinal 
neurones by nipecotic acid and compound XIII is suggestive 
of the importance of the uptake process in terminating 
the depressant action of this amino acid. Of the compounds 
listed in Table 2 only XIII and the structurally related 
cyclic amino acids perhydro-1,2-oxazine-6-carboxylic acid 
and nipecotic acid are significant inhibitors of high 
affinity GABA uptake (Krogsgaard-Larsen and Johnston, 
1975), a system which has been shown to have considerable 
structural and conformational specificity (Iversen and 
Neal, 1968; Iversen and Johnston, 1971; Beart and Johnston, 
1973; Beart, Johnston and Uhr, 1972; Johnston, 1971). 
The intramolecular distance between the charged centres 
in nipecotic acid and compound XIII is 4.236-4.758 ~ 
(X-ray analysis, see Krogsgaard-Larsen, Johnston, Curtis, 
Game and McCulloch, 1975) and 4e4 ~ (Dreiding stereomodels, 
Krogsgaard-Larsen and Hjeds, 1974), respectively. 
Muscimol (Johnston, 1971) and compound IV (Krogsgaard-
Larsen and Johnston, 1975) are potent neuronal depressants, 
but very weak inhibitors of GABA uptake, and hence it is 
evident from Table 2 that the structural and conform-
ational requirements for interaction of GABA analogues 
with the uptake system and postsynaptic receptors must 
be different. 
Trans-4-aminocrotonic acid was demonstrated to be 
a bicuculline-sensitive depressant of spinal neurones 
with a potency similar to that of GABA. Hence this 
compound substitutes for GABA at the postsynaptic receptor, 
in the GABA uptake system (Johnston, Curtis, Beart, Game, 
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McCulloch and Twitchin, 1974) and it is also a substrate 
for the GABA catabolising enzyme GABA:2-oxoglutarate 
aminotransferase (Beart and Johnston, 1973). The folded 
GABA analogue, cis-4-aminocrotonic acid was not a 
substrate for GABA:2-oxoglutarateaminotransferase, does 
not inhibit GABA uptake by rat brain slices (Johnston, 
Curtis, Beart, Game, McCulloch and Twitchin, 1974) and is 
a weak bicuculline-insensitive depressant of spinal 
neurones. Similarly, neither cis-2- nor trans-2-
aminocyclohexane-l-carboxylic acid inhibited the uptake of 
GABA by rat brain slices (Beart, Johnston and Uhr, 1972) 
and both these compounds were weak or inactive as 
depressants of spinal neurones. It would thus appear 
likely that extended conformations of GABA are important 
with respect to the interaction of GABA and the specific 
macromolecules which mediate GABA uptake and neuronal 
depression, however, the biological activities of the 
compounds in Table 2 have indicated that the two 
processes have slightly different structural and conform-
ational requirements. 
It would seem reasonable to assume that after 
electrophoretic ejection from solutions at pHs from 2-3.5 
the GABA analogues that have been investigated in these 
experiments take up ionic forms that depend only upon the 
local pH. Electrophoretically or pressure-ejected GABA 
from a neutral solution (Krnjevic and Phillis, 1963), or 
electrophoretically ejected GABA from solutions at either 
pH 2.5-3 or pH 11-12 (Curtis, Phillis and Watkins, 1959) 
depresses central neurones. The isoelectric point for 
GABA at 350c is pH 7.5 (see King, 1954), and consequently 
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the predominant form in feline extraneuronal fluid would 
be the zwitterion. The dissociation constants of the 
ionizable groups in the GABA analogues of Table 4, appear 
to be distributed over an appreciable range, and are thus 
possibly somewhat less important than structural and 
conformational factors. 
TABLE 4 Ionisation constants for GABA and some 
conformationally restricted analogues of GABA 
Compound 
GABA 
cis-4-Arninocrotonic acid 
trans-4-Aminocrotonic acid 
cis-3-Aminocyclohexane-l-
carboxylic acid 
trans-3-Aminocyclohexane-l-
carboxylic acid 
4-Aminotetrolic acid 
3-Hydroxy-5-(2-aminoethyl)-
isoxazole (X) 
3-Hydroxy-5-(3-aminopropyl)-
isoxazole (XVI) 
3-Hydroxy-5-aminomethyl-
isoxazole (muscimol) 
Piperidine-3-carboxylic acid (nipecotic acid) 
pK values 
T20°c) - Reference 
4.04 10.71 King, 1954 
3.53 9.84 1 
3.55 9.46 2 
3.70 
3.85 
1,,80 8.34 
5.12 9 .. 46 
5.37 10.36 
4.78 8.43 
3.86 10.28 
3 
3 
4 
5 
5 
Eugster, 
1969 
6 
5,6,7,8-Tetrahydro-4H-isoxa-
zolo[4,5-d]azepin-3-ol (XII) 4.84 9.20 5 
4,5,6,7-Tetrahydroisoxazolo-
[4,5-c]pyridin-3-ol (XIII) 4.33 9.06 5 
References: 1, Johnston, Curtis, Beart, Game, McCulloch and Twitchin, 1974; 2, Beart, Johnston and Uhr, 1972; 3, Hewgill and Jefferies, 1955; 4, Beart 
and Johnston, 1972; 5, Brehm, Krogsgaard-Larsen and Hjeds, 1974; 6, Krogsgaard-Larsen and Johnston, 1975. 
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The relatively weak and slow depressant action of 
cis-4-aminocrotonic acid, which could not be blocked by 
either bicuculline or strychnine, is of interest in view 
of the similar weak and apparently BMC-insensitive 
depressant effects of compounds V and VI which are slow 
in onset. In addition, no evidence was found for the 
interaction of SCPG with the bicuculline-sensitive 
receptors associated with GABA-mediated synaptic inhibition 
Davies and Watkins (1974) have also reported a bicuculline-
insensitive depression of cerebral cortical neurones by 
SCPG, and of the various GABA 'receptors' present in 
mammalian central nervous tissue, SCPG possibly only 
interacts with those of GABA:2-oxoglutarate aminotransferase 
(Curtis, Game, Johnston and McCulloch, 1974). Interaction 
of SCPG with glycine receptors seems unlikely in view of 
the minimal effect of this compound on Renshaw cells and 
the strychnine-insensitive depression of spinal inter-
neurones. Unlike SCPG, cis-4-aminocrotonic acid appeared 
to be equally potent as a depressant of the firing of 
Renshaw cells and spinal interneurones. Isoxazoles V 
and VI were not tested on Renshaw cells. 
The reduction in vitro by SCPG of high affinity 
L-glutamate uptake by rat brain slices (Curtis, Game, 
Johnston and McCulloch, 1974) does not account for the 
depression of neuronal firing by SCPG. Furthermore, 
antagonism at excitant amino acid receptors or a reduced 
release of excitatory transmitters does not readily 
account for the depressant effects of SC PG. If glycine 
and GABA receptors are not involved in this depressant 
action, then it would seem possible that the excitability 
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change results from interaction with another type of 
neuronal receptor, which may be associated with the 
operation of an inhibitory transmitter other than glycine 
or GABA. This transmitter may be structurally related to 
the phenylethylamine moiety of SCPG rather than to the 
GABA portion of the molecule, but the lack of correlation 
between the depressant effects of SCPG and noradrenaline, 
a phenylethylamine related compound (Fig. 9), suggests 
that the hypothesised transmitter is unlikely to be 
noradrenaline. 
Although not tested directly in the present 
experiments, SCPG probably has an action on spinal 
motoneurones similar to that observed with interneurones, 
pyramidal tract neurones and Purkinje cells, since 
relatively low doses administered systemically markedly 
reduced spinal monosynaptic reflexes (see also Bein, 1972). 
The relative ineffectiveness of electrophoretically 
administered SCPG as a depressant of Renshaw cell firing 
was unexpected, although an earlier report indicated 
that SCPG usually had no action on the firing of bulbar 
reticular neurones which were sensitive to glycine and 
GABA (Hosli, Tebecis and Haas, 1971). When this compound 
was systemically administered in doses sufficient to 
reduce spinal monosynaptic reflexes there was no apparent 
change in the rhythmic wave of inverted phase ('Renshaw 
ripple') recorded from the dorso-lateral surface of the 
spinal cord in response to antidromic stimulation of the 
ventral roots and believed to be due to Renshaw cell 
discharges (Eccles, Fatt and Koketsu, 1954). Hence, 
neither electrophoretically nor systemically administered 
SCPG was shown to significantly affect the excitability 
of Renshaw cells. 
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Preliminary experiments have indicated an increase 
in membrane conductance and decreased excitability when 
SCPG was administered electrophoretically near spinal 
motoneurones (Curtis, Game, Johnston and McCulloch, 1974). 
Such a post-synaptic effect, however, does not explain 
the reduction of excitatory postsynaptic potentials of 
these cells in the absence of alterations in either 
inhibitory postsynaptic potentials or membrane excitability 
reported to follow systemic administration of SCPG 
(Pierau and Zimmermann, 1973), observations which suggest 
a presynaptic effect of this agent at excitatory synapses 
on motoneurones, but not at those on spinal inhibitory 
neurones. The absence of a significant effect of SCPG on 
the 'quadriceps notch' which was recorded from the dorso-
lateral surface of the spinal cord in response to stimu-
lation of the quadriceps nerve, and is possibly generated 
by excitation of quadriceps la inhibitory interneurones, 
may indicate that inhibitory interneurones, like Renshaw 
cells, are relatively insensitive to this compound, but 
this would need to be tested at the cellular level. 
When administered systemically SCPG simultaneously 
reduced monosynaptic reflexes and DRPs, generally 
accepted as a measure of primary afferent depolarisation 
(PAD) (Schmidt, 1971), a process which is associated with 
presynaptic inhibition of spinal reflexes. GABA appears 
to participate in the development of PAD; evidence for 
this participation includes reduction of PAD and the 
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inhibitory effect on reflexes of incoming volleys by 
picrotoxinin and bicuculline (Schmidt, 1971; Curtis, 
Duggan, Felix and Johnston, 1971; Levy and Anderson, 1972), 
but direct evidence for terminal depolarisation has not 
been obtained in the cat. When applied topically to the 
spinal cord, GABA and 3-amino-1-propanesulphonic acid 
depressed DRPs and dorsal root reflexes and thus may have 
depolarised primary afferent fibres (Eccles, Schmidt and 
Willis, 1963). Electrophoretically administered GABA, 
however, depressed terminal excitability (Curtis and Ryall, 
1966a). These topically administered amino acids, like 
systemically administered SCPG, may reduce DRPs not only 
by depolarising primary afferent terminals, but also by 
depressing the interneurones on the pathway that is 
responsible for generating PAD~ 
The structural basis of the antagonism of the 
inhibitory effect of glycine by the isoxazoles XII and 
XIII and by nipecotic acid is not clear. Interestingly, 
however, this activity, which is relatively weak compared 
with that reported for the specific glycine antagonist 
strychnine (Curtis, Duggan and Johnston, 1971) seems to 
increase with increasing substitution of the amino group 
of the model compounds. 
In summary, it should be emphasised that conclusive 
evidence concerning the 'active conformations' of GABA 
cannot be derived from this analysis. Only a limited 
number of model compounds has been investigated, and it 
is conceivable that these compounds interact with a limited 
population of synapses operated by GABA. Some of the 
compounds that were investigated were only weak depressants 
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of spinal neurones, and consequently the sensitivities o f 
these effects to bicuculline have not been clearly 
established, and the conclusions drawn from these 
particular compounds must be treated with caution. The 
present evidence favours extended conformers of GABA as 
the active ones at bicuculline-sensitive postsynaptic 
synapses, and there are indications that the macromolecules 
that mediate the postsynaptic GABA-like depressant action 
and the high affinity uptake of GABA have different 
structural and conformational requirements. The distances 
between the charged centres of GABA agonists and inhibitors 
of GABA uptake required for biological activity generally 
appear to be within different but apparently rather 
narrow ranges. 
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IV. BICUCULLINE ANALOGUES AS GABA ANTAGONISTS 
AND ANTICHOLINESTERASES 
The convulsant pthalide isoquinoline alkaloid 
bicuculline (Manske, 1933) has proved of considerable value 
in studying inhibitory processes in the mammalian central 
nervous system mediated by GABA. When administered 
electrophoretically near single neurones, (+)-bicuculline 
selectively reduces the inhibitory effects of GABA (or 
GABA-like amino acids - see Curtis, Hosli and Johnston, 
1968; Curtis, Duggan, Felix and Johnston, 1971; Curtis, 
Duggan, Felix, Johnston and McLennan, 1971) with little 
or no reduction of the effects of glycine (and glycine-
like amino acids) or noradrenaline. Selective antagonism 
of this type has been demonstrated in the spinal cord 
(Curtis, Duggan, Felix and Johnston, 1971) and the 
following supraspinal regions: cuneate nucleus (Kelly 
and Renaud, 1973), medullary reticular formation (Tebecis, 
Hosli and Haas, 1971; Tebecis, 1973), hypoglossal nucleus 
(Duggan, Lodge and Biscoe, 1973), lateral vestibular 
nucleus (Curtis, Duggan, Felix, Johnston and McLennan, 
1971), hypothalamus (Nicoll and Barker, 1971; Dreifuss 
and Mathews, 1972), thalamic ventrobasal complex (Curtis, 
Duggan, Felix, Johnston and McLennan, 1971), lateral 
geniculate nucleus (Curtis and Tebecis, 1972), cerebellar 
interpositus nucleus (Kawaguchi and Ono, 1973), septal 
nuclei (McLennan and Miller, 1974), cerebellar, cerebral 
and hippocampal cortices (Curtis, Duggan, Felix, Johnston 
and McLennan, 1971), and the olfactory bulb (Felix and 
McLennan, 1971; Nicoll, 1971). Furthermore, bicuculline 
(administered intravenously or electrophoretically) has 
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been shown to suppress various synaptic inhibitions that 
are suspected of being mediated by GABA on the basis of 
neurochemical and neuropharmacological evidence, and many 
of which are found in those previously quoted regions of 
the central nervous system in which bicuculline has been 
demonstrated to be a specific GABA antagonist (see Curtis 
and Johnston, 1974a, 1974b). 
Certain difficulties have been experienced in the 
experimental use of bicuculline, largely because a 
saturated solution at pH 3, as used in microelectrophoretic 
experiments, contains approximately 5 mM bicuculline 
hydrochloride which is even less soluble at a more 
physiological pH (Curtis, Duggan, Felix and Johnston, 
1971; Pong and Graham, 1972). Some controversy has thus 
arisen regarding bicuculline-GABA antagonism in the mammalian 
central nervous system, and much of this controversy is 
undoubtedly due to improper preparation of bicuculline 
solutions (see Curtis and Johnston, 1974b). Some 
controversy has also arisen as a result of the difficulties 
associated with the interpreation of the non-equilibrium 
'dose-response' measurements employed by Hill and Simmonds 
(1973) (see also Straughan, Neal, Simmonds, Collins and 
Hill, 1971). This type of evaluation of microelectro-
phoretic antagonism was discussed in the introduction to 
this thesis and the matter is further considered in the 
next section (V). 
Despite the published evidence indicating that the 
convulsant action of bicuculline and a number of 
structurally related alkaloids is related to selective 
antagonism of the inhibitory action of GABA-like amino 
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acids on central neurones, many of which are insensitive 
to acetylcholine (see Curtis and Johnston, 1974b), the 
suggestion has been made that the "physiological" effects 
of bicuculline may be more closely related to "some aspect 
of the function of the cholinergic system than to effects 
on the GABA system" (Svenneby and Roberts, 1973). This 
suggestion was based on the observation that bicuculline 
hydrochloride and bicuculline methochloride (N-methyl-
bicuculline) competitively inhibit brain acetylcholine-
sterase activity in vitro, but have no effect on the enzyme 
associated with the synthesis (L-glutamate-1-carboxylase) 
and degradation (GABA-2-oxoglutarate aminotransferase) of 
GABA by a crude mitochondrial fraction of mouse brain. It 
is, however, very likely that the receptors of GABA-
metabolising enzymes and of GABA transport sites differ 
in their susceptibility to antagonists from that of 
receptors associated with the postsynaptic action 
of GABA: inhibitors of GABA enzymes and transport 
(Curtis, Duggan and Johnston, 1970) appear not to block 
the inhibitory action of this amino acid (see also 
Section III). 
Bicuculline excites central neurones, especially 
those which can also be excited by acetylcholine (Curtis, 
Duggan, Felix and Johnston, 1971; Curtis, Duggan, Felix, 
Johnston and McLennan, 1971). Such excitation could 
be associated with the inhibition of cholinesterases and 
the enhancement of synaptically released acetylcholine. 
Concentrations of these alkaloids adequate to suppress 
the inhibitory action of GABA, however, do not invariably 
excite neurones and bicuculline can excite non-
cholinoceptive spinal inte rneur ones . Thus it is likely 
that other factors are involved in t he excitat i on , 
including reduction of 'background' GABA-mediated 
inhibition and direct excitation. 
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A series of bicuculline analogues has thus been 
investigated for a specific GABA antagonist with physio-
chemical properties that might be more suitable than 
those of bicuculline for microelectrophoresis. In 
addition this investigation sought to obtain structure-
activity relationships regarding the convulsants that were 
investigated (Fig. 12). A study was made of the effects 
of these compounds, which are all structurally related to 
bicuculline, upon the sensitivity of neurones to the 
inhibitory amino acid GABA. In view of the excitant 
action of bicuculline a study was also made on spinal 
Renshaw cells to determine the relative importance of any 
anti-cholinesterase activity of bicuculline hydrochloride 
and bicuculline methochloride. 
Fig. 12: 
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Structures of some bicuculline analogues. 
(1) 
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RESULTS 
Bicuculline analogues as antagonists of GABA and 
spinal inhibitions 
(a) Bicucine methyl ester and corlumine 
Bicucine methyl ester when administered with 
cationic currents (30-60 nA) from solutions of less 
than 5 rnM in 165 rnM NaCl at pH 3 consistently and 
selectively blocked or reduced the inhibitory action 
of GABA, but not that of glycine, on three Renshaw 
cells and one spinal interneurone (1 preparation). 
An increase in firing frequency was occasionally 
observed during the continuous administration of 
bicucine methyl ester which was of similar potency to 
bicuculline (5 rnM in 165 rnM NaCl, pH 3) when the two 
compounds were compared as GABA antagonists on the 
same neurones. One of these comparisons is illustrated 
in Fig. 13 which is a recording from a Renshaw cell. 
Bicucine methyl ester (30 nA) selectively antagonised 
the depressant action of GABA (5 nA) on this cell 
(Fig. 13A) and the antagonism was similar to that seen 
with bicuculline (30 nA) (Fig. 13B). Corlumine (15 rnM 
in 165 rnM NaCl, pH 3) was also similar in action and 
potency to bicuculline when compared on three Renshaw 
cells (1 preparation) with similar currents (30-100 
nA). The selective antagonism of GABA by corlumine 
(60 nA) is compared with that due to bicuculline 
(60 nA) on the Renshaw cell depicted in Fig. 14. In 
addition, when administered intravenously in an other 
spinal cord preparation, corlurnine (1-2.5 mg/kg) 
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Effects of bicucine methyl ester (BME) and bicuculline 
on the depressant actions of glycine and GABA. The firing 
rate of a Renshaw cell excited by electrophoretically ejected 
DL-homocysteate (DLH, 7 nA) was depressed by glycine (GL, 2 nA) 
and GABA (5 nA), indicated by the broken and solid horizontal 
lines, respectively. A, responses before, during and after 
the continuous administration of BME (approximately 5 rnM in 
165 rnM NaCl) by a current of 30 nA; B, responses before, 
during and after the continuous administration of bicuculline 
(5 rnM in 165 mM NaCl) by a current of 30 nA. The solid 
horizontal bars and vertical broken lines indicate the periods 
of continuous administration. Ordinates: firing frequency 
in spikes per second. Abscissae: time in minutes. 
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reduced the prolonged (presynaptic) inhibition of the 
gastrocnemius- soleus (GS) monosynaptic reflexes by 
repetitive stimulation (4 volleys, 320 Hz, 3 x threshold) 
of posterior biceps semitendinosus (PBST) afferents, 
without affecting the short latency ('direct') 
inhibition of PBST monosynaptic reflexes by impulses in 
the lowest threshold quadriceps (Q) afferent fibres 
(2 x threshold). The effects of corlumine (2 mg/kg) 
on these spinal inhibitions are illustrated in Fig. 14C 
and D: although the 'direct' inhibition was unaffected, 
there was a small, but significant, decrease in 
'presynaptic' inhibition. This dose of corlumine had 
minimal effect on blood pressure and there were no 
obvious signs of the animal convulsing~ 
(b) N-Methyl-bicuculleine and bicuculline tetraphenol 
In contrast to corlumine and bicucine methyl ester, 
N-methyl-bicuculleine (anion, 5 mM in 165 mM NaCl, 
pH 8-9) was either inactive (I neurone) or selectively 
reduced the inhibitory action of glycine without 
affecting the ,action of GABA (2 Renshaw cells, 
1 interneurone) when administered with anionic currents 
of 60-200 nA (1 preparation). Bicuculline tetraphenol 
(7.5 mM in 165 mM NaCl, pH 3) was a non-selective 
antagonist of GABA and glycine. Although bicuculline 
and strychnine were selective antagonists of GABA and 
glycine respectively, on the 5 neurones tested 
(3 interneurones, 2 Renshaw cells; 2 preparations), 
bicuculline tetraphenol at all 'dose' levels (5-60 nA) 
was non-selective and appeared to be more potent as a 
glycine antagonist than a GABA antagonist. Fig. 15A 
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illustrates the effect of two 'dose levels' of 
bicuculline tetraphenol on a spinal interneurone that 
was responding to the depressant action of glycine and 
GABA. Bicuculline tetraphenol (20 nA) reduced the 
depressant action of glycine (12 nA) to less than half 
the control response whilst the action of GABA (18 nA) 
was only slightly reduced. Bicuculline tetraphenol 
(35 nA) almost abolished the glycine and GABA responses, 
but there was rapid and complete recovery when administ-
ration of bicuculline tetraphenol ceased. Bicuculline 
methochloride (see later) (BMC: 5 nA) had minimal 
effect on the glycine response and reduced the GABA 
response to about 30% of the control (Fig. 15B). 
Strychnine (12 nA) was similarly a selective antagonist 
on this interneurone, almost abolishing the depressant 
action of glycine (12 nA) and having no effect on the 
response to GABA (18 nA) (Fig. 15C). Unlike bicuculline 
methochloride, corlumine, bicucine methylester and 
N-methyl bicuculleine, bicuculline tetraphenol had no 
significant effect upon the firing frequency of the 
cells on which it was tested. 
(c) Bicuculline methochloride 
Bicuculline methochloride, ejected with currents 
of 10-80 nA from either a 10 rnM solution in 165 rnM 
NaCl (pH 3.5) or from a 100 rnM aqueous solution, 
reduced the sensitivity of spinal neurones to GABA; 
the influence on the action of glycine was minimal 
(4 Renshaw cells, 6 interneurones; 4 preparations). 
The effects were readily reversible and the substance 
appeared to be more potent than bicuculline on the 
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Effects of bicuculline tetraphenol (BTP), bicuculline 
methochloride (BMC) and strychnine on the depressant actions 
of GABA and glycine. The rate of firing of a dorsal horn 
interneurone excited by DLH (0 nA) was depressed by electro-
phoretically administered GABA (GA, 18 nA) and glycine 
(GL, 12 nA) indicated by solid and broken horizontal lines, 
respectively. A, responses before, during and after the 
ejection of BTP (7.5 mM in 165 mM NaCl) by successive currents 
of 20 and 35 nA; B, before, during and after the ejection of 
BMC (10 mM in 165 mM NaCl) with a current of 5 nA; C, before, 
during and after the ejection of strychnine (2 mM in 165 mM 
NaCl) with a current 0f 12 nA. The solid horizontal bars 
and broken vertical lines indicate periods of continuous 
electrophoretic ejection. 
( 2 ) 
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basis of comparison of equally effective electrophor-
etic currents on six neurones. An example of the 
difference in potencies is seen in Fig, 16: bicuculline 
(40 nA, 5 rnM in 165 mM NaCl) had little or no effect 
on the response of a spinal Renshaw cell to GABA (5 nA) 
and glycine (10 nA), however, BMC (10 nA, 10 rnM in 
165 rnM NaCl) considerably attenuated the GABA response 
while the glycine response remained unaffected. A 
tendency for BMC to excite neurones was seen in 
approximately 50% of the cells tested and such an 
excitation was less commonly observed during administ-
ration of bicuculline (see Fig. 16A and B). 
Bicuculline, bicuculline methochloride and the 
sensitivity of Renshaw cells to acetylcholine 
No association was observed between acetylcholin-
esterase inhibition and antagonism by either bicuculline 
or BMC of the effects of GABA on cholinoceptive Renshaw 
cells. Fig. 17 illustrates a typical experiment in which 
BMC in a concentration (35 nA) sufficient to block 
electrophoretically administered GABA (5 nA) enhanced 
the background firing rate of the cell, but did not 
accentuate the effectiveness of acetylcholine with respect 
to that of DLH. Similar observations were made upon this 
cell using bicuculline (150 nA). The type of experiment 
illustrated in Fig. 17A and B was performed on a total of 
eight Renshaw cells (three preparations) with identical 
results. The effects of intravenous bicuculline, and 
physostigmine salicylate, on Renshaw cell responses to 
DL-homocysteate and acetylcholine were compared on three 
A 
B 
Fig. 16: 
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Effects of bicuculline and bicuculline methochloride (BMC) on the depressant actions of glycine and GABA. The 
rate of firing of a Renshaw cell, excited by the continuous 
electrophoretic administration of DLH (4 nA) was depressed 
by GABA (5 nA) and glycine (10 nA), indicated by the 
respective horizontal lines. A, before, during and after 
the continuous administration of bicuculline (5 mM in 165 mM 
NaCl) with a current of 40 nA; B, before, durinq and after 
the administration of BMC (10 mM in 165 mM NaCl) with a 
current of 10 nA. The broken horizontal bars and broken 
vertical lines indicate periods of continuous electrophoretic 
administration. 
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Renshaw cells (one cell per preparation). Fig. 17C is 
a continuation of the experiment with the same Renshaw 
cell that is illustrated in Fig, 17A and B. Physostigmine 
salicylate was administered intravenously (0 05 µgm/kg, 
approximately O 12 µM if uniformly distributed in body 
water) producing marked enhancement of the excitatory 
action of acetylcholine and prolongation of the synaptic 
response of the cell by a ventral root volley from 40-50 
msec to over 200 msec (Eccles, Fatt and Koketsu, 1954). 
Similar effects of systemically administered physostigmine 
were observed with the two other Renshaw cells, effects 
which did not follow the administration of bicuculline 
hydrochloride, 0.2 mgm/kg. 
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Fig. 17: 
Effects of bicuculline methochloride (BMC, A and B) 
and physostigmine (C) on the action of amino acids and 
acetylcholine (ACh) on a Renshaw cell. A, effect of 
electrophoretically administered BMC (5 mM in 165 mM NaCl) 
with a current of 30 nA during the time of the solid 
horizontal bar, on the inhibition of DLH (15 nA) maintained 
firing by glycine (GL, 4 nA for 11 sec) and GABA (GA, 5 nA 
for 11 sec); B, effect of electrophoretic BMC (35 nA) on 
firing by DLH (15 nA for 11 sec) and ACh (0 nA = removal of 
retaining current for 11 sec); C, effect of intravenous 
physostigmine salicylate (0.5 mg/kg) on the firing in 
response to DLH (15 nA) and ACh (0 nA). The star indicates 
firing in excess of 120 spikes per sec. 
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DISCUSSION 
Of the bicuculline analogues that were tested the 
most effective and also the most water soluble was 
bicuculline methochloride (BMC). The specific GABA 
antagonistic action of BMC was readily reversible, and 
the substance was more potent than bicuculline hydro-
chloride as an electrophoretic GABA antagonist. BMC has 
recently been reported to be an effective GABA antagonist 
in the rat cerebral cortex, cuneate nucleus (Collins and 
Hill, 1974) and brain stem (Dray and Straughan, 1974). 
The higher potency of bicuculline methochloride with 
respect to the hydrochloride as an electrophoretic 
antagonist of GABA may be a consequence of the complete 
dissociation of BMC into the N-methyl bicuculline cation 
and chloride in aqueous solution, whereas only approximately 
10% of the protonated bicuculline would be present in a 
bicuculline hydrochloride solution at 2s 0 c (Andrews and 
Johnston, 1973). In addition, data from molecular orbital 
calculations and proton magnetic resonance spectra suggests 
a different range of preferred rotational conformers for 
the N-methyl bicuculline cation and the protonated 
bicuculline cation, for rotation around the c1-c9 bond 
in bicuculline and its salts is not free (Andrews and 
Johnston, 1973). The convulsant dose of BMC (intravenous) 
for mature mice was approximately 12 mg/kg (bicuculline, 
0.2 mg/kg), while the dose (intraperitoneal) for 10 day 
old rats was 10 mg/kg (bicuculline, 1 mg/kg) (Johnston, 
Beart, Curtis, Game, McCulloch and MacLachlan, 1972). 
The relative ineffectiveness of BMC as a systemically 
administered convulsant is possibly a consequence of a 
blood-brain barrier and/or metabolic degradation. 
Bicuculline methiodide ('N-methyl bicuculline'), which 
antagonises GABA in the frog spinal cord (Davidoff, 
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Silvey, Kobetz and Spira, 1973) is a more potent convulsant 
than bicuculline when administered intracisternally to 
rats (Pong and Graham, 1972). At the crayfish 
(Pacifastacus leniusculus) neuromuscular junction and 
stretch receptor bicuculline and BMC were approximately 
equipotent (McLennan, 1973). 
Bicucine methyl ester and corlumine were similar 
in action and potency to bicuculline when compared 
electrophoretically. The effect of corlumine on the 
inhibition of spinal reflexes was also investigated. 
Short latency spinal inhibitions are sensitive to the 
glycine antagonist strychnine, and strychnine-like 
compounds. Thus 'direct' inhibition is reversibly reduced 
by relatively low concentration of intravenously 
administered strychnine (Bradley, Easton and Eccles, 1953), 
and there is a large body of evidence which indicates that 
short latency spinal inhibitions are mediated by glycine 
(see Curtis and Johnston, 1974a). In contrast, spinal 
'presynaptic' or prolonged inhibition is insensitive to 
strychnine, but reduced by picrotoxinin (Eccles, Schmidt 
and Willis, 1963), which has no effect on spinal 'direct' 
inhibition, and by bicuculline (Curtis, Duggan, Felix and 
Johnston, 1971). It is thus likely that this type of 
prolonged inhibition involves the release of GABA from 
the terminals of a particular type of inhibitory 
interneurone (Schmidt, 1971; Curtis and Johnston, 1974a) · 
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By investigating the effects of convulsants on spinal 
inhibitions it is possible to obtain information regarding 
the possible GABA or glycine antagonistic properties of 
different compounds. The results with electrophoretically 
administered corlurnine were thus confirmed by an invest-
igation of the effects of this convulsant on spinal 
inhibitions. 
The effect of systemically administered corlumine 
in slightly reducing the prolonged inhibition of gastroc-
nemius reflexes by repetitive stimulation of the posterior 
biceps semitendinosus nerves was weaker than that reported 
for bicuculline (Curtis, Duggan, Felix, and Johnston, 
1971) and systemically administered corlumine is a less 
potent convulsant than bicuculline, the convulsant dose 
for corlumine in rabbits being 3 mg/kg (intravenous: Rice, 
1938) whilst that for bicuculline is 0.2 mg/kg (Welch and 
Henderson, 1934). Additional tests would be required to 
obtain an accurate comparison of the effects of bicuculline 
and corlumine on spinal inhibitions. 
Electrophoretically administered corlumine did 
not significantly antagonise the inhibitory action of 
glycine, and systemically administered corlumine had no 
effect on the direct inhibition of posterior biceps 
semitendinosus reflexes by volleys in the lowest threshold 
afferent fibres of the ipsilateral quadriceps nerve, an 
inhibition that is reduced by strychnine (Bradley, Easton 
and Eccles, 1953). In contrast, N-methyl-bicuculleine 
was a glycine antagonist and is thus similar to the 
reported actions of strychnine (Curtis, Duggan and 
Johnston, 1971) and laudanosine (Curtis, Duggan, Felix 
and Johnston, 1971) 
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The structures of corlurnine and bicucine methyl 
ester and their abilities to antagonise GABA are consistent 
with the models of GABA-bicuculline antagonism suggested 
by Curtis, Duggan, Felix and Johnston (1970) or Steward, 
Player, Quilliam, Brown and Pringle (1971) (see Section I). 
The property of bicuculline tetraphenol to antagonise GABA 
is also consistent with these models, however, those 
features of the bicuculline molecule that are described 
by the bicuculline-GABA antagonism model are obviously 
not the only features of importance. Opening the two 
dimethoxy rings in the bicuculline molecule to form 
bicuculline tetraphenol produces a less selective GABA 
antagonist, and hence these two rings appear to be 
important structure-activity features, provided the non-
specific antagonism demonstrated for bicuculline tetra-
phenol is not due to a non-receptor action of this 
compound. Bicuculline tetraphenol is structurally 
related to the glycine antagonist, laudanosine, but many 
apparently structurally unrelated compounds are glycine 
antagonists. 
The excitation of central neurones by (+)-bicuculline 
and some of its analogues, in particular (+)-bicuculline 
methochloride appears not to be related to GABA antagonism 
for similar excitation occurs with (-)-bicuculline 
rnethochloride which like (-)-bicuculline is not a GABA 
antagonist ((-)-BMC: Collins and Hill, 1974; Hill, 
Simmonds and Straughan, 1974; (-)-bicuculline: Johnston 
and Curtis, 1973). Picrotoxin, bicuculline and 
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strychnine directly excite isolated lobster axons by 
causing a depolarisation which is associated with a rise 
in membrane resistance (Freeman, 1973), the minimal 
effective concentration of picrotoxin to produce this 
excitation was 5 x 10-5 - l x 10- 4 Mand the minimal 
effective concentration of bicuculline was similar. This 
concentration range is similar to that used in various 
crustacean preparations to antagonise the effect of GABA 
or to reduce synaptic inhibition (see McLennan, 1970 -
crayfish, Eustacus armatus; Shank, Pong, Freeman and 
Graham, 1974 - lobster, Homarus americanus), but the 
concentrations produced after systemic administration of 
convulsant doses of bicuculline to mammals are probably 
well below this range. (The convulsant dose of bicuculline 
for mammals is approximately 0.2 mg of the hydrochloride 
per kg body weight (Wellch and Henderson, 1934), equivalent 
to approximately 10-6 M if uniformly distributed in body 
fluids.) Similarly, doses of bicuculline that are 
sufficient to reduce bicuculline-sensitive spinal, cere-
bellar and cerebral inhibitions (0.5-0.6 mg/kg: Curtis, 
Duggan, Felix and Johnston, 1971; Curtis, Duggan, Felix, 
Johnston and McLennan, 1971) are unlikely to produce the 
direct excitant effect that was observed in vitro by 
Freeman (1973). The possibility still exists, however, 
that the excitation of central neurones by bicuculline 
and some of its analogues is due to a non-synaptic action 
of these compounds. Such a non-synaptic action would not 
necessarily detract from the value of bicuculline as a 
GABA antagonist, for in properly designed electrophoretic 
experiments, non-bicuculline-sensitive depressants are 
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used as controls and the firing frequency of neurones can 
usually be maintained constant, so that control responses 
to depressants are obtained with the neurones firing at 
the same frequency as that during the administration of 
. 
bicuculline. The demonstration that there are 
bicuculline-insensitive inhibitions (Curtis, Duggan, Felix 
and Johnston, 1971) is evidence that the reduction of 
inhibitions by bicuculline is not due to neuronal 
excitation. 
The experiments on Renshaw cells excited with 
alternate pulses of acetylcholine and DL-homocysteate 
provided no support for the proposal by Svenneby and 
Roberts regarding the participation of central cholinergic 
systems in the convulsant action of bicuculline and 
related alkaloids (and it seems more reasonable to 
consider that this action primarily involves antagonism 
of GABA-like amino acids). Physostigmine, a competitive 
antagonist of acetylcholinesterase with an apparent K. 
l 
of 0.06 µM (Augustinsson and Nachmansohn, 1949) and 
thus some 100 times more potent in vitro than bicuculline 
hydrochloride (K. 65 µM; Svenneby and Roberts, 1973), l 
clearly diminished the activity of this enzyme in vivo 
and greatly enhanced the sensitivity of Renshaw cells to 
acetylcholine9 Such an effect was not apparent with 
systemic doses of bicuculline hydrochloride adequate to 
influence GABA-mediated central inhibitions (Curtis and 
Johnston, 1974b). Miller and McLennan (1974) have 
recently reported that electrophoretically administered 
BMC enhanced the excitant effect of electrophoretic 
pulses of acetylcholine on acetylcholine sensitive 
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neurones of the rat septal nuclei, but a control agonist 
was not used to determine the specificity of the effect. 
The above experiments have shown that the central 
effects of bicuculline and BMC cannot be adequately 
explained on the basis of a weak anticholinesterase effect, 
measured in vitro, The K. values for BMC (25 µM) and l 
bicuculline hydrochloride (65 µM) as competitive inhibitors 
of mouse brain acetylcholinesterase (Svenneby and Roberts, 
1973) would appear to be of the wrong order of magnitude 
of that expected by a potent centrally acting drug when 
its mechanism of action is tested in vitro. For 
comparison, the apparent binding constants of strychnine 
(0.3 µM) to rat spinal synaptic membrane fractions (Young 
and Snyder, 1973) is several orders of magnitude less than 
the K. values measured by Svenneby and Roberts. Similar l 
systemic concentrations of strychnine hydrochloride and 
bicuculline hydrochloride are effective on glycine and 
GABA mediated inhibitions, respectively. Thus doses of 
strychnine of 0.01-0.2 mg/kg (0.025-0.5 µM) antagonise 
glycine mediated central inhibitions (Curtis and Johnston, 
1974b) and 0.05-0.1 mg/kg (0.15-0.3 µM) of bicuculline 
hydrochloride suppresses the Purkinje cell inhibition of 
Deiters' neurones in the cat (Curtis, Duggan and Felix, 
1970). In view of the in vivo doses of strychnine, 
bicuculline (and physostigmine) required for central 
effects, a K. of the order of 0.01-0.1 µM would be l 
expected for a binding of bicuculline measured in vitro, 
if it reflects the central mechanism of this convulsant 
Evidence has been provided for a sodium dependent binding 
of GABA by synaptosomal fractions of rat cerebellar cortex 
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which can be competitively inhibited by bicuculline, and 
may represent binding to the postsynaptic GABA receptor 
(Peck, Schaeffer and Clark, 1973). These particular 
experiments, however, indicated an apparent Ki of 80 µM 
for bicuculline hydrochloride, of the same order of 
magnitude as the K. values for BMC and bicuculline l 
hydrochloride as competitive inhibitors of mouse brain 
acetylcholinesterase, a binding which has been shown to 
be unrelated to the main central action of bicuculline. 
Accordingly the binding measured by Peck and co-workers 
seems unlikely to represent post-synaptic GABA receptors. 
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V. SOME CONVULSANTS AS ANTAGONISTS OF INHIBITORY 
AMINO ACIDS 
There are many different mechanisms of action that 
could explain the convulsions that are produced by 
centrally acting convulsant substances (see Watkins, 1968), 
and the mechanisms of action of relatively few of the known 
convulsant poisons have been elucidated. It is of 
fundamental pharmacological interest to determine the 
mechanism of action of a convulsant, and if the mechanism 
of action is found to be selective blockade of the action 
of an inhibitory transmitter substance on the postsynaptic 
membrane, then the convulsant could be a useful 
pharmacological antagonist - useful for determining the 
role of inhibitory substances and in structure-activity 
relationship studies. For these reasons the central 
actions of some potential antagonists of the inhibitory 
amino acids, glycine and GABA, have been investigated. 
The compounds investigated included three convulsants 
that are structurally related to picrotoxin, together 
with penicillin and d-tubocurarine, 
Although the chemically related compounds 
dendrobine and picrotoxinin (Fig~ 18) are both convul-
sants when administered to mammals, there is evidence 
to indicate that these substances differ in their central 
modes of action. Dendrobine, which occurs in the 
ornamental orchid Dendrobium nobile and is an active 
constituent of the Chinese herbal preparation Chin-shih-hu 
(Chen K K and Chen AL 1935 . Inubushi, Sasaki, Tsuda, f • • f • •f I 
Yasui, Konita, Matsumoto, Katarao and Nakano, 1964; 
PICROTOXININ PICROTIN 
TUTIN CORIAM YRTIN 
DENDROBINE SHIKIMIN 
Fig. 18: 
Structures of some convulsants chemically related 
to picrotoxinin. 
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Porter, 1967), is a glycine antagonist when administered 
electrophoretically near feline spinal neurones (Curtis, 
Duggan, Felix and Johnston, 1971) Further evidence of 
the strychnine-like activity (Curtis, Duggan, Johnston, 
1971) of this alkaloid was the diminution of spinal 
'direct' inhibition observed after systemic administration 
(Curtis, Duggan, Felix and Johnston, 1971). In contrast, 
picrotoxinin, the active principle of picrotoxin (see 
Porter, 1967) which is isolated from plants of the moon-
seed family, Menispermaceae, reduces a number of central 
inhibitions considered to be mediated by GABA at both the 
spinal and supraspinal level (see Curtis and Johnston, 
1974a, 1974b) ~ Thus although consistent antagonism has 
not been demonstrated electrophoretically between picro-
toxinin and GABA, picrotoxin is generally considered to be 
a selective GABA antagonist in mammals, particularly as 
the GABA antagonist bicuculline reduces many of these 
picrotoxinin sensitive central inhibitions in the cat 
(see Curtis and Johnston, 1974b) and antagonism between 
picrotoxinin and GABA has been clearly demonstrated in 
crustacea (Takeuchi, A. and Takeuchi, N., 1969). In view 
of the differences in the central actions of dendrobine 
and picrotoxinin, a study was made of three other 
structurally related convulsants, coriamyrtin, shikimin 
and tutin (Fig@ 18). Shikimin has been isolated from the 
ripe fruit of the evergreen tree Shikimin (Kajimoto, 
Fujimori and Hirota, 1955; Kajimoto, Ota, Fujimori, Harada 
and Hirota, 1955), and tutin occurs in the berries of 
the indigenous New Zealand tutu plant, Coriaria arborea 
(Pastier, 1971; Fitchett and Malcolm, 1909; Marshall, 
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1906). Coriamyrtin was first isolated from the European 
Coriaria myrtifolia (see Porter, 1967) and was later 
found to be a close structural analogue of tutin, 
differing only in the absence of the secondary hydroxyl 
group of tutin. Tutin and coriamyrtin are reported to have 
very similar central effects (Marshall, 1912), there 
appears, however, to be no published reports concerning 
its action on central inhibitory processes. Picrotoxinin, 
tutin and coriamyrtin have similar convulsant doses in 
mice (Jarboe, Porter and Buckler, 1968), but the convulsive 
dose of shikimin in mice is about 100 times that of 
picrotoxinin, the convulsions being preceeded by general 
paralysis (Kajimoto, Ota, Fujimori, Harada and Hirota, 
1955). Picrotin, not investigated in these experiments, 
is SO-times less potent than picrotoxinin as a convulsant 
(Jarboe, Porter and Buckler, 1968). 
The epileptogenic action of penicillin on the 
mammalian cerebral cortex is well documented: after 
topical, intracerebral or systemic administration there 
is abnormal and paroxysmal activity which may lead to 
major seizures (Ajmone-Marsan, 1969; Gloor, 1969; Prince, 
1969). When administered electrophoretically (40 nA) 
near single neurones of the cerebral cortex, penicillin 
reputedly enhanced the amplitude of certain excitatory 
synaptic potentials (Walsh, 1971), Prolonged depolarising 
postsynaptic potentials have been recorded from moto-
neurones after penicillin was administered topically to 
the feline spinal cord (Kao and Crill, 1972). On the 
basis of antagonism by penicillin of the depolarising 
effect of GABA on dorsal root terminals of the amphibian 
spinal cord, Davidoff (1972a) suggested that the 
convulsant properties of penicillin may be associated 
with antagonism of inhibitions mediated by GABA within 
the mammalian central nervous system. Hence a study 
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was made of the action of electrophoretically administered 
penicillin upon the inhibition of spinal and cortical 
neurones by GABA and glycine, and a comparison made 
between penicillin and bicuculline, a known GABA antagonist 
in these regions of the cat central nervous system (see 
Curtis and Johnston 1974a, 1974b) 
d-Tubocurarine is a convulsant when administered 
topically to the cerebral cortex (Chang, 1953; Feldberg, 
Malcolm and Darian-Smith, 1957), a property which is not 
common to neuromuscular blocking agents (Banerjee, 
Feldberg and Georgiev, 1970). Until recently no evidence 
had been published that curare suppresses inhibitory 
mechanisms in either the cerebral (Bhargava and Meldrum, 
1969; Banerjee, Feldberg and Georgiev, 1970) or 
hippocampal (Feldberg and Lotti, 1970) cortices. Hill 
and co-workers, however, have interpreted certain experi-
ments in the feline cerebral cortex to indicate that the 
convulsant action of d-tubocurarine is due, at least in 
part, to antagonism of GABA mediated inhibition in that 
cortex (Hill, Simmonds and Straughan, 1972). In these 
experiments the effects of glycine were apparently also 
antagonised in both the cortex (Hill, Simmonds and 
Straughan, 1972) and the cuneate nucleus (Hill, Simmonds 
and Straughan, 1973a), nevertheless the claim was made 
that d-tubocurarine is a useful GABA antagonist. 
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Although there is now a considerable body of 
evidence, largely derived from microelectrophoretic 
experiments, that strychnine and bicuculline are adequately 
selective glycine and GABA antagonists, respectively, to 
provide reliable information regarding the probable 
nature of an inhibitory transmitter, doubt has been 
expressed, in recent publications concerning the 
convulsant action of d-tubocurarine (Hill, Simmonds and 
Straughan, 1973b; Dray and Straughan, 1974), regarding 
the usefulness of bicuculline as a GABA antagonist. 
Furthermore, the claim was made that d-tubocurarine (dTC) 
is not only more potent than bicuculline (and picrotoxin) 
as an antagonist of the inhibitory action of GABA on the 
firing of feline cortical neurones, but additionally is 
more useful "in terms of practical microiontophoresis". 
The proposal of Hill and co-workers (Hill, Simmonds and 
Straughan, 1973b) regarding the usefulness of dTC as a 
GABA antagonist appears to ignore the 11 marked excitant 
effect" of dTC on cortical neurones and the little, if 
any, selectivity demonstrated between the inhibitory 
actions of glycine and GABA (see also Hill, Simmonds and 
Straughan, 1972, 1973a). This apparent lack of specificity 
contrasts with previously reported observations of the 
selective antagonism, by bicuculline, of the inhibitory 
action of GABA-like amino acids upon neurones in the 
feline cerebral cortex, other supraspinal regions and the 
spinal cord (see Section IV). Consequently dTC has been 
examined as an amino acid antagonist in the feline spinal 
cord, and in particular its activity as a GABA antagonist 
compared with that of a more soluble bicuculline analogue, 
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bicuculline methochloride (BMC: Johnston, Beart, Curtis, 
Game, McCulloch and MacLachlan, 1972; see also Section IV 
of this thesis). 
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RESULTS 
(1) Shikimin 
The low aqueous solubility of shikimin prevented 
electrophoretic testing, but intravenous doses of 1.0 
mg/kg caused dilation of the cat's pupils, salivation and 
oscillations in blood pressure - typical effects of an 
intravenously administered convulsant of the picrotoxinin 
type. Doses of 1.5 mg/kg, which had little or no effect 
on the direct inhibition of posterior biceps semitendinosus 
(PBST) monosynaptic reflex by impulses in the lowest 
threshold quadriceps (Q) afferent fibres, considerably 
reduced the long latency and duration inhibition of the 
gastrocnemius soleus (GS) monosynaptic reflex by repet-
itive stimulation (4 volleys, 320 Hz, 3 x threshold) of 
PBST afferents (2 preparations). Fig. 19A illustrates 
the effect of shikimin (1.0 mg/kg, intravenous) on the long 
latency inhibition of 4 PBST 3T on GS. Three hours after 
the last dose of shikimin was administered to this 
preparation, 0.1 mg/kg strychnine was administered intra-
venously and the early (peak) inhibition that was resistant 
to shikimin (1.5 mg/kg, intravenous) was reduced by 50% 
(at the 15 msec inhibitory-testing volley interval) 
without altering the late inhibition. 
(2) Tutin 
Tutin (1,5-3.0 mg/kg, intravenous) had a similar 
action to that of shikimin upon prolonged (presynaptic) 
spinal inhibition (Fig. 19C) and, like bicuculline, 
reduced the dorsal root potential generated by the 
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afferent inhibiting PBST volley (Curtis, Duggan, Felix 
and Johnston, 1971). In three experiments, doses of 
1.5-3.0 mg/kg did not influence the direct inhibition of 
PBST reflexes, although effects that are typical of 
intravenously administered picrotoxinin-like convulsants 
were usually observed (oscillating blood pressure, 
salivation, dilated pupils and an increase in the number 
of spontaneous discharges in the dorsal and ventral roots). 
Intravenous doses that were greater than 3 mg/kg were 
required to produce any reduction in the direct inhibition 
of PBST reflexes and Fig. 19B illustrates that 6.4 mg/kg 
slightly reduced this inhibition. Doses of 0.5 mg/kg or 
higher reduced the 'presynaptic' inhibition of GS or 
flexor digitorum longus (FDL) reflexes Fig. 19C 
illustrates the reduction of the prolonged inhibition of 
the GS reflex after 3.4 mg/kg tutin, an effect that was 
observed simultaneously with a reduction in the early 
phase of the prolonged inhibition of GS reflexes. The 
alteration in both the early and late phase of this 
inhibitory curve (Fig. 19C) suggests that as well as 
reducing the inhibitory effect of GABA, tutin may also 
influence that of glycine. These actions of tutin were 
readily apparent in microelectrophoretic studies carried 
out on 9 dorsal horn interneurones (5 preparations), 
particularly when comparisons were made with the action 
of bicuculline methochloride (5 neurones). These neurones 
were either firing spontaneously or were activated by the 
continuous electrophoretic ejection of DL-homocysteate. 
Electrophoretically administered tutin (50 mM in 165 mM 
NaCl, 5-10 nA) selectively and reversibly antagonised 
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Effects of shikimin (A) and tutin (B, C) on the 
inhibition of spinal monosynaptic reflexes recorded from 
the first sacral ventral roots. A and C, gastrocnemius-
soleus (GS) reflexes, inhibited by 4 PBST volleys (3 x 
threshold, 320 Hz), B, PBST reflexes inhibited by one 
quadriceps (Q) volley (2 x threshold] . The curves relate 
per cent inhibition (ordinates) to the interval (abscissae) 
between the inhibitory and testing volleys, each symbol 
indicating the mean value of four observations of the reflex 
(area). Open circles: control observations. Filled circles: 
A, 3 min after a total dose of shikimin of 1.0 mg/kg 
intravenous, 0.5 mg/kg of which had been administered 22 min 
earlier; C, 30 min after tutin 3.4 mg/kg intravenous; B, 
30 min after an additional dose of 3.0 mg/kg administered 
15 min after C. 
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electrophoretically administered GABA when in relatively 
low concentrations. Higher concentrations of tutin 
(10-40 nA) sufficient to almost abolish the GABA response, 
antagonised both GABA and glycine. The neurone from which 
the records of Fig. 20 were derived was firing spontaneously 
and the firing rate was almost reduced to zero by GABA 
(15 nA) or glycine (20 nA). During the administration of 
tutin with a current of 10 nA (Fig. 20B) the effect of 
GABA was reduced, that of glycine was unaltered. An 
increase in the rate of tutin administration (20 nA), 
however, such that the effect of GABA was almost abolished 
(Fig. 20C), also considerably attenuated the inhibitory 
effect of glycine. This typical observation with 
increasing 'doses' of tutin was in marked contrast to 
observations made with bicuculline methochloride where 
concentrations sufficient to suppress the effect of GABA 
had little or no influence on the inhibition of firing by 
glycine (Fig. D-E). 
(3) Coriamyrtin 
Coriamyrtin was tested electrophoretically on three 
spinal interneurones and three Renshaw cells in two 
preparations. The very limited supply, and the low aqueous 
solubility, of this compound prevented it being tested by 
systemic administration and also precluded an extensive 
investigation of its effects at the cellular level. 
Electrophoretic currents of the order of 20-60 nA, from 
an approximately 5 mM solution (a saturated solution in 
165 mM NaCl), reversibly and selectively blocked the 
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Fig. 20~ 
The effects of tutin (A - C) and bicuculline metho-
chloride (D - F) on the inhibition of the spontaneous firing 
of a dorsal horn interneurone by GABA (15 nA) and glycine 
(20 nA), as indicated by the solid and broken horizontal 
lines respectively. A, control; B, during the electrophoretic 
administration of tutin (50 mM in 165 mM NaCl) with a current 
of 10 nA for 3.2 min; C, tutin, 20 nA for 3.8 min; D, 2 min 
after the termination of the tutin administration; E, during 
administration of bicuculline methochloride (BMC, 10 mM in 
165 mM NaCl) with a current of 20 nA for 3.3 min; F, 3 min 
after termination of the bicuculline methochloride current. 
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inhibitory effect of GABA on 2 of the 3 neurones that were 
tested. Fig. 21 illustrates the effect of coriamyrtin 
(60 nA) on a Renshaw cell the DLH induced firing of which 
was being alternately depressed by GABA and glycine. 
Both tutin and coriamyrtin (as in Fig. 21) occasionally 
excited cells during continuous electrophoretic administ-
ration, but this effect was not as commonly observed as 
with bicuculline methochloride (see Section IV). 
(4) Penicillin . 
Intravenously administered benzylpenicillin reduced 
the prolonged inhibition of spinal reflexes. The effect 
of penicillin on the inhibition of the GS monosynaptic 
reflex by repetitive stimulation (4 volleys, 320 Hz, 
3 x threshold) of PBST afferents was tested in two 
preparations and in both instances 2 x 10 6 U/kg (1.2 g/kg) 
considerably reduced the prolonged (presynaptic) inhibition, 
but there was little or no change in the short latency 
inhibition of this reflex (Fig. 22A). The same dose of 
penicillin reduced the amplitude of dorsal root potentials 
generated by the afferent inhibiting PBST volley (Fig. 
22B). The usual signs associated with the intravenous 
administration of a picrotoxinin-like convulsant were not 
apparent in these two unparalysed preparations - the cats' 
pupils remained moderately dilated and responsive to 
light, there was no salivation and only a slight increase 
in pulse pressure. 
When electrophoretically administered with anionic 
currents of 40-250 nA, from a 0.5 M solution within four 
hours of preparation, penicillin reversibly reduced the 
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Effect of coriamyrtin on the depressant actions of 
GABA and glycine. The rate of DL-homocysteate (DLH, 8 nA) 
induced firing of a Renshaw cell was depressed by electro-
phoretically administered GABA (GA, 5 nA) and glycine 
(GL, -4 nA), indicated by the solid and broken horizontal 
bars, respectively: responses to GA and GL before, during 
and after coriamyrtin (approximately 5 mM in 165 mM NaCl), 
administered with a current of 60 nA. The duration of the 
coriamyrtin ejection is indicated by the solid horizontal 
bar and broken vertical lines. Because of the excitant 
effect of coriamyrtin the DLH current was reduced from 
8 to 6 nA at the cormnencement of the coriamyrtin ejection 
period. 
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Effects of penicillin on prolonged spinal inhibition 
and dorsal root potentials. A, gastrocnemius soleus (GS) 
monosynaptic reflex recorded from the first sacral ventral 
roots and inhibited by repetitive stimulation (4 volleys, 
320 Hz, 3 x threshold) of posterior biceps semitendinosus (PBST) afferents. The curves relate percent inhibition 
(ordinates) to the interval between the inhibitory and 
testing volleys (abscissae), each symbol indicating the 
mean value of 4 observations of the reflex (area). Open 
circles: control observations. Filled circles: 5 min after 
penicillin 1.2 g/kg intravenous. B, dorsal root potentials 
recorded with an amplifier time constant of 1 sec from the 
most caudal rootlet of the sixth lumbar dorsal root in 
response to repetitive stimulation of the PBST afferents 
as in A (4PBST 3T). 
penicillin 1.2 g/kg. 
DRP illustrated before and 12 min after 
Voltage calibration: 100 µV. Time 
calibration: 300 msec. 
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inhibitory effect of GABA on the firing of spinal inter-
neurones and Renshaw cells, without diminishing that of 
glycine to the same extent. This action was rapid in both 
onset and recovery, but at high 'dose' levels the 
amplitude of extracellularly recorded action potentials 
tended to be reduced, When compared with bicuculline, 
penicillin was a weaker GABA antagonist, The effects of 
penicillin and bicuculline on the sensitivity of a Renshaw 
cell to GABA and glycine are illustrated in Fig. 23. 
The firing frequency of this cell, maintained by DLH (10 nA) 
was characterised by the frequent occurrence of bursts of 
high frequency discharge which are indicated by the sharp 
upward deflections of the record. The firing of this 
neurone was completely suppressed by glycine (5 nA) and 
GABA (10 nA) and the rate was reduced to approximately 
25% by GABA (5 nA) (Fig. 23A). During the continuous 
administration of penicillin (120 nA) the effects of GABA 
were considerably attenuated (Fig. 23B), whereas those of 
glycine were unaltered, as is clear from a comparison with 
the actions of glycine (5 nA and 10 nA) immediately after 
termination of the penicillin ejection (Fig. 23C). This 
latter tracing also shows recovery of the sensitivity of 
the neurone to GABA and the restoration of the bursts of 
high frequency discharge which were suppressed during the 
administration of penicillin (Fig 23B). The records of 
Fig 23D-F show a similar series of responses before, 
during and immediately after the electrophoretic 
administration of bicuculline (5 mM in 165 mM NaCl, 60 nA). 
Again, there was little or no reduction of the inhibitory 
effect of glycine, but considerable reduction of that of 
GABA. In contrast to penicillin, however, there was 
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accentuation rather than depression of the bursts of 
firing. Although the current used to administer bicuculline 
near this cell was half of that ejecting penicillin, the 
dilution of the bicuculline solution was such that 
approximately 2 nA (of the 60 nA) would have carried 
bicuculline cations from the micropipette. Hence the 
concentration of penicillin required to reduce the effect 
of a given amount of GABA was higher than that of 
bicuculline. Observations similar to these illustrated 
in Fig. 23 were made upon 8 Renshaw cells and 4 spinal 
interneurones (3 preparations). 
Penicillin (30-100 nA) usually enhanced the 
firing rate of postcruciate neurones and reduced the 
inhibitory effect of GABA on all 9 cells tested 
(2 preparations). The inhibition of 2 of these neurones 
by glycine appeared to be as sensitive to antagonism by 
penicillin as that produced by GABA, but a full assess-
ment of the specificity of the antibiotic as an antagonist 
of inhibitory amino acid receptors in the cortex was not 
made because of the relatively weak effects of glycine on 
these neurones (Curtis, Duggan, Felix, Johnston and 
McLennan, 1971). 
An enhancement of the firing rates of cerebellar 
Purkinje cells was also observed with electrophoretic 
currents of penicillin (30-180 nA) and as observed in 
the spinal cord and postcruciate cortex, the inhibitory 
effect of GABA was reduced. Four Purkinje cells were 
tested (three preparations) and the firing rates of three 
of these cells were inhibited by local cerebellar surface 
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Fig. 23: 
The effects of penicillin and bicuculline on the 
inhibition of the firing of a Renshaw cell by glycine 
and GABA. The electrophoretic administration of amino 
acids, penicillin and bicuculline is indicated by 
horizontal lines. The cell was excited by the continuous 
administration of DLH (10 nA) and was inhibited by glycine 
(dotted line, 0.5 nA) and GABA (solid line, 5, 10 nA). 
A, before; B, 2 min after beginning to eject penicillin 
with a current of 120 nA, the substance having been 
previously administered with 60 nA for 3 min; C, inunediately 
after terminating this current; D, before; E, 1 min after 
beginning to eject bicuculline (60 nA); F, inunediately after 
terminating this current. 
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stimulation, This inhibition was not affected by the 
maximum currents of penicillin that could be passed from 
three penicillin barrels and it is likely that the 
concentration of penicillin so produced was inadequate 
to suppress the inhibition, 
(5) d-Tubocurarine (dTC) 
The most commonly observed effect of dTC chloride 
when administered with cationic currents of 20-300 nA 
(from a 5 mM solution in 165 mM NaCl) was a reduction of 
the inhibitory action of both GABA and glycine. This 
'non-specific' antagonism was observed with 48% (2 
Renshaw cells, 10 spinal interneurones) of neurones from 
a total of 25 tested thoroughly in 9 spinal cord 
preparations. Tubocurarine had no effect on the 
inhibitory action of either GABA or glycine upon 32% 
(3 Renshaw cells, 5 interneurones) of the cells, whilst 
it antagonised only glycine on 12% (1 Renshaw cell, 
2 interneurones) and only GABA on 8% (2 interneurones). 
In comparison, BMC (25-75 nA) specifically antagonised 
the inhibitory action of GABA on 14 of the 15 neurones 
(4 Renshaw cells, 10 interneurones) tested with both dTC 
and BMC. Strychnine also consistently and specifically 
antagonised the inhibitory action of glycine on all 
(2 Renshaw cells, 9 interneurones) neurones tested with 
both dTC and strychnine. These effects of BMC and 
strychnine were observed irrespective of the type of 
effect that dTC had on the actions of GABA and glycine. 
Almost all cells were excited by dTC and this effect 
appeared to be unrelated to the type of amino acid 
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Fig. 24: 
Maximal effects of strychnine (A), b icu c ulline metho-
chloride (B) and (+)-tubocurarine (C) on the i nhibition of 
firing of a spinal interneurone by glycine (GL , filled 
triangle= 9 sec. administration) and GABA (GA, filled circle 
= 13 sec. administration). Firi ng was mai n tained at a 
constant level with DLH (10-35 nA). Fro m left to right: 
control responses, during administrati on o f the indicated 
alkaloid, recovery. A, GL 15 nA, GA 20 nA , strychnine 
(2 mM in 165 mM NaCl) 40 nA for 2 min. Recovery at 5 min 
was incomplete. B, 6\ min after A., GL 15 nA, GA 12.5 nA, 
bicuculline methochloride (BMC, 10 mM in 165 mM NaCl), 40 nA 
for 4 min. Recovery at 2 min. C, 2 min after B., GL 15 nA, 
GA 12.5 nA, bicuculline methochl oride (BMC, 10 mM in 165 
mM NaCl), 40 nA for 4 min. Recovery 2 min. C, 2 min after 
B., GL 15 nA, GA 12.5 nA, (+)-tubocurarine (5 mM in 165 mM 
NaCl) 100 nA for 3 min afte r 40 nA for 2 min., 60 nA for 
3 min, 80 nA for 2 min. Recove r y at 2 min. 
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DISCUSSION 
Amongst the convulsants that were investigated, 
only shikimin and tutin were tested for their effects on 
the inhibition of spinal reflexes. Shikimin considerably 
reduced 'presynaptic' inhibition without having a signifi-
cant effect upon 'direct' inhibition and hence its central 
convulsant action appeared to be similar to that of 
picrotoxinin and bicuculline (Curtis, Duggan, Felix and 
Johnston, 1971). (For a discussion of the significance 
of 'presynaptic' and 'direct' inhibitions of spinal 
reflexes and the mode of action of convulsants see 
Section IV). Unfortunately, the low solubility of shikimin 
prevented electrophoretic testing and more detailed 
experiments would be required at a cellular level to 
assess its effectiveness and selectivity as a GABA 
antagonist. Tutin, in low concentrations also reduced 
'presynaptic' but not 'direct' inhibition, however, 
higher concentrations slightly reduced 'direct' inhibition. 
This finding, together with a reduction in the early phase 
of 'presynaptic' inhibitory curves (Fig. 19C), suggested 
that tutin might influence the inhibitory action of 
glycine as well as that of GABA. These two effects of 
tutin were readily apparent in the microelectrophoretic 
studies when increasing 'doses' of tutin antagonised both 
GABA and glycine. Thus the convulsant action of 
systemically administered tutin is due, at least in part, 
to antagonism of the inhibitory action of glycine and 
GABA. Although some selectivity was apparent for tutin 
as a GABA antagonist, this convulsant would be of little 
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use in microelectrophoretic studies of the nature of 
amino acid central inhibitory transmitters Tutin has 
recently been reported to antagonise the GABA mediated 
increase in the muscle membrane conductance of the lobster 
(Homarus vulgaris) neuromuscular junction (Nistri, 
Constanti and Quilliam, 1974). In the lobster preparation 
tutin appeared to be approximately equipotent with 
picrotoxin; 1.5 x 10-6 - 6.0 x 10- 6 M tutin or picrotoxin 
displaced the dose response curve to the right in a non-
parallel manner. 
Coriamyrtin may be more selective than tutin as a 
GABA antagonist, but it was impossible to investigate 
the effect of systemically administered coriamyrtin and 
to investigate thoroughly its effects at a cellular level . 
If there is a real difference in the degree of 
selectivity of these two compounds then it must be due to 
the secondary hydroxyl group which is absent from the 
structure of coriamyrtin, as this is the only difference 
between the two structures. This hydroxyl is cis to the 
lactone structure which is common to tutin, coriamyrtin, 
picrotoxin and dendrobine (Fig. 18) (but is absent from 
the shikimin molecule), and the close proximity of the 
lactone function and the hydroxyl group may make inter-
conversion of the lactone from a five to a six membered 
ring possible. This interconversion thus could not occur 
in the coriamyrtin molecule. The other hydroxyl group, 
the bridgehead hydroxyl, is common to picrotoxinin, tutin, 
coriamyrtin and shikimin, but not to dendrobine, and it 
appears to be essential for the convulsant activity of 
those members of the series that have it in their structures 
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(Jarboe, Porter and Buckler ~ 1968) Neither the dendro-
bine nor the shikimin molecule has an oxirane ring, but 
from the structures of the remaining compounds of the 
series it seems that the presence and location of the 
oxirane ring are not important molecular features. 
The explanation of the differences in pharmacol-
ogical action between picrotoxinin and these related 
compounds is not readily apparent from their structures. 
Concentrations of dendrobine exceeding those required to 
suppress the inhibitory action of glycine were without 
effect on the action of GABA (Curtis, Duggan, Felix and 
Johnston, 1971; Curtis, Davies, Game, Johnston and 
McCulloch, 1973) Dendrobine, the only nitrogen containing 
member of this series can thus be considered as strychnine-
like. Although relatively large intravenous doses of 
picrotoxinin (2 mg/kg, equivalent to 4 mg picrotoxin/kg) 
have not been found to modify spinal direct inhibition, the 
results of microelectrophoretic experiments on spinal 
interneurones have not provided uniquivocal evidence of 
a high degree of selectivity of this substance as a GABA 
antagonist (Curtis, Duggan, Felix, Johnston, 1971). 
The reduction of dorsal root potentials and spinal 
prolonged (presynaptic) inhibition, but not short latency 
inhibition, by penicillin suggested that penicillin is 
an antagonist of the inhibitory action of GABA. The doses 
of penicillin that were required to modify spinal 
inhibitions were relatively high and may have been partly 
due to poor penetration of a blood-brain barrier 
(Fishman, 1966). Electrophoretic testing of penicillin 
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confirmed that it was a GABA antagonist. It was weaker, 
however, than bicuculline, a finding that was consistent 
with that of Davidoff who found it to be approximately 
1/100 as effective as bicuculline in reducing 'presynaptic' 
inhibition and the depolarising action of GABA in the 
amphibian spinal cord (Davidoff, 1972a), Davidoff has 
recently extended these experiments with penicillin to 
the feline spinal cord preparation where the effects of 
penicillin included antagonism of the depressant action 
of GABA when electrophoretically administered near inter-
neurones, and reduction of spinal prolonged inhibition 
(Davidoff, 1972b). 
In the hermit crab (Eupagurus bernhardus) 
penicillin (1 x 10- 4 - 1 x 10-3 M) has not been shown to 
antagonise the increase in membrane conductance induced 
by GABA at the neuromuscular junction, although lower 
concentrations of picrotoxin non-competitively antagonised 
this action of GABA (Earl and Large, 1973). Bicuculline, 
however, was reported to be either inactive or 40-50 times 
less potent than picrotoxin as an antagonist of GABA, or 
neurally evoked inhibition, in this preparation (Earle 
and Large, 1972, 1974), but in contrast bicuculline was 
more potent than picrotoxinin as a GABA antagonist at the 
stretch receptor of the crayfish (Eustacus armatus, 
McLennan, 1970). It thus seems likely that there is a 
species difference amongst crustacean GABA receptors and 
this possibility has been further considered by McLennan 
who has reported that bicuculline, bicuculline metho-
chloride and picrotoxin were all approximately equipotent 
in concentrations of O 5 - 13 x 10- 7 Mon stretch 
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receptor neurones of the crayfish Pacifastacus leniusculus 
(McLennan, 1973), a result that significantly differed 
from the earlier comparison in Eustacus armatus (McLennan, 
1970). A difference was also found between the GABA 
receptors of the stretch receptor neurones and those of 
the neuromuscular junction of Pacifastacus leniusculus, 
for in the latter preparation the bicucullines were much 
less potent. Hence a useful comparison cannot be made 
between relative potencies of GABA antagonists when they 
are determined in different species of crustacea, 
similarly it is unlikely that results in crustacea can 
be extrapolated to the mammalian CNS. 
Consideration of the structures of penicillin, 
bicuculline and GABA, when in the conformations depicted 
in Fig. 25, leads to the observation that in the structure 
of penicillin the benzyl grouping, the nitrogen atom on 
carbon 6 and the carboxylate anion can be in similar 
absolute positions to the equivalent groupings in 
bicuculline (shown by the 'boxed in' structures). When 
the benzyl groupings of penicillin and bicuculline and the 
carboxylate anion of penicillin and the C-C=O grouping 
of bicuculline are superimposed the nitrogen atoms of 
each molecule can be within approximately 0.8 ~ of each 
other. (Other superimposable conformations are possible.) 
The similar relationship between bicuculline and certain 
conformations of some inhibitory substances whose actions 
are blocked by bicuculline (muscimol, imidazole acetic 
acid and 4-aminotetrolic acid: Beart, Curtis and Johnston, 
1971; Curtis, Duggan, Felix and Johnston, 1971) have been 
previously discussed (Section I). Hence the structure-
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activity relationships of penicillin support the 
hypothesis that GABA interacts with its receptor in a 
partially extended conformation, however penicillin, 
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like bicuculline, does not significantly inhibit the uptake 
of GABA by cat spinal cord slices (Balcar and Johnston, 
1973), this uptake being mediated by a receptor that 
appears to be structurally different from the postsynaptic 
GABA receptor. 
Since the action of penicillin on the inhibition 
of other neurones by GABA is unlikely to differ from that 
demonstrated in the spinal cord, cerebral and cerebellar 
cortices, these results provide strong support for 
Davidoff's original proposal (Davidoff, 1972a). The acute 
convulsant effects of penicillin in the mammalian CNS may 
well arise mainly from interference with inhibitory 
transmitter functions of GABA and the differential 
sensitivity of various portions of the nervous system 
(Gloor, 1969) presumably stems both from the relative 
importance of GABA-mediated inhibitions in the functioning 
neural networks directly affected, and from their inter-
connections with other regions. 
These experiments have clearly demonstrated that 
the convulsant or epileptogenic activities of tutin, 
coriamyrtin, shikimin, d-tubocurarine and penicillin may 
be due, at least in part to antagonism of the inhibitory 
amino acids, GABA and glycine The comparison of the 
influence of dTC, BMC and strychnine on the inhibitory 
actions of GABA and glycine provided no support for the 
proposition that dTC is a useful GABA antagonist (Hill, 
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Simmonds and Straughan, 1973b). The usefulness of an 
antagonist of transmitter action at particular synapses 
depends both on its relative potency and the selectivity 
or specificity which it exhibits towards the effects of 
other substances and hence upon the degrees of confidence 
with which it can be used to aid transmitter identification 
at other sites. In this regard the utility of atropine 
and curare-like agents at peripheral muscarinic and 
nicotinic sites is well recognised, under conditions 
where excitation or inhibition of postsynaptic structures 
usually involves the activation of only one type of 
synapse~ In contrast, most central neurones are influenced 
by a number of different transmitters and the tentative 
identification of a transmitter frequently depends upon 
a comparison between the effects of an antagonist of the 
appropriate synaptic process and its interaction with 
artificially administered compounds which mimic the 
action of the synaptically released transmitter. The 
basis for such tentative identification is thus selectivity 
of action of antagonist, and dTC would be of extremely 
dubious value in determining whether a glycine-like or 
GABA-like amino acid was the transmitter at central 
inhibitory synapses. 
Amongst the convulsants that were investigated 
only coriamyrtin and penicillin were shown to selectively 
antagonise the inhibitory action of GABA. Coriamyrtin, 
however, is not readily available and penicillin is too 
weak to be of practical value as a GABA antagonist and 
its distribution after systemic administration is 
hindered by a blood-brain barrier9 
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VI. EXCITATION OF SPINAL NEURONES BY CONFORMATIONALLY 
RESTRICTED ANALOGUES OF L-GLUTAMIC ACID. 
The relative flexibility of the L-glutamic acid 
molecule presents certain difficulties in determining the 
shape of the molecule during activation of receptors 
associated with excitation of central neurones. Van Gelder's 
proposal that L-glutamate interacts with its receptor in a 
folded conformation (Van Gelder, 1970) was discussed in 
the introduction to this thesis (Section I), and in an 
attempt to gain some insight into the possible shape(s) of 
glutamic acid during receptor interaction a study was made 
of four conformationally restricted analogues: (±)-cis-l-
aminocyclohexane-1,3-dicarboxylic acid ('cycloglutamic 
acid'), ibotenic acid, kainic acid and its dihydro 
derivative. 
Ibotenic acid, an isoxazole isolated from the 
mushroom Amanita muscaria (see Eugster, 1967) and kainic 
acid, a pyrrolidine derivative isolated from the seaweed 
Digenea simplex (Ueno, Nawa, Ueyanagi, Morimoto, Nakamori 
and Matsuoka, 1955; Murayama, Morimura, Nakamura and 
Sunagawa, 1965) have previously been shown to excite central 
neurones (Johnston, Curtis, de Groat and Duggan, 1968; 
Shinozaki and Konishi, 1970). 'Cycloglutamic acid' is an 
inhibitor of glutamine synthetase (Gass and Meister, 1970) 
and thus presumably interacts with an active site on this 
enzyme capable of interacting with glutamate. In each of 
these cyclic compounds the ring restricts rotation about 
bonds equivalent to the c a -C S and/or Cs -C y in L-glutamic 
acid. 
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RESULTS 
The approximate relative potencies (Table 5) of 
the amino acids when electrophoretically ejected with 
anionic currents were assessed on the basis of results 
obtained with 22 interneurones and 15 Renshaw cells (10 
spinal cord preparations) using the following solutions: 
'cyclo-glutamic' acid (IM, adjusted to pH 7.3 with NaOH), 
dihydrokainic acid (0.2 M, pH 7), L-glutamic acid (0.5 M, 
pH 8), DL-homocysteic acid (0.2 M, pH 7.5), ibotenic acid 
(0.2 M, pH 7), kainic acid (0.1 M, pH 8) and N-methyl-D-
aspartic acid (0.1 M, pH 8). 
TABLE 5 
Amino acid 
Kainic 
Approximate potency ranges of excitant 
amino acids relative to L-glutamic acid, 
based on the ejecting currents required 
to achieve equal increases in firing 
frequency of spinal neurones. 
Potency range relative to 
that of L-glutamic acid; 
number of neurones tested 
in brackets 
8 - 80 (19) 
N-Methyl-D-aspartic 7 - 20 ( 10) 
DL-Homocysteic 3 7 (12) 
Ibotenic 2 6 ( 6 ) 
L-Glutamic 1 (35) 
'Cycloglutamic' 0.7 - 0.8 ( 3) 
Dihydrokainic 0. 06 - 0.6 ( 5 ) 
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Kainic acid was more potent than N-methyl-D-aspartic 
acid, previously the most potent amino acid excitant 
reported (Curtis and Watkins, 1963), but dihydrokainic 
acid was the weakest excitant of the series. Fig. 26 
illustrates the effect of kainic acid on the firing rate 
of an interneurone in comparison with that of L-glutamic, 
DL-homocysteic and N-methyl-D-aspartic acids. The actions 
of kainic and N-methyl-D-aspartic acids were relatively 
slow in both onset and offset, compared with that of 
L-glutarnic acid; this was also apparent with 'cyclo-
glutamic', dihydrokainic and ibotenic acids. 
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Fig. 26: 
SPINAL INTERNEURONE 
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L-G LUT 
80 nA 
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Comparisons of the excitatory actions of L-glutamic 
(L-GLUT, 80 nA), DL-homocysteic (15 nA), N-methyl-D-
aspartic (10 nA) and kainic (1 nA) acids on a spinal 
interneurone. The horizontal bars indicate periods of 
electrophoretic ejection. Ordinate: firing frequency 
in spikes per second. Abscissa: time in minutes. 
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DISCUSSION 
An analysis of molecular models indicates that 
there is a unique juxtaposition of the equivalent 
ionizable groups in 'cyclo-glutamic', L-glutamic, ibotenic 
and kainic acids in the conformations illustrated in Fig. 27. 
L-glutamic acid is shown in a partially extended 
conformation with the Ca-CS substituents eclipsed and the 
CS-Cy substituents staggered; this and the conformations 
shown for ibotenic and kainic acids would be expected to 
be relatively stable forms. The boat form of 'cyclo-
glutamic' acid would, however, be less stable than a chair 
form. The close structural similarities of these amino 
acids in the conformations depicted in Fig. 27, suggests 
that they all interact with the same receptor and that 
L-glutamate interacts with the receptor in a partially 
extended conformation. Tests with a specific glutamate 
antagonist, when one becomes available, may be able to 
confirm that these compounds interact with a common 
receptor. 
The observation that dihydrokainic acid was much 
less potent than kainic acid, indicates that the double 
bond in the kainic acid molecule is an important feature 
in determining the potency of the molecule as an excitant. 
This double bond, the conformation of which is arbitrarily 
illustrated in Fig. 27, might bind to a specific site on 
the receptor or might influence the preferred conformation 
and the electronic properties of the neighbouring carboxyl 
group. Alternatively, the double bond might only influence 
the electronic properties of the carboxyl group. 
HO 
Fig. 27: 
HO 
GLUTAMIC ACID 
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HO 
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HO 
" CY CLO-GLUT AMIC ACID 
Conformations of glutamic, ibotenic, kainic and 
'cycloglutamic' acids in which the ionisable groups occupy 
the same absolute positions. 
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The ionizable groups of L-aspartic acid and NMDA 
acid cannot match those illustrated in Fig. 27 for L-
glutamic acid and its analogues, hence it is possible that 
excitation by L-glutamic acid and L-aspartic acids results 
from preferential interaction by these two amino acids 
with different receptors. L-glutamic acid might interact 
with 'glutamic acid prefering' receptors in partially 
extended conformations (approximating that shown in Fig. 27), 
and perhaps also with 'aspartic acid prefering' receptors 
in partially folded conformations. On the other hand, 
L-aspartic acid may interact only poorly, if at all, with 
'glutamic acid prefering' receptors since the carbon 
chain of L-aspartic acid is one atom shorter than that of 
L-glutamic acid. Two populations of receptors for 
excitant amino acids, one 'aspartic acid prefering' and 
one 'glutamic acid prefering' would provide an explanation 
of the differences in the relative potency of L-glutamic 
and L-aspartic acids as excitants of different central 
neurones. For example, the differential sensitivity of 
Renshaw cells and dorsal horn interneurones to L-glutamate 
and L-aspartate (Duggan, 1974) may be due to different 
populations of receptors for these excitant amino acids 
(see Section VII). 
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VII. THE DIFFERENTIAL SENSITIVITY OF SPINAL INTERNEURONES 
AND RENSHAW CELLS TO KAINATE AND N-METHYL-D-ASPARTATE (NMDA) 
Duggan found that Renshaw cells, which have not 
been shown to be monosynaptically excited by impulses in 
primary afferent fibres (Curtis and Ryall, 1966b; Ryall 
and Piercey, 1971) are more sensitive to electrophoretically 
administered L-aspartate than to L-glutamate, whereas 
spinal dorsal horn interneurones that are monosynaptically 
activated from the periphery are more sensitive to 
L-glutamate than to L-aspartate (Duggan, 1974). The 
problems associated with assessing the relative sensitivity 
of particular neurones to electrophoretically administered 
compounds were discussed in the introduction to this 
thesis (Section I), but despite these difficulties the 
differential sensitivity of Renshaw cells and spinal dorsal 
horn interneurones supports the hypothesis that L-glutamate 
is an excitatory transmitter released by primary afferent 
fibres and L-aspartate an excitatory transmitter released 
by excitatory spinal interneurones (Graham, Shank, Werman 
and Aprison, 1967). This hypothesis was previously based 
on neurochemical evidence of the spinal distribution of 
these excitant amino acids. High levels of L-glutamate 
occur in dorsal roots (Graham, Shank, Werman and Aprison, 
1967) and dorsal root ga~glia (Duggan and Johnston, 1970) 
whilst within the cord the highest levels are found in 
dorsal grey matter (Graham, Shank, Werman and Aprison, 
1967). In contrast, L-aspartate levels are highest in the 
ventral grey. Furthermore, the number of interneurones in 
; 
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the central region of the spinal cord can be reduced by 
temporary aortic occlusion and the resulting inter-
neuronal loss has been correlated with the subsequent 
decrease in aspartate levels (Davidoff, Graham, Shank, 
Werman and Aprison, 1967). 
Although Renshaw cells were reported to be 
consistently more sensitive to L-aspartate than to 
L-glutamate, the mean glutamate:aspartate 'potency ratio' 
was only 1.2 whilst the mean 'potency ratio' for inter-
neurones was only 0.8, where the 'potency ratio' was an 
equipotent current ratio, the ratio of ejecting currents 
which produced equal a n d submaximal responses (Duggan, 
1974). The molecules of glutamate and aspartate are 
flexible and the relatively small potency difference may 
result from glutamate interacting with both glutamate and 
aspartate receptors. The structure- activity relationships 
of kainic, ibotenic and 'cycloglutamic' acids, as discussed 
in the previous section (Section VI), suggest that glutamate 
might interact with the glutamate receptor in a partially 
extended conformation and perhaps also with the aspartate 
receptor in a partially folded conformation. Aspartate, 
however, has one less carbon atom in its chain and thus 
probably cannot interact with such a glutamate receptor. 
If L-glutamate is 'non-specific', in that it interacts 
with both glutamate and aspartate receptors, then a greater 
relative difference in the sensitivities of Renshaw cells 
and interneurones would be expected with glutamic acid 
analogues that were more selective for the glutamate 
receptor. 
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Due to its restricted conformation it is unlikely 
that kainic acid could occupy aspartate receptors and 
hence should be more selective than glutamate in terms of 
interacting with glutamate, but not with aspartate 
receptors. NMDA which is comparible in potency to kainate 
is probably too small a molecule to interact with the 
glutamate receptor and hence an investigation was made 
of the relative sensitivities of dorsal horn inter-
neurones and Renshaw cells to kainate and NMDA. 
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RESULTS 
Seventeen Renshaw cells and 21 spinal inter-
neurones activated with a short central latency (<2 msec) 
from peripheral nerves were tested in 7 cats using 7 
micropipettes. Responses to kainate (5 rnM in 250 mM 
NaCl, pH adjusted to 8.3 with NaOH) and NMDA (50 rnM in 
200 rnM NaCl, pH 8.3) were generally slower in onset and 
recovery than those to glutamate or aspartate (Fig. 28). 
TABLE 6 Sensitivity ratios of spinal inter-
neurones and Renshaw cells to kainate, 
relative to NMDA 
Cell type Classes of values of sensitivity ratios 
Interneurone 
Renshaw 
>10 
16 
0 
10 
4 
0 
<10 
1 
17 
The table contains numbers of cells with values of 
sensitivity ratio in classes. 
A highly significant difference (P<0.001 for the 
Chi-squared statistic of the contingency table, and 
P<0.001 for Student's t statistic for the means and 
standard errors) was found in the relative sensitivities 
of the two groups of neurones (Table 6). Fig. 28 illu-
strates a comparison of the sensitivity of a Renshaw cell 
and an interneurone to the excitants electrophoretically 
ejected from the same micropipette. The sensitivity ratio 
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(K:NMDA) for the interneurone was 16 and for the Renshaw 
cell it was 2.5; all of the Renshaw cells that were tested 
had sensitivity ratios that were less than 10, whilst only 
one of the sample of 21 interneurones had a ratio that 
was less than 10. The mean and standard error of the 
sensitivity ratios were 17.8 ~ 2.2 for interneurones and 
4.3 ~ 0.5 for Renshaw cells, there being a 4-5 fold 
difference in the sensitivity ratios for the two groups 
of neurones. Thus, with sensitivity to NMDA as the basis 
of comparison, interneurones were relatively more sensitive 
to kainate than were Renshaw cells. 
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Comparisons of the relative sensitivities of a spinal 
interneurone and a Renshaw cell to electrophoretically 
administered kainate {KA) and N-methyl-D-aspartate {NMDA). 
The horizontal bars indicate periods of ejection and the 
currents shown have been corrected for dilution in NaCl 
{see text): Kainate = 5 rnM in 250 mM NaCl and NMDA = 50 mM 
in 200 mM NaCl. The sensitivity ratio {KA:NMDA) of the 
interneurone was 16 and that 0£ the Renshaw cell was 2.5. 
A typical response to L-aspartate {L-ASP, 100 nA) is 
included for comparison with the responses to kainate and 
NMDA. Ordinates: firing frequency in spikes per second. 
Abscissa: time in minutes. 
DISCUSSION 
The observed differences in the relative 
sensitivities of interneurones and Renshaw cells to 
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kainate and NMDA were considerably larger than those 
reported for L-glutamate and L-aspartate by Duggan (1974). 
The various factors which might account for the differences 
in the sensitivities of neurones to two agonists, factors 
such as lack of exact information regarding micropipette 
characteristics, diffusion and inactivation of ejected 
agonists within the tissue and the location and specificity 
of receptors on particular neuronal membranes, have been 
discussed in the introduction to this thesis (Section I). 
In addition, the factors which are applicable to the 
determination of the relative sensitivity of two particular 
types of neurones to two agonists have also been discussed 
in general terms, and they will now be related to the 
results of the present investigations. 
The microelectrophoretic technique does not enable 
a measurement to be made of the relative intrinsic activity 
or efficacy of kainate and NMDA at neuronal receptors. 
In addition, kainate and NMDA are probably distributed 
differently in the tissue from glutamate and aspartate 
during electrophoretic administration. L-glutamate and 
L-aspartate are taken up by high affinity transport 
systems in slices of spinal cord in vitro, and NMDA appears 
not to be a substrate for these systems (Balcar and 
Johnston, 1972b). The slow recovery of kainate and NMDA 
responses suggests that active uptake of these excitants 
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contributes very little to the termination of their 
respenses, although to some extent these slow time courses 
may reflect slow dissociation of amino acid- receptor 
complexes. Kainate is a weak competitive inhibitor of 
glutamate high affinity uptake by brain tissue slices 
(see McCulloch, Johnston, Game and Curtis, 1974) and thus 
can only be a relatively poor substrate for this transport 
system. It is possible that both kainate and NMDA may 
be taken up by other transport processes, and this 
possibility needs to be investigated using radioactively 
labelled compounds. To allow a full discussion of the 
present results, however, it would ultimately be necessary 
to compare the neurochemical environment of the Renshaw 
cell with that of the dorsal horn interneurone. 
The neurochemical environment of Renshaw cells and 
interneurones determines, in part, the tissue volume that 
is affected by electrophoretically ejected kainate and 
NMDA. The relative sensitivity of these two types of 
neurones would depend not only on the relative distribution 
volumes of ejected kainate and NMDA, but also on the 
distribution patterns of the excitatory receptors. At 
present the location of amino acid excitatory synapses 
on Renshaw cells and interneurones is not known, but it 
seems likely from studies in other regions of the central 
nervous system that they are located predominantly on the 
dendrites (see Eccles, 1964). 
If it is assumed that kainate is more selective 
for the glutamate receptor than is glutamate, and that 
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NMDA is too small a molecule to interact with the glutamate 
receptor, then the present results are consistent with the 
presence of both glutamate and aspartate receptors on 
spinal neurones, there being fewer glutamate receptors, in 
comparison with aspartate receptors, on Renshaw cells than 
on interneurones. Hence, if the excitatory amino acid 
receptors are located on postsynaptic membranes (see Curtis , 
Duggan, Felix, Johnston, Tebecis and Watkins, 1972) then 
the results also provide additional support for the 
proposition that glutamate is the excitatory transmitter 
at primary afferent synapses in the spinal cord and that 
aspartate is the excitatory transmitter released by spinal 
excitatory interneurones. By using amino acid analogues 
to reveal such significant differences in the amino acid 
sensitivity of particular populations of neurones it may 
be possible to distinguish glutamate-mediated excitatory 
pathways from those mediated by aspartate in other regions 
of the central nervous system, although the use of specific 
antagonists of the excitants will be required to fully 
assess the synaptic role of these amino acids. A study of 
the interactions between such antagonists and kainate and 
NMDA may also provide an indication of the degree of 
specificity of all these compounds in relation to amino 
acid receptors at excitatory synapses. 
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VIII. POTENTIAL ANTAGONISTS OF THE POST-SYNAPTIC ACTION 
OF L-GLUTAMIC ACID 
Specific post-synaptic antagonists of glutamate or 
aspartate would be of considerable use in assessing the 
transmitter roles of these two excitant amino acids and 
in studying the nature of the receptors that are involved. 
For these reasons many compounds have been tested 
electrophoretically as potential glutamate or aspartate 
antagonists (see, for example, Curtis, Duggan, Felix, 
Johnston, Tebecis and Watkins, 1972; Haldeman and McLennan, 
1972; Davies and Watkins, 1973), but few have shown a 
sufficient degree of selectivity towards amino acid 
excitation to unequivocally distinguish amino acid from 
cholinergic synaptic excitation, and no antagonist has 
yet been shown to unequivocally distinguish between 
aspartic and glutarnic acid excitation. 
Lysergic acid diethylarnide has been reported to 
block the excitation of neurones in the feline brain stern, 
but only those neurones that were excited by 5-
hydroxytryptarnine were susceptible to antagonism of 
glutamate excitation by lysergic acid diethylarnide 
(Boakes, Bradley, Briggs and Dray, 1970). Although 
lysergic acid diethylarnide antagonised the excitatory 
action of L-glutarnate without antagonising the excitatory 
response to acetylcholine or DLH, it also antagonised the 
excitatory action of 5-hydroxytryptarnine and its effect 
on L-aspartic excitation was not tested. Of the glutarnic 
acid derivatives that have been tested as potential 
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glutamate antagonists, a-methyl-DL-glutamate and L-
glutamic acid diethyl ester (GDEE), which themselves 
possess little or no excitatory activity, were reported 
to be more effective in reversibly reducing the excitatory 
action of L-glutamate than those of acetylcholine, L-
aspartate or DLH on neurones of the feline thalamic nuclei 
(Haldeman, Huffman, Marshall and McLennan, 1972). The 
synaptic excitation of cells in the nucleus ventralis 
posterolateralis, evoked by electrical stimulation of 
hind limb afferent nerves, was also reduced by GDEE, 
although blockade of synaptic activation was not necessarily 
observed on every occasion when the response to 
electrophoretically administered L-glutamate was abolished. 
The relative selectivity of L-glutamate antagonism by 
GDEE was further demonstrated on the amino acid excitation 
of neurones in the feline cuneate nucleus and spinal cord, 
and in addition the reduction in the sensitivity of 
cuneate neurones and spinal neurones to L-glutamate by 
GDEE was accompanied by reduced synaptic excitation by 
impulses in the dorsal columns and peripheral nerves 
respectively (Haldeman and McLennan, 1972). Stone (1973) 
has also reported that GDEE both reduces the glutamate 
induced excitation of pyramidal tract interneurones in the 
rat cerebral cortex more than acetylcholine induced 
excitation, and blocks synaptically evoked spikes resulting 
from pyramidal tract stimulation. Another study of 
a-methyl-glutamate and GDEE failed to demonstrate selective 
antagonism of the excitation of feline spinal interneurones, 
Renshaw cells, ventrobasal thalamic neurones, lateral 
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geniculate neurones and pyramidal tract neurones by 
L-glutamate, L-aspartate and DLH (Curtis, Duggan, Felix, 
Johnston, Tebecis and Watkins, 1972). Steinberg, Altman 
and ten Bruggencate (1974) found no consistent antagonism 
by GDEE of the excitation of feline red nucleus neurones 
by L-aspartate, DLH and L-glutamate, although DLH and L-
glutamate excitation were apparently reduced. These 
experiments in the red nucleus indicated a tendency for 
GDEE to hyperpolarise cell membranes and a further report 
(Zieglegansberger and Puil, 1973b) that both a-methyl-
glutamate and GDEE hyperpolarise spinal neurones and 
increase membrane conductance suggests that the reduction 
of amino acid excitation is not completely due to selective 
antagonism at neuronal membrane receptors. Similarly 11 
it is unlikely that praline which has been reported to 
antagonise the depolarisation of retinal neurones by 
L-glutamate (Van Harreveld and Fifkova, 1973) will prove 
to be a useful glutamate antagonist for it is a glycine-
like amino acid (see Curtis and Johnston, (1974a; Young 
and Snyder, 1973) and consequently may alter the 
conductance of retinal neuronal membranes. 
Aporphines have been tested for antiglutamate 
activity, and although nuciferine (1-5,6-dimethoxyaporphine) 
when administered electrophoretically blocked the excitant 
action of both acetylcholine and L-glutamate on Renshaw 
cells of the rat (Duggan, Lodge, Biscoe and Headley, 1973), 
and apomorphine diminished the sensitivity of feline 
Renshaw cells to acetylcholine, L-glutamate and L-aspartate 
(Curtis, Duggan, Felix, Johnston, Tebecis and Watkins, 
1972), 2-methoxyaporphine did not affect acetylcholine 
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excitation of feline Renshaw cells, ventrobasal thalamo-
cortical neurones or pyramidal tract neurones, but it 
simultaneously reduced the effects of L-aspartate, 
L-glutamate and DLH. In this same study Curtis and co-
workers found that L-methionine-DL-sulphoximine (MSO) 
reduced the excitatory effects of L-aspartate, L-glutamate 
and DLH, but did not affect acetylcholine excitation, of 
neurones in the feline spinal cord, ventrobasal thalamus, 
lateral geniculate nucleus and cerebral cortex. Similar 
results were obtained using DL-methionine-DL-sulphoximine 
(Haldeman and McLennan, 1972), however the low solubility 
of MSO and its inability to distinguish between L-aspartic 
and L-glutamic acid excitation detracts from its usefulness. 
Due to the limited ability of the presently 
available glutamate antagonists to specifically antagonise 
glutamate at the post-synaptic receptor, investigations 
continue to be made to find a more specific glutamate 
antagonist. From glutamate structure-activity relationship 
studies it would seem necessary for a glutamate antagonist 
molecule to have a basic group plus one or two electro-
negative groups in place of the fully anionic groups of 
the agonist molecules. On this basis a number of compounds 
(Table 7) have been tested for glutamate antagonism, which 
have a basic group and oxygen atoms (or electronegative 
groups) situated little differently from where they are 
located in the extended forms of glutamate and aspartate 
(see Sections I and VI). In addition, a number of 
compounds (Table 7) have been tested which have a 
structural resemblance to glutamate and have central 
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actions which may be due to glutamate antagonism (for 
example, the action of a CNS depressant or a 'central 
muscle relaxant'). A study has also been made of the 
effects of l-hydroxy-3-amino-pyrrolidone-2 (HAP) on central 
neurones. When administered electrophoretically HAP has 
been reported to reduce the sensitivity of neurones in 
the cerebral cortex of the cat to L-glutamate and 
L-aspartate with little or no influence on either the 
spontaneous firing rate, the sensitivity to acetylcholine, 
or the amplitude of extracellularly recorded action 
potentials (Davies and Watkins, 1973). Systemically 
administered HAP produces a variety of centrally mediated 
depressant effects in a number of species, including 
depression of spinal polysynaptic reflexes (Banta, De Vos, 
Grisjsen, Hillen, Noach and Sim, 1971), and hence the 
effect of HAP on spinal neurones was investigated. 
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RESULTS AND DISCUSSION 
(1) Compounds of Table 7 
The compounds listed in Table 7 were tested as 
potential glutamate antagonists on spinal interneurones 
and Renshaw cells. A total of 11 spinal cord preparations 
were used and apart from those compounds which were either 
weak excitants (compounds V, VI and VIII) or had no 
detectable effect (compounds III, IX, XV, XVI and XXII I.),they 
were all found to be depressants and unsuitable as specific 
glutamate antagonists. The compounds were ejected with 
either cationic or anionic currents (20-100 nA), depending 
upon the predominant species present in the solution used 
(see Table 7), except for compound XXV which was tested 
with both cationic and anionic currents. 
(a) Compounds I and II (tetrazole derivatives) 
Compounds I and II were weak depressants 
(approximately 1/8 and 1/4 of the potency of GABA 
respectively) of spinal neurones. Fig. 29 illustrates 
the use of a Renshaw cell to test a potential glutamate 
antagonist, in this case compound II: compound II was 
ejected by a cationic current of 25 nA and this 
reversibly reduced the excitant effect of electropho-
retic pulses of both acetylcholine (15 nA) and DLH 
(20 nA), this non-specific depressant effect becoming 
more pronounced with continuing administration of 
compound II. Although the neurone depicted in this 
figure fired at a low spontaneous rate, other neurones 
TABLE 7 COMPOUNDS TESTED FOR ANTAGONISM OF L-GLUTAMIC ACID EXCITATION 
No. COMPOUND FORMULA SOLUTION No. CURRENT ANTAGONISM 
Molarity pH N EURONES (nA) 
N:N}- A weak neuronal I 5-Aaino~thyltetrazole 10 (. CH1-HH1 0.2 3 (HCl) 3 (+) 20-90 LG LA ACh DLH N-N depressant 
N:N~ A weak neuronal II 5-Aainoethyltetrazolc 10 (. CH2-CH1-HH1 0.2 5 HBr 6 (+) 20-50 LG LA ACh DLH M-N depressant 
III 1,2,4-Triazole-3-sul- ,ty--50,H 0.2 5 (NaOH) 4 (-) 30-50 No effect detected. phonic acid N-NH 
IV 1(2-Pyridyl)-1,2,4-tri- 0-fHYSO,H 0.2 8 (NaOH) 3 (-) 20-80 LG LA 
azolc-3-su!phonic acid N-N 
Weak exci tation N 
occasionally 
~ observed. V 4-(4-Pyridyl)-1,2,4-tri- 0.2 8 (NaOH) 9 (-) 25-100 
azole-3-sulphOnic acid rtYSO,H 
N-N 
y 4- (l-Pyridyl)-1,2,4-tri- I 3 (-) 40-50 LG LA VI 0.2 8 (NaOH) 
azole-3-sulphonic acid rtYSO,H 
N-N 
Pyridine-2-phosphonic 0-~o 0.2 8 (NaOH) 3 (-) 20-60 LG LA VII 1-oH 
acid N 'oH 
H,N, /co,H 
Weak excitation CH 
VIII DL-lfillardine I 0.2 3 (HCl) 3 (+) 20-40 
°''~ 
observed. 
O~N 0 H 
IX 
"') 0.2 4 (HCl) 3 (+) 20-50 No e ffect de tected. l-(2-Aminoethyl) uracil N I H,N-CH,-C, 
CH 1-CH 1-NH, I 
X 1-(2-Aainoethyll uracil HN I y~ 0.2 4 (HCl) 7 (+) 30-80 LG LA 
No. 
XI 
XII 
XIII 
XIV 
xv 
XVI 
XVII 
COMPOUND 
l,J-Di-(2-aminoethyl) 
uraci 1 
DL-o -(2-Amino-l-methyl-
ethyl benzhydrol 
L-Glutami ~ acid di-
tert-butyl ester 
4-rluoroglutamic acid 
d1ethyl ester 
4-rluoroglutamic acid-
1-amide 
DL-Aspa rtic ac,d di thyl 
ester 
N-M th y l-DL -as µartic 
acid d1ethyl e ster 
XVIII N-Met hyl-DL-as ;:,art1c 
ac,d d1-n-proµyl es t er 
FORMULA SOLUTION 
Molarity pH 
4 di-HCl 
0.2 5 HCl 
a" ff /c-oc,H,111 
( t ) c H 0-C-CH -CH -CH O • 2 
, t 1 1 ' 
NH, 
5 HCl 
0 
c,H,o, ~ )'c:-oc,H, 
C-CH-CH-CH ~ t 'NH1 
0.2 5 HCl (NaOH) 
3 HCl (NaOH) 
3 HCl 
0 
c,H,o\ .}:-oc,H, 
/,C-CH,-CH 
0'/ 'NHCH, 
0.2 4 HBr 
4 (HCl.) 
XIX Ambenoxan 
((;r::),_CH,-NH-CH,-CH,-0-CH,-CH,-OCH, 0.2 5 HCl 
xx 
8-(~- Trifluoromc thyl-
µhcnyl)-y-aminobutyr,c 
acid 
0.2 3 (HCl) 
No. 
NEURONES 
CURRENT 
(nA) 
5 (+) 40-80 
7 (+) 20-50 
9 (+) 10-60 
3 (+) 20-60 
5 (+) 30-60 
8 (+) 20-50 
3 (+) 30-60 
3 (+) 35-60 
4 (+) 20-50 
4 (+) 30-50 
ANTAGONISM 
LG LA 
LG 
LG LA ACh 
LG LA ACh 
LG ACh 
LA ACh 
LG LA ACh 
LG LA 
REMARKS 
Spike amplitude 
reduced. 
Spike amplitude 
reduced. 
Spike amplitude 
reduced. 
No ef fect d e tec ted. 
No effect detec ted. 
Spontaneous rate 
depressed. 
Spike al'lplitude 
reduced. Spontaneous 
rate de pressed. 
No. 
XXI 
XXII 
XXIII 
XXIV 
XXV 
COMPOUND FORMULA SOLUTION No. CURRENT ANTAGONISM REMARKS 
Molarity pH NEURONES (nA) 
8-(£-Chlorophenyl)-y- ""·-"·Q""·-00" 
aminobutyric acid ( SCPG) 0.2 3 4 (+) 30-60 LG LA ACh 
Cl 
m-Aminobenzo1c acid 2i"·"· Spike ethyl ester methanesul- 0.020*3 MS 4 (+) 30-100 LG LA ACh amplitude phonate (metacaine) reduced. NH, 
2-Methyl-l-(o-tolyll- o:::ycH, 0.025*3 HCl 5 (+) 20-50 effect detected. NX) No 4(3H)-qui nazolinone ~I 
:-.. 
CH3 
""··w 1-S,6-Dimethoxyaporphine cH,o :-.. I N'cH, 0.050*3 HCl 4 (+) 30-50 Spike amplitude (nuci fer ine) LG ACh reduced. vi ;:,... 
No effect detected 
0 (-) 10-90 or spike amplitude L-Meth1onine-D,L-sulphox- II 0.2 8 10 reduced. imine phosphate CH,-ri-CH,-CH,-~H-COOH (+) 30-80 NP03H 1 NH, 
Weak exci tat i on 
observed, but 
HOOC-CH,-rH-COOH inconsi s ten t. L-1\spart i c acid 1 8 (NaOH) 
NH1 
L-Glutamic acid HOOC-CH1-CH,-~H-COOH 1 8 (NaOH) 
NH, 
LG L-glu tamic acid 
*in 0.165 M NaCl LA L-aspartic acid 
ACh = acetylcholine 
Notes to table 7 
l. If the solution of a compound was prepared from a salt, the type 
of salt used is indicated after the p H of the solution. If the 
pH of the solution was adjusted the added acid or alkali is 
indicated, in brackets, in the pH column. 
2. Only the compounds which are listed in the table as antagonising 
the excitant action of acetylcholine were tested on Renshaw cells. 
RENSHAW CELL 
II 25 
DLH 
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Fig. 29: 
Effect of compound II (5-aminoethyltetrazole) on 
the chemical excitation of a Renshaw cell. The cell was 
excited by alternate electrophoretic pulses of acetylcholine 
(ACh, 15 nA) and DL-homocysteate (DLH, 20 nA), indicated 
by the broken and solid horizontal lines, respectively. 
Compound II (25 nA) was administered for the period indicated 
by the solid horizontal bar and broken vertical lines. 
Ordinate: firing frequency in spikes per second. Abscissa: 
time in minutes. 
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were tested in which it was possible to demonstrate a 
reduction in spontaneous rate during the continuous 
administration of either compound I or compound II. 
If the tetrazole ring is electronegative, compound I 
(5-amino-methyltetrazole) could be glycine-like and 
compound II (5-aminoethyltetrazole) GABA-like. 
Alternatively, these two weak depressants could be 
histamine-like for the structure of compound II, in 
particular, resembles the histamine molecule which has 
been reported to depress some central neurones including 
spinal motoneurones (Phillis, Tebecis and York, 1968) 
and brain stem neurones (Haas, Anderson and Hosli, 1972) 
by a mechanism which appears to be insensitive to 
strychnine and either picrotoxin (Phillis, Tebecis and 
York, 1968) or bicuculline (Haas, Anderson and Hosli, 
1972) . 
{b) Compounds III - VII (triazole derivatives and 
pyridine-2-phosphonic acid) 
Compound III (1,2,4-triazole-3-sulphonic acid) 
was inactive, however, pyridyl derivatives of this 
compound which consequently had two possible basic 
groups (the triazole ring or the nitrogen atom in the 
pyridine ring) were either weak excitants (compounds 
V and VI) or reduced both glutamate and aspartate 
mediated excitation (compound IV), depending upon the 
position of the pyridine ring. Pyridine-2-phosphonic 
acid (compound VII) also reduced both types of amino 
acid excitation. 
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(c) Compounds VIII - XI (uracil derivatives) 
DL-Willardine (compound VIII) was a weak excitant 
and the structure of this uracil derivative has a 
close r~semblance to that of glutamate, one of the 
oxygen atoms of the uracil moiety being the second anionic 
group. Derivatives of uracil produced by substitution 
of the 2-aminoethyl group for one of the nitrogen bound 
protons of the uracil molecule produced either an 
inactive compound (compound IX) or a compound which 
reduced both glutamate and aspartate mediated excitation, 
depending on which nitrogen atom carried the substituent. 
1,3-Di-(2-aminoethyl) uracil (compound XI) also reduced 
excitation due to both glutamate and a$partate. 
Although compound XI did show some selectivity in 
reducing excitation due to L-glutamate (Fig. 30), it 
was not a consistent observation and furthermore this 
compound tended to reduce the height of extracellularly 
recorded action potentials, a procaine-like action 
(Curtis and Phillis, 1960). The type of experiment 
illustrated in Fig. 30 was used to determine whether 
a potential glutamate antagonist would differentiate 
between excitation of a neurone by L-glutamate and 
excitation by L-aspartate. The interneurone in Fig.30 
was alternately excited by electrophoretic pulses of 
L-glutamate (35 nA) and L-aspartate (40 nA); during the 
continuous administration of compound XI the excitation 
due to both of these amino acid excitants was reduced, 
but that due to L-aspartate was affected to a lesser 
degree. 
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Fig. 30: 
Effect of compound XI (1,3-di-(2-aminoethyl)-uracil) 
on the amino acid excitation of a spinal interneurone. The 
neurone was excited by alternate electrophoretic pulses 
of L-glutamate (L-G, 35 nA) and L-aspartate (L-A, 40 nA), 
indicated by the respective broken horizontal lines. Compound 
XI (40 nA) was administered for the period indicated by the 
horizontal bar and broken vertical lines. 
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(d) Compound XII 
Compound XII is one of a series of diphenylamino 
propanols synthesised and studied by Keasling and 
Moffett (Keasling and Moffett, 1971). These compounds 
are reported to have an unusual dose-related spectrum 
of pharmacological activity when systemically 
administered - low doses are central stimulants, moderate 
doses produce mixed stimulation and depression, whilst 
high doses produce convulsions in rats and mice and 
paralysis in cats and dogs. Compound XII has a basic 
group and an anionic group that are similar distances 
apart to the basic group and one of the carboxyl groups 
in the glutamate molecule. The compound was active on 
four of the seven interneurones on which it was tested, 
but in each case it reduced the spike height as well as 
antagonising the excitatory action of glutamate. 
(e) Compounds XIII - XVIII 
In view of the reported activity of L-glutamate 
diethyl ester as a glutamate antagonist (Haldeman, 
Huffman, Marshall and McLennan, 1972) it is likely that 
other esters of the excitatory amino acids may be 
glutamate or aspartate antagonists. L-Glutamic acid 
di-tert-butylester (compound XIII), however, antagonised 
the excitatory actions of both amino acids and acetyl-
choline and also reduced the amplitude of extracellularly 
recorded action potentials. Diethyl-DL-aspartic acid 
(compound XVI) was inactive when tested on eight neurones. 
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It is likely that esters derived from amino acids 
that are stronger excitants than L-glutamic acid would 
have a higher affinity for the receptor(s) than L-
glutamic acid diethylester. N-Methyl-DL-aspartic acid 
is about 3-6 times as potent as L-aspartic acid (Curtis 
and Watkins, 1963), however, N-methyl-DL-aspartic acid 
diethylester (compound XVII) and N-methyl-DL-aspartic 
acid di-n-propylester (compound XVIII) were non-specific 
depressants of spinal neurones. y-Fluoro-glutamate is 
a more potent excitant of spinal neurones than L- glutamate 
(Curtis, Duggan, Felix, Johnston, Tebecis and Watkins, 
1972), however 4-fluoroglutamate diethylester (compound 
XIV) was a non-specific depressant, reducing excitation 
by amino acids and acetylcholine. 4-Fluoroglutamic 
acid-1-amide (compound XV) was also inactive. The lack 
of specific glutamate or aspartate antagonism displayed 
by the esters that were tested suggests that L-glutamate 
diethyl ester may be unique among the esters of 
excitatory amino acid ester, if indeed it is a specific 
glutamate antagonist. Some esters of kainic acid have 
yet to be investigated. 
(f) Compound XIX (Ambenoxan) 
Ambenoxan (compound XIX) is a 2-substituted 
aminomethyl-1,4-benzodioxane the central actions of 
which are critically dependent upon the dose level 
(Meldrum and Bhargava, 1968; Green, Shapiro and Wilson, 
1969). In the rabbit, rapid intravenous injections of 
low doses of ambenoxan (less than 10 mg/kg) produce 
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sedation and loss of muscle tone, whilst high doses 
produce cortical seizure followed by sedation and loss 
of muscle tone. The straight alkoxy side chain was 
apparently essential for the muscle relaxant activity 
and increasing the length of the chain increased the 
convulsant activity. Ambenoxan, which has four possible 
electronegative centres (the oxygen atoms) and one 
electropositive centre (the nitrogen atom) was a non-
specific depressant reducing the excitation of inter-
neurones to L-aspartate and L-glutamate, and reducing 
the excitation of Renshaw cells by the amino acids, 
acetylcholine and by ventral root stimulation. Further-
more, when electrophoretically administered, this 
compound consistently reduced the amplitude of extra-
cellularly recorded action potentials. 
(g) S-(p-Chlorophenyl)-GABA (Lioresal) and 
S- (m-trifluoromethylphenyl)-GABA 
S- (p-chlorophenyl)-GABA has been separately 
investigated as a depressant of neuronal activity and 
the results of those investigations are reported else-
where in this thesis (Section III). However, the compound 
(compound XXI) was also included in this series for 
testing as a potential glutamate antagonist. This 
compound dep ressed glutamate, aspartate and acetyl-
choline induced neuronal activity. B-(m-trifluoro-
methylphenyl)-GABA )compound XX) similarly depressed 
glutamate and aspartate induced neuronal activity. 
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(h) Compounds XXIII (Methaqualone) and XXII (Metacaine). 
Methaqualone (compound XXIII) has been described 
as a potent hypnotic and anticonvulsant and in addition 
it reduces spinal polysnaptic reflexes (Swift, Dickens 
and Becker, 1960). A mechanism of action of this 
compound at the cellular level has apparently not been 
reported in the literature, and in these tests 
methaqualone was inactive when administered to individual 
neurones. Similarly, a mechanism of action has not yet 
been reported for Metacaine (compound XXII; Tricaine) 
which has been effectively used as an anaesthetic for 
fish and some other cold-blooded animals (Ball and 
Cowen, 1959; Stefanova, Puchta and Romanovsky, 1962). 
Low concentrations of metacaine are required to 
completely immobilise fi~h, and the mode of action of 
metacaine could be partly explained by interruption of 
neuromuscular transmission, possibly by a presynaptic 
action (Maeno, 1966). Its effects, however, on central 
neurones have not been reported. When tested on four 
Renshaw cells, metacaine consistently reduced the 
excitatory action of both L-glutamate and acetylcholine 
and significantly reduced the height of the action 
potential. The compound was thus a non-specific 
neuronal depressant, similar to procaine (Curtis and 
Phillis, 1960). 
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(i) Compound XXIV (nuciferine) 
Nuciferine (compound XXIV) is structurally related 
to 2-methoxy aporphine which antagonises the excitant 
action of L-glutamate on central neurones with minimal 
effect on that of acetylcholine (Curtis, Duggan, Felix, 
Johnston, Tebecis and Watkins, 1972). The use of 
2-methoxyaporphine, however, is technically difficult 
due to its low aqueous solubility and furthermore, it 
generally antagonises L-aspartate and L-glutamate 
excitation to the same extent. Hence, nuciferine, which 
has been shown to be a CNS depressant producing similar 
effects to chlorpromazine (Macko, Douglas, Weisbach and 
Waltz, 1972) was tested as a potential glutamate 
antagonist. Nuciferine was tested on four Renshaw cells 
and consistently reduced the excitatory activity of both 
L-glutamate and acetylcholine, a finding that agreed 
with a recent report concerning its activity on rat 
Renshaw cells (Duggan, Lodge, Biscoe and Headley, 1973). 
( j ) L-Methionine-DL-sulphoximine phosphate (MSO 
phosphate, compound XXV) 
L-Methionine-DL-sulphoximine (MSO) has been 
thoroughly tested as an excitatory amino acid antagonist 
and it has been shown to have limited usefulness as such 
an antagonist because of technical difficulties 
associated with its low aqueous solubility (Curtis, 
Duggan, Felix, Johnston, Tebecis and Watkins, 1972). 
MSO is a convulsant when administered systemically and 
inhibits brain glutamine synthetase. This inhibition 
( 2) 
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is associated with the conversion of methionine 
sulphoximine to methionine sulphoximine phosphate which 
is tightly bound to the enzyme (Rowe, Ronzio and Meister, 
1969; Rao and Meister, 1972) and it seems likely that 
the phosphoryl moiety of MSO phosphate promotes the 
attachment of the compound to the enzyme (Rao and 
Meister, 1972). Thus MSO phosphate was tested as a 
potential glutamate antagonist. The action of MSO 
phosphate was tested on a total of ten neurones with 
both anionic and cationic currents. Anionic currents 
were either inactive or reduced the height of action 
potentials, whilst the results with cationic currents 
were inconsistent, some times producing excitation and 
in other tests producing non-specific depression. It 
thus appeared that MSO phosphate was even less useful 
than MSO as a glutamate or excitant amino acid 
antagonist. 
l-Hydroxy-3-aminopyrrolidone-2 (HAP) 
The effects of increasing concentrations of HAP 
(freshly prepared, 0.2 M, pH 5-6, HCl added) on the 
chemical sensitivity of a Renshaw cell are illustrated 
in Fig. 31 and similar results were obtained with 
21 other Renshaw cells (total of nine preparations). 
Relatively low cationic currents (10-20 nA) reversibly 
reduced the excitatory effects of glutamate, aspartate and 
DLH in a parallel manner in the absence of a change in the 
sensitivity to acetylcholine, whilst higher concentrations 
of HAP (above 20 nA) invariably reduced the excitatory 
action of acetylcholine on Renshaw cells. With the 
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Renshaw cell illustrated the concentration of HAP 
adequate to abolish the amino acid excitation also reduced 
acetylcholine excitation to less than 50% of control. 
Higher concentrations of HAP (above 150 nA: not 
illustrated) completely abolished the effects of acetyl-
choline. Excitation by glutamate, aspartate and DLH 
appeared to be equally sensitive to HAP; the seemingly 
greater sensitivity of the action of DLH on the cell used 
for Fig. 31, probably resulted from the lower frequency 
of excitation by this amino acid (Fig. 31A, F). Nine 
cells were carefully tested to determine the relative 
sensitivity of acetylcholine and glutamate excitation to 
HAP and concentrations of HAP adequate to reduce the 
sensitivity to glutamate by 50 - 70%, reduced the excitant 
action of acetylcholine by 15-60%. Three Renshaw cells 
were firing spontaneously and this firing was depressed 
by amounts of HAP which influenced amirnacid excitation of 
these cells. The synaptic excitation of Renshaw cells by 
volleys in ventral and dorsal roots (Curtis and Ryall, 
1966b) could also be reversibly reduced by HAP (6 Renshaw 
cells). Although the intense cholinergic excitation 
evoked by maximal stimulation of ventral root fibres was 
much less sensitive to HAP than non-cholinergic firing 
resulting from stimulation of peripheral afferents or 
dorsal root fibres, submaximal ventral root responses were 
only slightly less sensitive than responses of a similar 
magnitude evoked by dorsal root volleys (Fig. 32), but 
this differential sensitivity to HAP is consistent with 
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Effects o f l-hydroxy-3-aminopyrrolidone-2 (HAP) on 
the excitation of a Renshaw cell by electrophoretically 
administered acetylcholine (25 nA), L-glutamate (60 nA), 
L-aspartate (60 nA) and DL-homocysteate (15 nA). Times 
of administration are indicated by the horizontal solid, 
dotted and dashed lines above the records. A, control 
observations; B - E, HAP was administered with progressively 
increasing cationic currents for periods of 3-4 min. Each 
series of records shows the maximum effect at each dose level. 
F, 4 min after termination of the HAP current. 
RENSHAW CELL - SYNAPTIC EXCITATION 
A B C D 
HAP 80 HAP 160 
VENTRAL ROOT 
.. 
~~J,,,I -VP Zs 
9 .6 ± 0.3 8.5 ± 0.3 5 .5 ± 0 .1 6 .9 ± 0.3 
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3.9 ± 0 .2 2 .1 ± 0.2 
r--
0 1.5 ± 0 .1 
I I I ii I I ii I I I ii I ii I ii I I I I I I 
msec 
Fig. 32: 
Effect of l-hydroxy-3-aminopyrrolidone-2 (HAP) on 
the synaptic excitation of a Renshaw cell by volley in 
ventral roots (upper two rows, cholinergic excitation) and 
dorsal roots (lower two rows, non-cholinergic). A, control; 
B, during HAP 80 nA; C, during HAP 160 nA; D, incomplete 
recovery 4.5 min after terminating the HAP ejection and 
just prior to accidental displacement of the recording 
electrode from the vicinity of the neurone. The figures 
within each row give the mean number of spikes in 20 responses 
(± S.E.M.); the records were selected to illustrate the 
mean responses. The depressant effect of HAP are statistically 
significant (P<0.001 by Student's t test), apart from the 
ventral root responses of column B (P~0.012). Calibrations: 
1 mv, msec. 
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the proposition that the dorsal root excitation of Renshaw 
cells is non-cholinergic and possibly involves amino 
acids (Curtis and Ryall, 1966b). The spontaneous firing 
and excitation by glutamate, aspartate and DLH of five 
dorsal horn interneurones were also depressed by HAP using 
electrophoretic currents of 20-100 nA. 
The apparent insensitivity of acetylcholine 
excitation to low concentrations of HAP and the progressive 
reduction of the effects of this excitant by higher 
concentrations, probably excludes mere removal of an under-
lying non-cholinergic excitation of Renshaw cells as an 
explanation of the effects of HAP on the nicotinic 
excitation. 
An investigation of the effect of electrophoretically 
administered HAP on the sensitivity of identified neurones 
of the cerebral cortex (four pyramidal tract neurones: 
Fig. 33 illustrates one of these) and ventrobasal thalamus 
(eight thalamocortical relay neurones: Fig. 34 illustrates 
one of these) to acetylcholine and excitant amino acids 
yielded results that were similar to those obtained on 
spinal neurones. Acetylcholine excitation tended to be 
less sensitive to low concentrations of HAP than was amino 
acid excitation (except perhaps in the ventrobasal 
thalamus), but although the degree of selectivity was less 
than that required for a selective antagonist of amino 
acid excitation Davies and Watkins (1973) have reported 
that the degree of selectivity for HAP, in the feline 
cerebral cortex, was higher than that for either glutamate 
diethyl ester or methionine sulphoximine. Furthermore, 
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Fig. 33: 
Effects of l-hydroxy-3-aminopyrrolidone-2 (HAP) on 
the excitation of a pyramidal tract neurone of the post-
cruciate cortex by electrophoretically administered 
L-glutamate (L-G, 30 nA) and acetylcholine (ACh, 100 nA). 
Times of administration are indicated by the horizontal 
solid and broken lines above the records; the times of 
ejection of HAP are also indicated by the vertical broken 
lines. A, responses before and during the administration 
of HAP (50 nA); B, responses during and after HAP (100 nA). 
3/4 min elapsed between A and B, however, the ejection of 
HAP was continuous. 
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Effect of l-hydroxy-3-aminopyrrolidone-2 (HAP) on 
the excitation of a thalamo-cortical relay neurone of 
the ventrobasal thalamus by electrophoretically administered 
L-glutamate (L-G, 50 nA) and acetylcholine (ACh, 25 nA). 
Times of administration are indicated by the horizontal solid 
and broken lines above the records and the times of ejection 
of HAP are further indicated by the vertical broken lines. 
A, responses before and during HAP (20 nA); B, responses 
durins HAP (40 nA). A and Bare successive runs, HAP being 
ejected for a total period of 6 min. 
162 
HAP in the spinal cord, cerebral cortex and ventrobasal 
thalamus equally reduced the effects of both naturally 
occuring excitant amino acids, glutamate and aspartate, 
(and that of DLH), and thus would be of no use in 
distinguishing these putative transmitters from each other. 
On the basis of comparison of electrophoretic 
currents, HAP was much less effective as a neuronal 
depressant than either glycine or GABA on spinal neurones 
(Fig. 35A) and HAP has been reported to be a weaker 
depressant than glycine or GABA in the cuneate nucleus 
and weaker than GABA in the cerebral cortex (Davies and 
Watkins, 1973). The relative weakness of HAP as a 
neuronal depressant has presented difficulty in determining 
whether it is a bicuculline- or strychnine-sensitive 
depressant. However, studies on four Renshaw cells 
indicated that strychnine did not reduce the depressant 
effect of HAP and that BMC, in concentrations sufficient 
to block or markedly reduce the inhibitory action of GABA, 
had considerably less effect on that of HAP (Fig. 35B). 
This finding was in agreement with Davies and Watkins 
(1973) who found that HAP was not greatly affected by 
strychnine in the cuneate nucleus, or by bicuculline in 
the cerebral cortex and cuneate nucleus. In general 
glycine and GABA depress the excitation of Renshaw cells 
by glutamate, aspartate, DLH and acetylcholine to the same 
extent, thus the small degree of selectivity of HAP as 
an excitant amino acid antagonist and the failure of BMC 
and strychnine to reduce, to a significant extent, its 
depressant action suggests that its mechanism of action 
is basically different from that of glycine or GABA. 
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Effect of bicuculline rnethochloride (BMC) on the 
depressant action of l-hydroxy-3-arninopyrrolidone-2 (HAP) 
and GABA on a Renshaw cell excited by acetylcholine (ACh) 
and L-glutarnate (L-G). The cell was excited by alternate 
electrophoretic pulses of acetylcholine (0 nA = no retaining 
current) and L-glutarnate (60 nA), the horizontal broken lines 
indicate the periods of ejection of excitants. The horizontal 
solid bar and vertical broken lines indicate the periods of 
ejection of GABA, HAP and BMC (10 rnM in 165 rnM NaCl). A, 
responses to ACh and L-G before, during and after GABA (10 nA) 
and before, during and after HAP (40 nA); B, the effect of 
BMC (18 nA) on the depressant actions of GABA (10 nA) and 
HAP (40 nA) • 
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SUMMARY 
1. The present state of knowledge concerning the 
conformations of garnma-aminobutyric acid (GABA) and 
L-glutamic acid that are active in biological systems 
was reviewed, and the use of analogues of restricted 
conformation to further analyse GABA, L-glutamic acid 
and L-aspartic acid receptors was discussed in parallel 
with the use of the microelectrophoretic method. 
2. An investigation of GABA analogues of restricted 
conformation suggested that extended conformers of GABA 
are the active ones at bicuculline-sensitive postsynaptic 
receptors. The neuronal depressant actions of cis-4-
aminocrotonic acid and S-(p-chlorophenyl) -GABA do not 
appear to involve either GABA or glycine receptors. 
3. Of the several bicuculline analogues tested for 
selective GABA antagonism, bicuculline methochloride 
(BMC) was found to be more suitable and more potent than 
bicuculline as a microelectrophoretically administered 
GABA antagonist. The central effects of bicuculline and 
BMC could not be explained on the basis of a weak anti-
cholinesterase effect, measured in vitro, and it seems more 
reasonable to consider that these effects are due to 
antagonism of GABA-like amino acids. 
4. A possible explanation of the convulsant actions 
of tutin, shikimin, coriamyrtin and penicillin was found 
to be antagonism of GABA-like amino acids. Whilst these 
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convulsants may antagonise glycine-like amino acids when 
in relatively high concentrations, d-tubocurarine was non-
selective and antagonised glycine and GABA at all 'dose' 
levels. 
5. Kainic acid was found to be the most potent 
excitant amino acid presently known, and there is a unique 
juxtaposition of the equivalent ionisable groups in 
L-glutamic acid and the following analogues of restricted 
conformation: kainic, 'cycloglutamic' and ibotenic acids. 
6. With sensitivity to N-methyl-D-aspartate as a 
basis of comparison, spinal interneurones were relatively 
more sensitive to kainate than we re Renshaw cells, a 
finding which provides additional support for the 
proposition that glutamate could be the excitatory trans-
mitter at primary afferent synapses in the spinal cord. 
7. A number of possible antagonists of the excitatory 
action of L- glutamic acid were tested, including the 
reported antagonist l -hydroxy- 3-aminopyrrolidone-2(HAP), 
but none was found to be sufficiently selective to be a 
useful glutamate antagonist. 
165 
REFERENCES 
AJMONE-MARSAN, C. (1969) In: Basic Mechanisms of the 
Epilepsies, ed. H.H. JASPER, A.A. WARD and A. POPE, 
PP 299-319. Little Brown and Co., Boston. 
ANDERSEN, P. and CURTIS, D.R. (1964) Acta physiol. scand. 
61, 85-99 
ANDERSEN, P., ECCLES, J.C. and VOORHOEVE, P.E. (1964) 
J. Neurophysiol. 27, 1138-1153 
ANDREWS, P.R. and JOHNSTON, G.A.R. (1973) Nature: New 
Biology 243, 29-30 
ARIENS, E.J. (1954) Archs int. Pharmacodyn. Ther. 99, 
32-49 
AUGUSTINSSON, K.B. and NACHMANSOHN, D. (1949) J. biol. Chem. 
179, 543-559 
BALCAR, V.J. and JOHNSTON, G.A.R. (1972a) J. Neurochem. 
19, 2657-2666 
BALCAR, V.J. and JOHNSTON, G.A.R. (1972b) J. Neurobiol. 
3' 295-301 
BALCAR, V.J. and JOHNSTON, G.A.R. (1973) J. Neurochem. 
20, 529-539 
BALL, J.N. and COWEN, P.N. (1959) Nature, Lond. 184, 370 
BANERJEE, U., FELDBERG, W. and GEORGIEV, V.P. (1970) 
Br. J. Pharmac. 40, 6-22 
BARNARD, E.A. (1973) Neurosci. Res. Progr. Bull. 11, 231- 236 
BARNARD, E.A., WIECKOWSKI, J. and CHIU, T.H. (1971) 
Nature,Lond. 234, 207-209 
BEART, P.M., CURTIS, D.R. and JOHNSTON, G.A.R. (1971) 
Nature: New Biology 234, 80-81 
BEART, P.M. and JOHNSTON, G.A.R. (1972) Aust. J. Chem. 
25, 1359-1361 
BEART, P.M. and JOHNSTON, G.A.R. (1973) Brain Res. 49, 
459-462 
BEART, P.M., JOHNSTON, G.A.R. and UHR, M.L. (1972) 
J. Neurochem. 19, 1855-1861 
166 
BEIN, H.J. (1972) In: Spasticity - a Topical Survey, ed. 
W. BIRKMAYER, pp 76-82. Huber, Bern. 
BHARGAVA, V.K. and MELDRUM, B.S. (1969) Br. J. Pharmac. 
37, 112-122 
BIRKMAYER, W. (1972) Spasticity - a Topical Survey Huber, 
Bern. 
BISCOE, T.J., CURTIS, D.R. and RYALL, R.W. (1966) Int. J. 
Neuropharmac. 5, 429-434 
BOAKES, R.J., BRADLEY, P.B., BRIGGS, I. and DRAY, A. (1970) 
Br. J. Pharmac. 40, 202-218 
BONTA, I.L., DE VOS, C.J., GRISJSEN, H., HILLEN, F.C. 
NOACH, E.L. and SIM, A.W. (1971) Br. J. Pharmac. 
43, 514-535 
BONTA, I.L., DE VOS, C.J. and HILLEN, F.C. (1969) Archs int. 
Pharmacodyn. ~her. 182, 391 - 393 
BRADLEY, P.B. and CANDY, J.M. (1970) Br. J. Pharmac. 40, 
194-201 
BRADLEY, K., EASTON, D.M. and ECCLES, J.C. (1953) 
J. Physiol., Lond. 122, 474-488 
BRADSHAW, C.M., ROBERTS, M.H.T. and SZABADI, E. (1973) 
Br. J. Pharmac. 49, 667-677 
BREHM, L., HJEDS, H. and KROGSGAARD-LARSEN, P. (1972) 
Acta chem scand. 26, 1298-1299 
BREHM, L., KROGSGAARD-LARSEN, P. and HJEDS, H. (1974) 
Acta chem scand. B 28, 308-316 
BURKE, D., ANDREWS, C.J. and KNOWLES, L. (1971) 
J. Neural. Sci. 14, 199-208 
CANDY, J.M., BOAKES, R.J., KEY, B.J. and WORTON, E. (1974) 
Neuropharmacology 13, 423-430 
CARSLAW, H.S. and JAEGER, J.C. (1959) Conduction of Heat 
in Solids, Oxford University Press, London and 
New York. 
167 
CHANG, H. (1953) J. Neurophysiol. 16, 221-233 
CHEN, K.K. and CHEN, A.L. (1935) J. Pharmac. exp. ther. 
55, 319-325 
COLLINS, J.F. and HILL, R.G. (1974) Nature, Lond. 249, 
845-847 
CRAVEN, B.M. (1962) Acta crystallogr. 15, 387-396 
CRAWFORD, J.M. and CURTIS, D.R. (1964) Br. J. Pharmac. 
23, 313-329 
CURTIS, D.R. (1964) In: Physical Techniques in Biological 
Research, ed. W. NASTUK, vol. 5 pt. A, pp 144-190. 
Academic Press, New York. 
CURTIS, D.R., DAVIES, J., GAME, C.J.A., JOHNSTON, G.A.R. 
and McCULLOCH, R.M. (1973) Brain Res. 63, 419-423 
CURTIS, D.R., DUGGAN, A.W. and FELIX, D. (1970) Brain Res. 
23, 117-120 
CURTIS, D.R., DUGGAN, A.W., FELIX, D. and JOHNSTON, G.A.R. 
(1970) Nature, Lond. 226, 1222-1224 
CURTIS, D.R., DUGGAN, A.W. FELIX, D. and JOHNSTON, G.A.R. 
(1971) Brain Res. 32, 69 - 96 
CURTIS, D.R., DUGGAN, A.W., FELIX, D., JOHNSTON, G.A.R. 
and McLENNAN, H. (1971) Brain Res. 33, 57-73 
CURTIS, D.R., DUGGAN, A.W., FELIX, D., JOHNSTON, G.A.R., 
TEBECIS, A.K. and WATKINS, J.C. (1972) Brain Res. 
41, 283-301 
CURTIS, D.R., DUGGAN, A.W. and JOHNSTON, G.A.R. (1970) 
Exp. Brain Res. 10, 447-462 
CURTIS, D.R., DUGGAN, A.W. and JOHNSTON, G.A.R. (1971) 
Exp. Brain Res. 12, 547 - 565 
CURTIS, D.R. and ECCLES, R.M. (1958) J. Physiol, Lond. 
141, 435 - 445 
CURTIS, D.R., FELIX, D., GAME, C.J.A. and McCULLOCH, R.M. 
(1973) Brain Res. 51, 358-362 
CURTIS, D.R., GAME, C.J.A., JOHNSTON, G.A.R. and 
McCULLOCH, R.M. (1974) Brain Res. 70, 493-499 
CURTIS, D.R., HOSLI, L. and JOHNSTON, G.A.R. (1968) 
Exp. Brain Res. 6, 1-18 
168 
CURTIS, D.R. and JOHNSTON, G.A.R. (1974a) Ergebn. Physiol. 
69, 97-188 
CURTIS, D.R. and JOHNSTON, G.A.R. (1974b) In: Neuropoisons, 
ed. L.L. SIMPSON and D.R. CURTIS, vol.2, pp 207-
248. Plenum, New York and London. 
CURTIS, D.R. and KOIZUMI, K. (1961) J. Neurophysiol. 24, 
80-90 -
CURTIS, D.R., PERRIN, D.D. and WATKINS, J.C. (1960) 
J. Neurochern. 6, 1-20 
CURTIS, D.R. and PHILLIS, J.W. (1960) J. Physiol, Land. 
153, 17-34 
CURTIS, D.R., PHILLIS, J.W. and WATKINS, J.C. (1959) 
J. Physiol, Land. 146, 185-203 
CURTIS, D.R., PHILLIS, J.W. and WATKINS, J.C. (1960) 
J. Physiol, Land. 150, 656-682 
CURTIS, D.R., PHILLIS, J.W. and WATKINS, J.C. (1961) 
J. Physiol, Land. 158, 296-323 
CURTIS, D.R. and RYALL, R.W. (1966a) Exp. Brain Res. 
1, 195-204 
CURTIS, D.R. and RYALL, R.W. (1966b) Exp. Brain Res. 
2, 81-96 
CURTIS, D.R. and TEBECIS, A.K. (1972) Exp. Brain Res. 
16, 210-218 
CURTIS, D.R. and WATKINS, J.C. (1960) J. Neurochern. 
6, 117-141 
CURTIS, D.R. and WATKINS, J.C. (1961) Nature, Land. 
191, 1010-1011 
CURTIS, D.R. and WATKINS, J.C. (1963) J. Physiol., Land. 
166, 1-14 
CURTIS, D.R. and WATKINS, J.C. (1965) Pharrnac. Rev. 
17, 347-391 
DAVIDOFF, R.A. (1972a) Science, N.Y. 175, 331-333 
DAVIDOFF, R.A. (1972b) Brain Res. 45, 638-642 
169 
DAVIDOFF, R.A., GRAHAM, L.T. (Jr.), SHANK, R.P., WERMAN, R. 
and APRISON, M.H. (1967) J. Neurochern. 14, 
1025-1031 
DAVIDOFF, R.A., SILVEY, G.E., KOBETZ, S.A. and SPIRA, H.M. 
(1973) Expl Neurol. 38, 525-528 
DAVIES, J. and WATKINS, J.C. (1973) Brain Res. 59, 311-322 
DAVIES, J. and WATKINS, J.C. (1974) Brain Res. 70, 501-505 
del CASTILLO, J. and KATZ, B. (1955) J. Physiol., Lond. 
128, 157-181 
DRAY, A. and STRAUGHAN, D.W. (1974) Brit. J. Pharrnac. 
51, 133-134P 
DREIFUSS, J.J. and MATHEWS, E.K. (1972) Brain Res. 
45, 599-603 
DUGGAN, A.W. (1974) Exp. Brain Res. 19, 522-528 
DUGGAN, A.W. and JOHNSTON, G.A.R. (1970) J. Neurochern. 
17, 1205-1208 
DUGGAN, A.W., LODGE, D. and BISCOE, T.J. (1973) Exp. Brain 
Res. 17, 261-270 
DUGGAN, A.W., LODGE, D., BISCOE, T.J. and HEADLEY, P.M. 
(1973) Archs int. Pharrnacodyn. ther. 204, 147-149 
EARLE, J. and LARGE, W.A. (1972) J. Physiol., Lond. 
224, 45-46P 
EARLE, J. and LARGE, W.A. (1973) Br. J. Pharrnac. 48, 
318-320 
EARLE, J. and LARGE, W.A. (1974) J. Physiol., Lond. 236, 
113-127 
ECCLES, J.C. (1964) In: The Physiology of Synapses, 
pp 16-19. Springer-Verlag, Berlin-Gottingen-
Heidelberg. 
ECCLES, J.C. , ECCLES, R.M. and FATT, P. (1956) J. Physiol., 
Lond. 131, 154-169 
ECCLES, J.C. ' FATT, P. and KOKETSU, K. (1954) J. Physiol., 
Lond. 126, 524-562 
ECCLES, J.C., FATT, P. and LANDGREN, S. (1956) 
J.Neurophysiol. 19, 75-98 
170 
ECCLES, J.C., FATT, P., LANDGREN, S. and WINSBURY, G.J. 
(1954) J. Physiol., Lond. 125, 590-606 
ECCLES, J.C., SCHMIDT, R.F. and WILLIS, W.D. (1963) 
J. Physiol., Land. 168, 500-530 
EIDE, E. and KALLSTROM, Y. (1968) Acta physiol. scand. 
73, 2A-3A 
EUGSTER, C.H. (1967) In: Ethnopharrnacologic Search for 
Psychoactive Drugs, ed. D.H. EFRON, B. HOLMSTEDT 
and N.S. KLINE, pp 416-418. U.S. Publ. Health 
Serv. Publication No. 1645 
EUGSTER, C.H. (1969) Fortschr. Chern. org. Natstoffe 
27, 261-321 
FAIGLE, J.W. and KEBERLE, H. (1972a) In: Spasticity -
a Topical Survey, ed. W. BIRKMAYER, pp 94-100. 
Huber, Bern. 
FAIGLE, J.W. and KEBERLE, H. (1972b) Postgrad. med. J. 
48, Suppl. 5, 9-13 
PASTIER, F.N. (1971) In: Research in Physiology, ed. 
F.F. KAO, K. KOIZUMI and M. VASSALLE, pp 653-659. 
Aulo Gaggi, Bologna. 
FELDBERG, W. and LOTTI, V.J. (1970) J. Physiol., Land. 
210, 697-716 
FELDBERG, W., MALCOLM, J.L. and DARIAN-SMITH, I. (1957) 
J. Physiol., Land. 138, 178-201 
FELIX, D. and McLENNAN, H. (1971) Brain Res. 25, 661-664 
FISHMAN, R.A. (1966) Archs Neural., Chicago 15, 113-124 
FITCHETT, F. and MALCOLM, J. (1909) Q. Jl exp. Physiol. 
2, 335-362 
FREEMAN A (1973) J. Neurobiol. 4, 567-582 ' . 
GASS, J.D. and MEISTER, A. (1970) Biochemistry, N.Y. 
9, 842-846 
GENT, J.P., MORGAN, R. and WOLSTENCROFT, J.H. (1974) 
Neuropharrnacology 13 , 441-447 
GILARDI, R.D. (1973) Nature: New Biology 245, 86-88 
GLOOR, P. (1969) Ann. N.Y. Acad. Sci. 166, 350-360 
GOTTESFELD, Z., KELLY, J.S. and RENAUD, L.P. (1972) 
Brain Res. 42, 319-335 
171 
GRAHAM, L.T. (Jr.), SHANK, R.P., WERMAN, R. and APRISON, M. H. 
(1967) J. Neurochem. 14, 465-472 
GRANIT, R. and PHILLIPS, C.G. (1956) J. Physiol., Lond. 
133, 520-547 
GREEN, P.N., SHAPERO, M. and WILSON, C. (1969) J. med. 
Chem. 12, 326-330 
HALDEMAN, S., HUFFMAN, R.D., MARSHALL, K.C. and McLENNAN, H. 
(1972) Brain Res. 39, 419-425 
HALDEMAN, S. and McLENNAN, H. (1972) Brain Res. 45, 393-400 
HAMMERSCHLAG, R., POTTER, L.T. and VINCI, J.M. (1971) 
Transactions of the American Society for 
Neurochemistry 2, 78 
HAAS, H.L. (1974) Brain Res. 76, 363-366 
.. 
HAAS, H.L., ANDERSON, E.G. and HOSLI, L. (1972) Brain Res. 
51, 269-278 
HEILBROWN, E. and MATTSON, Ch. (1974) J. Neurochem. 
22, 315-317 
HEWGILL, F.R. and JEFFERIES, P.R. (1955) J. Chem. Soc. 
2767-2772 
HILL, R.G. and SIMMONDS, M.A. (1973) Br. J. Pharmac. 
48, 1-11 
HILL, R.G., SIMMONDS, M.A. and STRAUGHAN, D.W. (1972) 
Nature, Lond. 240, 51-52 
HILL, R.G., SIMMONDS, M.A. and STRAUGHAN, D.W. (1973a) 
Br. J. Pharmac. 47, 642P-643P 
HILL, R.G., SIMMONDS, M.A. and STRAUGHAN, D.W. (1973b) 
Br. J. Pharmac. 49, 37-51 
HILL, R.G., SIMMONDS, M.A. and STRAUGHAN, D.W. (1974) 
J. Physiol., Lond. 239, 122P-123P 
HOFFER, B.J., NEFF, N.H. and SIGGINS, G.R. (1971) 
Neuropharrnacology 10, 175-180 
HOFFMAN, R. (1963) J. Chern. Phys. 39, 1397-1412 
172 
HOSLI, L., TEBECIS, A.K. and HAAS, H.L. (1971) Experientia 
27 f 732-733 
INUBUSHI, Y., SASAKI, Y., TSUDA, Y., YASUI, B., KONITA, T., 
MATSUMOTO, J., KATARAO, E. and NAKANO, J. (1964) 
Tetrahedron 20, 2007-2023 
IVERSEN, L.L. and JOHNSTON, G.A.R. (1971) J. Neurochern. 
18, 1939-1950 
IVERSEN, L.L. and NEAL, M.J. (1968) J. Neurochern. 15, 
1141-1149 
JAEGER, J.C. (1965) In: Studies in Physiology, ed. 
D.R. CURTIS and A.K. McINTYRE, pp 106-117. 
Springer-Verlag, Berlin and Heidelberg. 
JARBOE, C.H., PORTER, L.A. and BUCKLER, R.T. (1968) 
J. med. Chern. 11, 729-731 
JASPER, H.H. and AJMONE-MARSAN, C. (1954) A Stereotaxic 
Atlas of the Diencephalon of the Cat. National 
Research Council of Canada,Ottawa. 
JERSLEV, B., RAVN-JONSEN, E.J. and DANIELSEN, J. (1968) 
Acta crystallogr. (B) 24, 1156-1164 
JOHNSTON, G.A.R. (1971) Psychopharrnacologia 22, 230-233 
JOHNSON, E.S., ROBERTS, M.H.I. and STRAUGHAN, D.W. (1970) 
Br. J. Pharrnac. 38, 659-666 
JOHNSTON, G.A.R., BEART, P.M., CURTIS, D.R., GAME, C.J.A., 
McCULLOCH, R.M. and MACLACHLAN, R.M. (1972) 
Nature: New Biology 240, 219-220 
JOHNSTON, G.A.R. and CURTIS, D.R. (1973) Nature: 
New Biology 246, 190 
JOHNSTON, G.A.R., CURTIS, D.R., BEART, P.M., GAME, C.J.A., 
McCULLOCH, R.M. and TWITCHIN, B. (1974) 
J. Neurochern. (in press) 
JOHNSTON, G.A.R., CURTIS, D.R., de GROAT, W.C. and 
DUGGAN, A.W. (1968) Biochem. Pharmac. 17, 
2488-2489 
173 
JOHNSTON, G.A.R. and MITCHELL, J.F. (1971) J. Neurochem. 
18, 2441-2446 
KAJIMOTO, Y., FUJIMORI, H. and HIROTA, K. (1955) 
Tokushima J. exp. Med. 2, 104-107 
KAJIMOTO, Y., OTA, T., FUJIMORI, H., HARADA, K. and 
HIROTA, K. (1955) Tokushima J. exp. Med. 2, 
111-114 
KAO, L.I. and CRILL, W.E. (1972) Archs Neural., Chicago 
26, 156-161 
KAWAGUCHI, S. and ONO, T. (1973) Brain Res. 58, 260-265 
KEASLING, H.H. and MOFFETT, R.B. (1971) J. med. Chem. 
14, 1106 - 1111 
KEBERLE, H. and FAIGLE, J.W. (1972) In : Spasticity -
a Topical Survey, ed. W. BIRKMAYER, pp 90-93 
Huber, Bern. 
KELLY, J.S. and RENAUD, L.P. (1973) Br. J. Pharmac. 
48, 369-386 
KIER, L.B. and GEORGE, J.M. (1973) Experientia 29, 501-502 
KIER, L., GEORGE, J.M. and HOLTJE, H.D. (1974) J. Pharm.Sci. 
63, 1435-1445 
KIER, L.B. and TRUIT, E.B. (Jr) (1970) Experientia 26, 
988-999 
KING, E.J. (1954) J. Am. chem. Soc. 76, 1006-1008 
KRNJEVIC, K. (1964) Int. Rev. Neurobiol. 7, 41-98 
KRNJEVIC, K. (1974) Physiol. Rev. 54, 418-540 
KRNJEVIC, K., LAVERTY, R. and SHARMAN, D.F. (1963) 
Br. J. Pharmac. 20, 491-496 
KRNJEVIC, K., MITCHELL, J.F. and SZERB, J.C. (1963) 
J. Physiol, Lond. 165, 421-436 
174 
~ 
KRNJEVIC, K. and PHILLIS, J.W. (1963) J. Physiol. Lond. 
165, 274-304 
~ 
KRNJEVIC, K. and SCHWARTZ, S. (1967) Exp. Brain. Res. 
3, 306-319 
KROGSGAARD-LARSEN, P. and JOHNSTON, G.A.R. (1975) 
In preparation. 
KROGSGAARD-LARSEN, P., JOHNSTON, G.A.R., CURTIS, D.R. 
GAME, C.J.A. and McCULLOCH, R.M. (1975) 
In preparation. 
LEVY, R.A. and ANDERSON, E.G. (1972) Brain Res. 43, 
171-180 
MACKO, E., DOUGLAS, B., WEISBACH, J.A. and WALTZ, D.T. 
(1972) Archs. int. Pharmacodyn. ther. 197, 261-273 
MAENO, T. (1966) J. Pharmac. exp. Ther. 154, 449-455 
MANSKE, R.H.F. (1933) Can. J. Res. 8, 142-146 
MARSHALL, C.R. (1906) J. Physiol., Lond. 34, XXIX-XXX 
MARSHALL, C.R. (1912) J. Pharmac. exp. ther. 4, 135-150 
McCULLOCH, R.M., JOHNSTON, G.A.R., GAME, C.J.A. and 
CURTIS, D.R. (1974) Exp. Brain Res. (in press) 
McLENNAN, H. (1970) Nature, Lond. 228, 674-675 
McLENNAN, H. (1973) Can. J. Physiol. Pharmacol. 51, 774-775 
McLENNAN, H. and MILLER, J.J. (1974) J. Physiol., Lond. 
237, 625-633 
MELDRUM, B.S. and BHARGAVA, V.K. (1968) Int. J. 
Neuropharmacol. 7, 253-263 
MILLER, J.J. and McLENNAN, H. (1974) Neuropharmacology 
13, 785-787 
MONOD, J., CHANGEAUX, J.P. and JACOB, F. (1963) J. Mal.Biol. 
6, 306-329 
MURAYAMA, K., MORIMURA, S., NAKAMURA, Y. and SUNAGAWA, G. 
(1965) J. Pharm. Soc. Japan. 85, 757-765 
NASTUK, W.L. (1953) Fedn Proc. Fedn Am. Socs exp.Biol. 
12, 102 
175 
NICOLL, R.A. (1971) Brain Res. 35, 137-149 
NICOLL, R.A. and BARKER, J.L. (1971) Brain Res. 35, 501-511 
NISTRI, A., CONSTANTI, A. and QUILLIAM, J.P. (1974) 
Lancet 1 (7864) 996 - 997 
OBATA, K., TAKEDA, K. and SHINOZAKI, H. (1970) 
Neuropharmacology 9, 191-194 
OGSTON, A.G. (1955) J. Physiol.,Lond. 128, 222-223 
OSBOURNE, R.H., BRADFORD, H.F. and JONES, D.G. (1973)" 
J. Neurochem. 21, 407-419 
PARRY JONES, G., ROBERTS, R.T. and AHMED, A.I. (1971) 
Molec. Physics 22, 547-549 
PARTINGTON, P., FEENEY, J. and BURGEN, A.S.V. (1972) 
Mol. Pharmacol. 8, 269-277 
PECK, E.J. (Jr.), SCHAEFFER, J.M. and CLARK, J.H. (1973) 
Biochem. biophys. Res. Commun. 52, 394-400 
PHILLIPS, C.G. (1956) Q. Jl. exp. Physiol. 41, 58-69 
PHILLIPS, C.G. (1959) Q. Jl. exp. Physiol. 44, 1-25 
PHILLIPS, C.G. (1961) In: The Nature of Sleep, ed. 
G.E.W. WOLSTENHOLME and M. O'CONNOR, pp 4-24. 
Churchill, London. 
PHILLIS, J.W., TEBECIS, A.K. and YORK, D.H. (1968) 
Eur. J. Pharmacol. 4, 471-475 
PIERAU, Fr.K. and ZIMMERMANN, P. (1973) Brain Res. 
54, 376-380 
PONG, S.F. and GRAHAM, L.T. (Jr) (1972) Brain Res. 
42, 486-490 
PORTER, L.A. (1967) Chem. Rev. 67, 441-464 
PRINCE, D.A. (1969) In: Basic Mechanisms of the Epilepsies, 
ed. H.H. JASPER, A.A. WARD (Jr) and A. POPE, 
pp 320-328. Little Brown and Co., Boston. 
PULLMAN, B. and BERTHOD, H. (1974) C. r. hebd. Seanc. 
Acad. Sci., Paris, Ser. D 278, 1433-1436 
176 
QUASTEL, D.M.J. and CURTIS, D.R. (1965) Nature, Lond. 208, 
192-194 
RAO, S.L.N. and MEISTER, A. (1972) Biochemistry, N.Y. 
11, 1123-1127 
,,. 
RAVENTOS, J. (1937) Q. Jl. exp. Physiol. 26, 361-374 
RICE, H.V. (1938) J. Pharmac. exp. Ther. 63, 329-334 
ROWE, W.B., RONZIO, R.A. and MEISTER, A. (1969) 
Biochemistry, N.Y. 8, 2674-2680 
RYALL, R.W. and PIERCEY, M.F. (1971) J. Neurophysiol. 
34, 242-251 
SALMOIRAGHI, G.C. and WEIGHT, F. (1967) Anaesthesiology 
28, 54-64 
SC HM IDT , R . F . ( 1 9 7 1 ) Erg e bn . Phys i o 1 . 6 3 , 2 0 -1 01 
SEGAL, M., SIMS, K., MAGGIORA, L. and SMISSMAN, E. (1973) 
Nature: New Biology 245, 88-89 
SHANK, R.P., PONG, S.F., FREEMAN, A.R. and GRAHAM, L.T. (Jr) 
(1974) Brain Res. 72, 71-78 
SHINOZAKI, H. and KONISHI, S. (1970) Brain Res. 24, 368-371 
SIMMONDS, M.A. (1974) Neuropharmacology 13, 401-406 
SMYTHIES, J.R. (1971) Int. Rev. Neurobiol. 14, 233-331 
SMYTHIES, J.R. (1974) A. Rev. Pharmac. 14, 9-21 
SNYDER,S.H., LOGAN, W.J., BENNETT, J.P. and ARREGUI, A. 
(1973) Neurosci. Res. 5, 131-157 
STEFANOVA, Z., PUCHTA, V. and ROMANOVSKY, A. (1962) 
Pharmazie 17, 137-142 
STEINBERG, R., ALTMAN, H. and Ten BRUGGENCATE, G. (1974) 
Pfugers Arch. ges. Physiol. 347, R 55 
STEINER, F.A. (1969) Ann. N.Y. Acad. Sci. 166, 199-209 
STEWARD, E.G., PLAYER, R., QUILLIAM, J.P., BROWN, D.A. 
and PRINGLE, M.J. (1971) Nature: New Biology 
233, 87-88 
STEWARD, E.G., PLAYER, R.B. and WARNER, D. (1973) Nature: 
New Biology 245, 88 
177 
STONE, T.W. (1973) J. Physiol., Lond. 233, 211-225 
STRAUGHAN, D.W., NEAL, M.J., SIMMONDS, M.A., COLLINS, G. G.S. 
and HILL, R.G. (1971) Nature, Lond. 233, 352-354 
SVENNEBY, G. and ROBERTS, E. (1973) J. Neurochem. 
21, 1025-1026 
SWIFT, J.G., DICKENS, E.A. and BECKER, B.A. (1960) 
Archs int. Pharmacodyn. ther. 128, 112-125 
TAKEUCHI, A. and TAKEUCHI, N. (1969) J. Physiol., Lond. 
205, 377-391 
-TEBECIS, A.K. (1973) Expl. Neural. 40, 297-308 
-TEBEC~S, A.K., HOSLI, L. and HAAS, H.L. (1971) Experientia, 
27, 548 
TOMITA, K. (1971) Tetrahedron Lett. No. 27, 2587-2588 
TOMITA, K., HIGASHI, H. and FUJIWARA, T. (1973) Bull.chem. 
Soc. Japan 46, 2199-2204 
UENO, Y., NAWA, H., UEYANAGI, J., MORIMOTO, H., NAKAMORI, R. 
and MATSUOKA, T. (1955) J. Pharm. Soc. Japan. 
75, 807 - 811 
Van GELDER, N.M. (1971) Can. J. Physiol. Pharmacol. 49, 
513-519 
Van HARREVELD, A. and FIFKOVA, E. (1973) J. Neurochem. 
20, 947-962 
WALSH, G.O. (1971) Epilepsia 12, 1-11 
WARNER, D., PLAYER, R.B. and STEWARD, E.G. (1973) 
International Union of Crystallography First 
European Meeting B4 
WATKINS, J.C. (1968) Biochem.J. 106, 4P-7P 
WELCH, A.D. and HENDERSON, V.E. (1934) J. Pharmac. exp.ther. 
51, 482-491 
YAMAMOTO, C. (1967) J. Pharmac. exp. Ther. 156, 39-47 
YOUNG, A.B. and SNYDER, S.H. (1973) Proc. natn. Acad. 
Sci. USA 70, 2832-2836 
178 
.. 
ZIEGLGANSBERGER, W., HERZ, A. and TESCHEMACHER, H. (1969) 
Brain Res. 15, 298-300 
.. 
ZIEGLGANSBERGER, W. and PUIL, E.A. (1973a) Exp. Brain Res. 
17, 35-49 
.. 
ZIEGLGANSBERGER, W. and PUIL, E.A. (1973b) Arch. exp. Path. 
Pharmak. 277, R89 
.. 
ZIEGLGANSBERGER, W., SOTHMAN, G. and HERZ, A. (1974) 
Neuropharmacology 13, 417-422 
